Project Name,Region,Country,Site ID,Subject ID,Latest Visit (SV) (Source: Rave EDC: BO4),Subject Status (Source: PRIMARY Form),Input files,,,,,,,,,CPMD,,,,,,,,,,,,,,,,,,,,,,SSM,,,,,
,,,,,,,Missing Visits,Missing Page,# Coded terms,# Uncoded Terms,# Open issues in LNR,# Open Issues reported for 3rd party reconciliation in EDRR,Inactivated forms and folders,# eSAE dashboard review for DM,# eSAE dashboard review for safety,Visit status,Page status (Source: (Rave EDC : BO4)),,,,,Queries status (Source:(Rave EDC : BO4)),,,,,,,,Page Action Status (Source: (Rave EDC : BO4)),,,,,,Protocol Deviations (Source:(Rave EDC : BO4)),,PI Signatures (Source: (Rave EDC : BO4)),,,,,
,,,,,,,,,,,,,,,,# Expected Visits (Rave EDC : BO4),# Pages Entered,# Pages with Non-Conformant data,# Total CRFs with queries & Non-Conformant data,# Total CRFs without queries & Non-Conformant data,% Clean Entered CRF,# DM Queries,# Clinical Queries,# Medical Queries,# Site Queries,# Field Monitor Queries,# Coding Queries,# Safety Queries,#Total Queries,# CRFs Require Verification (SDV),# Forms Verified,# CRFs Frozen,# CRFs Not Frozen,# CRFs Locked,# CRFs Unlocked,# PDs Confirmed,# PDs Proposed,# CRFs Signed,CRFs overdue for signs within 45 days of Data entry,CRFs overdue for signs between 45 to 90 days of Data entry,CRFs overdue for signs beyond 90 days of Data entry,Broken Signatures,CRFs Never Signed
Responsible LF for action,,,,,,,,,,,,,,,,,,Site/CRA,,,,DM,CSE/CDD,CDMD/Medical Lead,Site/CRA,CRA,Coder,Safety Team,,CRA,,,DM,,,CD LF,,Investigator,,,,,
Study 22,ASIA,AUS,Site 2,Subject 2,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,1,0,0,0,1,12,60,0,0,0,0,2,0,59,1,0,0,0,1
Study 22,ASIA,AUS,Site 2,Subject 3,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,ASIA,AUS,Site 2,Subject 4,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 5,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 99,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 100,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 101,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,AUS,Site 2,Subject 3400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3401,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,3,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,AUS,Site 2,Subject 3405,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3406,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3408,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,ASIA,AUS,Site 2,Subject 3410,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 2,Subject 3411,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 6,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 7,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 8,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 102,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 103,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 104,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 774,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 776,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,ASIA,AUS,Site 3,Subject 779,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 780,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 781,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 782,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 3,Subject 784,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 9,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 10,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 105,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 106,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 787,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 788,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 789,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,8,0,0,1,7
Study 22,ASIA,AUS,Site 4,Subject 790,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 791,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 792,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 795,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 800,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,0,0,0,0,0,1,32,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30080,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30083,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,76,0,,,,0,0,0,1,0,0,0,1,1,29,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30084,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,2,0,0,0,2,9,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30085,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30088,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30089,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30091,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 4,Subject 30092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 107,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,7,54,0,0,0,0,0,0,54,1,0,0,0,1
Study 22,ASIA,AUS,Site 28,Subject 108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 2233,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 2234,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 2235,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4972,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4973,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4974,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4975,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 28,Subject 4977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,ASIA,AUS,Site 28,Subject 4978,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 2236,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,8,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4990,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4991,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,80,0,,,,0,0,0,2,0,0,0,2,11,10,0,0,0,0,0,0,71,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4992,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4994,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4995,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 4998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,7,0,0,0,7
Study 22,ASIA,AUS,Site 259,Subject 4999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,1,0,0,0,0,0,1,0,8,0,0,0,0,1,0,54,10,0,0,3,7
Study 22,ASIA,AUS,Site 259,Subject 5000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,43,8,0,0,1,7
Study 22,ASIA,AUS,Site 259,Subject 5001,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5003,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5004,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5005,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5006,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5008,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5009,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5012,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5013,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5015,Unplanned visit (1),Discontinued,,,,,,,,,,2,52,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5016,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 5017,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 30093,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 30094,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 30095,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,2,0,0,0,2,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 30096,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 259,Subject 30097,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 109,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,52,7,0,0,1,6
Study 22,ASIA,AUS,Site 29,Subject 30098,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,ASIA,AUS,Site 29,Subject 30099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30100,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30101,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30102,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30104,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,ASIA,AUS,Site 29,Subject 30105,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30106,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,ASIA,AUS,Site 29,Subject 30107,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,8,0,0,2,6
Study 22,ASIA,AUS,Site 29,Subject 30108,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30111,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30112,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30113,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,8,0,0,2,6
Study 22,ASIA,AUS,Site 29,Subject 30115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30116,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30117,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 29,Subject 30118,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 110,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,0,69,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 111,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 112,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 113,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 114,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 115,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 116,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 117,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,70,0,,,,1,0,0,3,0,0,0,4,2,14,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5021,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5022,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5025,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,AUS,Site 30,Subject 5027,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 118,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,84,0,,,,0,0,0,3,0,0,0,3,17,63,0,1,0,0,2,0,73,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 119,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 120,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 2854,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 2855,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 2856,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 2857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,50,7,0,0,0,7
Study 22,ASIA,AUS,Site 31,Subject 2858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 2859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 30119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 31,Subject 30120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 3484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 3485,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,1,1,0,0,2,1,60,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 3486,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 5069,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 5070,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 5071,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 451,Subject 5072,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 2860,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 2861,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 3527,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,83,0,,,,0,0,0,1,0,0,0,1,9,14,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5143,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5145,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,2,0,0,0,2,0,21,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5149,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5150,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5153,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5157,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,AUS,Site 357,Subject 5158,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 121,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 3870,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 3871,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 3872,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 3873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30121,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30122,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30123,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30124,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30125,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30126,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30127,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,ASIA,AUS,Site 32,Subject 30128,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 32,Subject 30129,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,38,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 122,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 123,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 125,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 128,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 129,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 33,Subject 131,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 3487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 3535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5336,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5338,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5339,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,36,5,0,0,0,5
Study 22,ASIA,AUS,Site 452,Subject 5342,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5343,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5344,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5345,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5346,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5347,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5348,End of Study (EOS) (1),Discontinued,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,ASIA,AUS,Site 452,Subject 5349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5350,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5351,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5352,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5353,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5354,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,AUS,Site 452,Subject 5355,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 190,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 192,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 193,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 196,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,ASIA,IND,Site 47,Subject 197,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 198,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 199,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 200,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 201,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 202,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 203,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 204,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 205,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 206,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 207,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,3,0,0,3,0
Study 22,ASIA,IND,Site 47,Subject 30131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,3,0,58,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30132,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30134,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30135,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30136,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30137,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30138,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30139,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30140,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30146,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30147,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30148,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30149,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30152,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30154,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,3,0,0,3,0
Study 22,ASIA,IND,Site 47,Subject 30158,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30160,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30161,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30162,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,39,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30163,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30164,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30165,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30166,Unplanned visit (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30167,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30168,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30169,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30170,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30171,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30172,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30173,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30174,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30175,Unplanned visit (2),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,19,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30176,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 47,Subject 30177,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 835,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 837,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 839,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 840,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 841,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 842,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 843,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 844,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 845,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,ASIA,IND,Site 109,Subject 847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 849,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30181,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30182,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30183,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30187,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30189,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30192,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30193,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30194,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30196,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,IND,Site 109,Subject 30198,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,ASIA,IND,Site 109,Subject 30200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,2,0,0,0,2,0,17,0,0,0,0,0,0,48,6,0,0,0,6
Study 22,ASIA,IND,Site 109,Subject 30201,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,IND,Site 109,Subject 30202,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30203,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30204,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30205,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30206,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30207,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30208,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,1,0,0,1,0
Study 22,ASIA,IND,Site 109,Subject 30209,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 109,Subject 30210,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3544,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3545,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3546,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3547,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3550,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3551,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 3552,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30211,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30212,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30213,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30214,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30215,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,ASIA,IND,Site 466,Subject 30216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30217,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30218,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30225,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30227,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30231,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30232,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30235,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30236,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30237,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30238,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30239,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30240,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30241,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 466,Subject 30242,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3553,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3554,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3555,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3557,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3558,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 3559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30243,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30244,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30245,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30246,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30247,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30248,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30253,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30255,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30256,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 467,Subject 30257,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 3560,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,54,7,0,0,0,7
Study 22,ASIA,IND,Site 468,Subject 3561,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 3562,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 3563,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 3564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 4880,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30258,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30259,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30261,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30263,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30264,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30266,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30267,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30268,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30269,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30270,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30272,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,8,0,0,1,7
Study 22,ASIA,IND,Site 468,Subject 30274,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,ASIA,IND,Site 468,Subject 30275,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,45,7,0,0,1,6
Study 22,ASIA,IND,Site 468,Subject 30276,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30277,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30279,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30280,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30281,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30282,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30283,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30286,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30287,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30290,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30292,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,ASIA,IND,Site 468,Subject 30294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,IND,Site 468,Subject 30295,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30296,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30301,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30303,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,IND,Site 468,Subject 30307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,IND,Site 468,Subject 30308,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30310,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30311,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30312,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 468,Subject 30313,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1645,Subject 30314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1645,Subject 30315,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1645,Subject 30316,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 4019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30317,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30318,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30319,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30320,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30324,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30329,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30332,Screening,Discontinued,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30334,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30342,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30343,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30344,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,10,2,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 597,Subject 30345,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30346,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,2,0,0,2,2,59,0,0,0,0,1,0,58,2,0,0,2,0
Study 22,ASIA,IND,Site 1646,Subject 30347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,1,0,1,0,0,0,2,0,6,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30350,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30351,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1646,Subject 30352,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30353,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30354,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30355,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,6,54,0,0,0,0,0,0,53,2,0,0,0,2
Study 22,ASIA,IND,Site 1647,Subject 30356,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,12,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30357,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30358,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30359,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30360,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30361,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30362,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30363,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30364,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30365,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30366,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30370,Unplanned visit (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,0,14,1,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30373,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30374,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,ASIA,IND,Site 1647,Subject 30376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30377,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30380,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,4,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,IND,Site 1647,Subject 30382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30383,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30385,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30386,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30388,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30389,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30390,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30391,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,IND,Site 1647,Subject 30392,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30393,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30394,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,8,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30396,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,28,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30400,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,1,0,0,0,0,0,1,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30402,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1648,Subject 30405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30408,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30409,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30410,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30412,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30413,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30414,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30415,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30416,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30417,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1649,Subject 30418,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30419,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30420,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30421,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30422,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,19,20,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30424,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,25,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30426,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30427,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30428,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30429,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30430,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30431,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30433,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30434,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30435,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30436,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30437,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30438,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1650,Subject 30439,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1651,Subject 30440,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1651,Subject 30441,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,28,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1651,Subject 30442,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30445,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30447,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30449,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30451,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30452,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30453,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30455,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30456,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30458,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30459,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30460,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,48,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,IND,Site 1652,Subject 30461,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1653,Subject 30462,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1653,Subject 30463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1653,Subject 30464,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1653,Subject 30465,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30466,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30467,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30469,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30470,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,6,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30471,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30472,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30473,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30474,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30475,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30476,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30477,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1654,Subject 30478,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 267,Subject 2294,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 267,Subject 30479,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 267,Subject 30480,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30482,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30484,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30487,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30488,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30489,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30490,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30493,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1655,Subject 30494,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30495,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30496,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,42,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30498,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30501,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,1,0,0,0,1
Study 22,ASIA,IND,Site 1656,Subject 30502,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30503,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30504,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1656,Subject 30505,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30506,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30507,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,1,0,0,2,0,0,0,3,13,49,0,0,0,0,0,0,55,3,0,0,3,0
Study 22,ASIA,IND,Site 1657,Subject 30508,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30509,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30510,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,29,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30511,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30512,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30513,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30514,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30518,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30521,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30522,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30523,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1657,Subject 30524,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30525,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30526,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30528,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30530,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1658,Subject 30531,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30534,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30535,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30536,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30537,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30538,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30539,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30540,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30541,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30542,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30543,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30544,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30546,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30547,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30548,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30550,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30551,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30557,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30559,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30560,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30561,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30562,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30567,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30569,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30571,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30573,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30575,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30578,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30579,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30581,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30583,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30584,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30587,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30588,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30592,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30593,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1659,Subject 30594,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30595,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30596,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30597,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,21,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30599,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30600,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30603,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30604,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1660,Subject 30605,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30606,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,3,0,0,0,3,9,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30610,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30611,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,16,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30612,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30613,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30615,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30616,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,ASIA,IND,Site 1661,Subject 30617,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30618,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30619,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30620,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30622,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30631,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1661,Subject 30632,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1662,Subject 30633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,1,0,0,0,0,0,0,1,8,42,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,ASIA,IND,Site 1662,Subject 30634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,1,0,0,0,0,0,0,1,1,3,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,ASIA,IND,Site 1662,Subject 30635,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1662,Subject 30636,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1662,Subject 30637,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1662,Subject 30638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,ASIA,IND,Site 1662,Subject 30639,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30640,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30641,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30642,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30643,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30644,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30647,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30649,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30652,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1663,Subject 30653,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30654,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30656,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,47,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30658,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30659,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30661,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30662,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30663,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30664,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30665,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30666,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1664,Subject 30667,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1665,Subject 30668,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,36,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1665,Subject 30669,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3874,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3878,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 3879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30670,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30672,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,ASIA,IND,Site 554,Subject 30673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30675,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 554,Subject 30676,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30677,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,77,0,,,,0,0,0,0,0,0,0,0,0,73,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30678,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30679,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,3,0,54,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30680,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30681,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30682,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30683,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30684,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30685,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30687,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,1,0,0,0,1,1,18,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30690,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30692,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30694,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30695,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30696,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30698,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30700,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30701,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30702,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30703,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30704,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30705,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1666,Subject 30706,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30707,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30708,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30709,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30710,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30711,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30712,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30713,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30714,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30715,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30716,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30720,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30721,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30723,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30724,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30730,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,ASIA,IND,Site 1667,Subject 30735,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30736,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30737,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1667,Subject 30738,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30739,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30745,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30746,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30747,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30748,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30749,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30750,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30751,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30752,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30753,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30754,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30755,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30756,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1668,Subject 30757,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30764,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1669,Subject 30765,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30768,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,47,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30771,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30773,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30775,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30776,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30777,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30778,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30779,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30780,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,IND,Site 1670,Subject 30781,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,1,0,0,1,0
Study 22,ASIA,IND,Site 1671,Subject 30782,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,IND,Site 1671,Subject 30783,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,IND,Site 1671,Subject 30784,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,11,39,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,ASIA,IND,Site 1671,Subject 30785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,IND,Site 1671,Subject 30786,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,IND,Site 1672,Subject 30787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,7,36,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1672,Subject 30788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,IND,Site 1672,Subject 30789,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30790,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30791,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30792,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30793,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,63,0,,,,0,0,0,0,0,0,0,0,0,18,1,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30794,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30795,Visit 1 (1),Discontinued,,,,,,,,,,2,34,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,33,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30796,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30797,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30798,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,22,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30799,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,1,0,0,0,1,8,8,0,0,0,0,1,0,52,9,0,0,1,8
Study 22,ASIA,MYS,Site 1673,Subject 30800,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,62,8,0,0,1,7
Study 22,ASIA,MYS,Site 1673,Subject 30801,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,60,8,0,0,1,7
Study 22,ASIA,MYS,Site 1673,Subject 30802,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,ASIA,MYS,Site 1673,Subject 30803,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,87,0,,,,0,0,0,3,0,0,0,3,2,32,0,0,0,0,0,0,67,2,0,0,2,0
Study 22,ASIA,MYS,Site 1673,Subject 30810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30811,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30812,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30816,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30817,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30818,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30819,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30820,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30821,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30822,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,14,1,0,0,1,0
Study 22,ASIA,MYS,Site 1673,Subject 30823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30826,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30827,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30828,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30832,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30833,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30834,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30835,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30837,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30839,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30840,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,ASIA,MYS,Site 1673,Subject 30843,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30844,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,ASIA,MYS,Site 1673,Subject 30845,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30846,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,MYS,Site 1673,Subject 30848,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30849,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30850,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30851,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30852,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30853,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,MYS,Site 1673,Subject 30854,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 3565,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,59,0,0,0,0,0,0,52,8,0,0,1,7
Study 22,ASIA,MYS,Site 469,Subject 4744,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 4745,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 4746,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 4747,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,ASIA,MYS,Site 469,Subject 4748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 4749,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 469,Subject 4750,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30855,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30856,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,101,0,,,,0,0,0,0,0,0,0,0,7,88,0,0,0,0,0,0,83,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30857,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,1,0,0,0,1,1,42,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30858,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,84,0,,,,0,0,0,2,0,0,0,2,1,23,0,1,0,0,0,0,74,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30859,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30860,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30861,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30862,Unplanned visit (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,5,12,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30863,Unplanned visit (1),On Trial,,,,,,,,,,6,79,0,,,,0,0,0,0,0,0,0,0,3,23,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30864,Unplanned visit (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1674,Subject 30867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,48,6,0,0,6,0
Study 22,ASIA,MYS,Site 1674,Subject 30868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,ASIA,MYS,Site 1675,Subject 30869,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30871,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30872,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30873,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30874,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30877,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,0,15,0,1,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30878,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,1,0,63,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1675,Subject 30881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30884,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30886,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1676,Subject 30889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,ASIA,MYS,Site 1677,Subject 30890,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30891,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,2,0,0,0,2,0,28,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30895,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30896,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30898,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30899,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30900,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,0,21,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30902,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,MYS,Site 1677,Subject 30903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,8,0,0,1,7
Study 22,ASIA,MYS,Site 1677,Subject 30904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,0,22,0,0,0,0,1,0,45,7,0,0,0,7
Study 22,ASIA,MYS,Site 1677,Subject 30905,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30906,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,1,62,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30908,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30909,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30910,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,MYS,Site 1678,Subject 30911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30912,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30913,Unplanned visit (2),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,2,0,0,0,2,32,50,0,0,0,0,0,0,68,2,0,0,2,0
Study 22,ASIA,MYS,Site 1679,Subject 30914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,2,12,0,1,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30918,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,ASIA,MYS,Site 1679,Subject 30919,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30920,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30922,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,4,9,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30925,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30926,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30927,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30928,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30929,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30930,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,MYS,Site 1679,Subject 30931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,ASIA,MYS,Site 1680,Subject 30932,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,4,42,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30933,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,7,51,0,0,0,0,0,0,48,1,2,0,1,2
Study 22,ASIA,MYS,Site 1681,Subject 30934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,40,0,12,0,5,7
Study 22,ASIA,MYS,Site 1681,Subject 30936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,35,12,0,0,2,10
Study 22,ASIA,MYS,Site 1681,Subject 30937,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30938,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30939,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30940,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1681,Subject 30941,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,MYS,Site 1682,Subject 30942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,ASIA,MYS,Site 1682,Subject 30943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1682,Subject 30944,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,MYS,Site 1682,Subject 30945,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30946,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,13,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30948,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,0,0,0,0,0,1,20,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30956,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30957,Visit 1 (1),Discontinued,,,,,,,,,,2,46,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30958,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30959,Visit 1 (1),On Trial,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,30,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,2,21,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30966,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30968,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,2,0,0,0,2,14,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30969,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30970,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30971,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30972,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30973,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30974,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30975,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,8,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30976,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30977,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30978,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30979,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30980,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,MYS,Site 1683,Subject 30981,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,48,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,MYS,Site 1684,Subject 30982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,MYS,Site 1684,Subject 30983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,MYS,Site 1684,Subject 30984,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,2,0,0,0,2,1,19,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,PHL,Site 57,Subject 351,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,14,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 352,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 353,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 354,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30987,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30989,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30991,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30992,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30993,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30994,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30995,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 57,Subject 30996,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 355,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,17,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,1,0,0,0,1,26,42,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 357,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,14,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 30997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 30998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 30999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31000,Unplanned visit (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,2,0,0,0,2,10,53,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31001,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31003,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31005,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31006,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31007,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31008,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31009,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31012,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31015,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31017,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31018,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31020,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31021,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31022,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31023,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31024,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31025,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31026,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 58,Subject 31027,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 3888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,5,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 3889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31028,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,3,0,0,0,3,3,12,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,ASIA,PHL,Site 557,Subject 31030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,ASIA,PHL,Site 557,Subject 31032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31033,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31035,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31040,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31042,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31043,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31044,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31046,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31047,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31048,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31049,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31050,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31051,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31052,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31053,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31054,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31055,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,PHL,Site 557,Subject 31056,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 1685,Subject 31057,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,3,36,0,0,0,0,0,0,0,0,0,38,0,38
Study 22,ASIA,PHL,Site 1685,Subject 31058,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,PHL,Site 1685,Subject 31059,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,PHL,Site 1685,Subject 31060,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,0,0,0,39,0,39
Study 22,ASIA,PHL,Site 1685,Subject 31061,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,PHL,Site 1685,Subject 31062,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,0,0,0,39,0,39
Study 22,ASIA,PHL,Site 1686,Subject 31063,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,36,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,PHL,Site 1686,Subject 31064,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 1686,Subject 31065,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,34,0,0,2,2,0
Study 22,ASIA,PHL,Site 1686,Subject 31066,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,PHL,Site 1686,Subject 31067,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 1686,Subject 31068,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,PHL,Site 1686,Subject 31069,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 358,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,82,0,,,,0,0,0,1,0,0,0,1,13,63,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 359,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 360,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,1,0,0,0,1,1,20,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6060,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6061,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6062,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6063,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6064,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6065,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6066,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6067,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6069,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6070,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6074,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6075,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6076,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 6077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 31070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 31071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 31072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,SGP,Site 59,Subject 31073,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,4,11,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,SGP,Site 5,Subject 11,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,SGP,Site 5,Subject 3566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,SGP,Site 6,Subject 12,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,1,0,50,1,0,0,1,0
Study 22,ASIA,SGP,Site 6,Subject 13,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,SGP,Site 6,Subject 31074,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,1,15,0,0,0,0,2,0,57,2,0,0,2,0
Study 22,ASIA,SGP,Site 6,Subject 31075,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,SGP,Site 6,Subject 31076,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,SGP,Site 6,Subject 31077,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,SGP,Site 6,Subject 31078,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,1,3,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,ASIA,SGP,Site 470,Subject 3570,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,7,43,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,SGP,Site 470,Subject 3571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,5,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,SGP,Site 470,Subject 31079,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,SGP,Site 470,Subject 31080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,ZAF,Site 61,Subject 370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 373,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 375,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 376,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 377,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 378,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 379,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31081,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31082,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31083,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31084,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31085,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31089,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31091,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31093,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31096,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31100,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31101,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31102,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,ZAF,Site 61,Subject 31103,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,7,48,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 382,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 383,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 384,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,8,6,0,0,0,0,0,0,48,2,0,0,2,0
Study 22,EMEA,ZAF,Site 62,Subject 387,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,2,0,0,0,2,8,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6101,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,ZAF,Site 62,Subject 6104,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6105,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6106,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6107,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 62,Subject 6108,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 391,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 392,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 393,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,7,31,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,EMEA,ZAF,Site 63,Subject 394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ZAF,Site 63,Subject 396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ZAF,Site 63,Subject 397,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 398,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 400,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 401,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 403,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 406,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 407,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6133,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6134,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6135,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6136,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6138,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6139,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6140,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,ZAF,Site 63,Subject 6141,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,7,0,0,0,7
Study 22,EMEA,ZAF,Site 63,Subject 6143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6144,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,10,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,ZAF,Site 63,Subject 6146,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6147,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6148,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 6149,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ZAF,Site 63,Subject 31104,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 414,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 415,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 417,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 419,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 420,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 421,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 422,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 424,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 435,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ZAF,Site 64,Subject 436,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 442,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,7,47,1,40,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 443,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,1,38,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 445,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 446,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,7,2,42,0,0,0,0,49,7,0,0,0,7
Study 22,EMEA,ZAF,Site 65,Subject 448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,3,37,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,ZAF,Site 65,Subject 449,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,1,40,0,0,0,0,47,7,0,0,0,7
Study 22,EMEA,ZAF,Site 65,Subject 451,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,6,2,45,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 453,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,2,48,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 455,Unplanned visit (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,2,15,3,39,0,0,0,0,53,1,0,0,1,0
Study 22,EMEA,ZAF,Site 65,Subject 456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,1,39,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 457,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 458,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,1,40,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 459,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 460,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 461,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 462,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 463,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 464,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,1,31,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,1,33,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,ZAF,Site 65,Subject 467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,6,1,36,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,ZAF,Site 65,Subject 468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,0,25,1,57,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,2,34,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 470,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 471,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,1,31,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,ZAF,Site 65,Subject 473,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 474,Screening,Screen Failure,,,,,,,,,,1,29,0,,,,0,0,0,0,0,0,0,0,0,11,24,1,0,0,0,0,22,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,1,38,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 476,Unplanned visit (1),On Trial,,,,,,,,,,5,79,0,,,,0,0,0,2,0,0,0,2,8,25,1,31,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,2,33,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,6,1,31,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,ZAF,Site 65,Subject 31107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,1,31,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,1,31,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31109,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,5,2,37,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31111,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31112,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,1,31,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 65,Subject 31113,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,14,1,31,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 477,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 480,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,3,12,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,EMEA,ZAF,Site 67,Subject 481,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 484,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 485,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 488,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 31114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 31115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 67,Subject 31116,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,1,0,0,0,0,0,0,1,2,0,0,0,0,0,0,0,0,13,0,0,0,13
Study 22,EMEA,ZAF,Site 68,Subject 490,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 491,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,7,21,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 492,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 493,Unplanned visit (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,3,0,0,0,3
Study 22,EMEA,ZAF,Site 68,Subject 494,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31117,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31118,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31119,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31120,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31121,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31122,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31124,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31125,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31127,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31128,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31129,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31130,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31131,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31132,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31133,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31134,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31135,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31137,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31138,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31141,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31142,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31144,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31147,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31149,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31150,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,0,0,45,3,0,0,0,3
Study 22,EMEA,ZAF,Site 68,Subject 31151,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,48,3,0,0,1,2
Study 22,EMEA,ZAF,Site 68,Subject 31152,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31153,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31157,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 68,Subject 31158,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 504,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 505,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 506,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 509,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 510,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 70,Subject 511,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 516,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 518,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 519,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 521,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 522,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 523,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 525,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 526,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 527,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31161,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31162,Unplanned visit (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31164,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31165,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 71,Subject 31166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 545,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 548,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,51,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 549,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 550,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 551,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 553,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,EMEA,ZAF,Site 73,Subject 556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 557,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31167,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,2,0,0,0,2,1,18,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31169,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31174,Visit 1 (1),Discontinued,,,,,,,,,,2,19,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31175,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31176,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,3,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31179,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31180,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 73,Subject 31181,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 558,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,37,0,0,0,0,0,0,44,2,0,0,1,1
Study 22,EMEA,ZAF,Site 74,Subject 559,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 560,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 561,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 562,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 563,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 564,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 565,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,36,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 566,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31182,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31183,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31184,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31186,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31188,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31189,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31190,Unplanned visit (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,ZAF,Site 74,Subject 31191,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31192,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31193,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31194,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31195,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31196,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31198,Unplanned visit (2),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31199,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31200,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31201,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31202,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31203,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31207,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31208,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31209,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31210,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31211,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31212,Unplanned visit (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,7,0,0,0,7
Study 22,EMEA,ZAF,Site 74,Subject 31214,Unplanned visit (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31215,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31216,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31217,Unplanned visit (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31218,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ZAF,Site 74,Subject 31219,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,TWN,Site 7,Subject 14,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,51,0,0,0,0,0,0,50,0,2,0,2,0
Study 22,ASIA,TWN,Site 7,Subject 594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,1,0,1,0,0,0,2,4,9,0,0,0,0,1,0,54,0,3,0,2,1
Study 22,ASIA,TWN,Site 7,Subject 595,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,0,0,0,0,0,3,20,0,0,0,0,0,0,59,0,1,0,1,0
Study 22,ASIA,TWN,Site 7,Subject 596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,1,0,1,0
Study 22,ASIA,TWN,Site 7,Subject 597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,3,10,0,0,0,0,2,0,56,0,8,0,1,7
Study 22,ASIA,TWN,Site 7,Subject 6176,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 7,Subject 6177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 7,Subject 6178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 7,Subject 6179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 7,Subject 6180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,1,0,0,1
Study 22,ASIA,TWN,Site 7,Subject 6181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,ASIA,TWN,Site 7,Subject 6182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,12,9,0,0,0,0,0,0,47,2,3,0,5,0
Study 22,ASIA,TWN,Site 7,Subject 6183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,ASIA,TWN,Site 7,Subject 6184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,ASIA,TWN,Site 8,Subject 15,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,6,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 598,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 3506,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,36,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 3572,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 3573,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6225,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,1,11,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6227,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6228,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 6231,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31225,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31226,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31227,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31228,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31229,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31230,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31231,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,TWN,Site 8,Subject 31232,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 4752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,9,43,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,ASIA,TWN,Site 775,Subject 6232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 6233,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,ASIA,TWN,Site 775,Subject 6234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,TWN,Site 775,Subject 6235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,ASIA,TWN,Site 775,Subject 6236,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 6237,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31233,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,TWN,Site 775,Subject 31235,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31236,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31237,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,ASIA,TWN,Site 775,Subject 31239,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31240,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31241,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31242,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31243,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31244,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31245,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31247,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,ASIA,TWN,Site 775,Subject 31251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,9,5,0,0,0,0,0,0,42,3,0,0,0,3
Study 22,ASIA,TWN,Site 775,Subject 31252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31253,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,ASIA,TWN,Site 775,Subject 31255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31256,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31257,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 775,Subject 31258,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 3507,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 3508,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,1,0,0,0,1,1,66,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 3574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 3575,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 3576,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,56,7,0,0,0,7
Study 22,ASIA,TWN,Site 459,Subject 3577,Unplanned visit (2),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 31259,Unplanned visit (3),On Trial,,,,,,,,,,4,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,TWN,Site 459,Subject 31260,Unplanned visit (3),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 3578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,40,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 3579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31262,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31263,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31264,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,ASIA,TWN,Site 471,Subject 31267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,ASIA,TWN,Site 471,Subject 31268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31269,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,5,0,0,5,0
Study 22,ASIA,TWN,Site 471,Subject 31271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,ASIA,TWN,Site 471,Subject 31272,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,35,8,0,0,1,7
Study 22,ASIA,TWN,Site 471,Subject 31274,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31275,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,33,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31276,Unplanned visit (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31277,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 471,Subject 31278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,36,7,0,0,0,7
Study 22,ASIA,TWN,Site 472,Subject 3580,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,7,55,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,2,0,0,0,2,4,29,0,0,0,0,1,0,65,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3582,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3583,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 3587,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 31279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 31280,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,ASIA,TWN,Site 472,Subject 31281,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 3588,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 3589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 3590,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 3591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31284,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,1,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31285,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31286,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31289,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31290,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31296,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31297,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31298,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,TWN,Site 473,Subject 31299,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,46,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3593,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3594,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3595,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 3599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31300,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,ASIA,TWN,Site 474,Subject 31303,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,1,,,,0,0,0,3,0,0,0,3,1,26,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 474,Subject 31307,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 3509,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,2,0,0,0,2,0,56,0,0,0,0,1,0,54,1,0,0,1,0
Study 22,ASIA,TWN,Site 460,Subject 3510,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 3511,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,2,0,0,2,0
Study 22,ASIA,TWN,Site 460,Subject 31308,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31309,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31310,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,1,0,0,1,0
Study 22,ASIA,TWN,Site 460,Subject 31311,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31312,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,1,0,0,2,0,0,0,3,5,8,0,0,0,0,0,0,51,7,0,0,1,6
Study 22,ASIA,TWN,Site 460,Subject 31313,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31314,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31315,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31316,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,0,4,0,0,0,0,0,0,43,8,0,0,2,6
Study 22,ASIA,TWN,Site 460,Subject 31317,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31318,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,TWN,Site 460,Subject 31319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31322,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31326,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,ASIA,TWN,Site 460,Subject 31327,Unplanned visit (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31328,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31329,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,3,0,0,1,0,0,0,4,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,ASIA,TWN,Site 460,Subject 31334,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,ASIA,TWN,Site 460,Subject 31337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,ASIA,TWN,Site 460,Subject 31338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,2,12,0,0,0,0,1,0,46,8,0,0,1,7
Study 22,ASIA,TWN,Site 460,Subject 31339,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31341,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31342,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31343,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31344,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31345,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31346,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,TWN,Site 460,Subject 31347,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 16,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 3512,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,2,0,0,0,2,2,14,0,0,0,0,1,0,54,1,0,0,1,0
Study 22,ASIA,THA,Site 9,Subject 3513,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31351,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,ASIA,THA,Site 9,Subject 31354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,ASIA,THA,Site 9,Subject 31355,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31356,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31357,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,2,0,0,0,2,0,25,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31364,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31365,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 9,Subject 31366,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 3600,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,2,59,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 3601,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 3602,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31367,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31371,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,1,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31373,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31374,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31377,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31378,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 475,Subject 31383,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 3603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 3604,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31384,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,1,1,0
Study 22,ASIA,THA,Site 476,Subject 31385,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31386,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31387,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,50,6,0,0,0,6
Study 22,ASIA,THA,Site 476,Subject 31388,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,ASIA,THA,Site 476,Subject 31389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31391,Unplanned visit (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,3,0,0,0,3,1,14,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31393,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31394,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,81,0,,,,0,0,0,2,0,0,0,2,1,24,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31395,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31396,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31397,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31401,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,ASIA,THA,Site 476,Subject 31402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31405,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 476,Subject 31406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,ASIA,THA,Site 476,Subject 31407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,41,6,0,0,0,6
Study 22,ASIA,THA,Site 476,Subject 31408,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 3514,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 3515,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31409,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31410,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31412,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31413,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31414,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31415,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,ASIA,THA,Site 461,Subject 31417,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,ASIA,THA,Site 461,Subject 31419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31420,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31421,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,3,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 461,Subject 31427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 477,Subject 3605,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,15,17,0,17,0,0,0,15,0,0,0,0,0
Study 22,ASIA,THA,Site 478,Subject 3611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,49,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 3612,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,THA,Site 478,Subject 3613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 31428,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,49,3,0,0,1,2
Study 22,ASIA,THA,Site 478,Subject 31429,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,49,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 31430,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 31431,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,50,1,0,0,0,1
Study 22,ASIA,THA,Site 478,Subject 31432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,49,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 31433,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,ASIA,THA,Site 478,Subject 31434,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,2,0,0,1,1
Study 22,ASIA,THA,Site 478,Subject 31435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,1,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,ASIA,THA,Site 478,Subject 31436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,THA,Site 478,Subject 31437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,ASIA,THA,Site 478,Subject 31438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,ASIA,THA,Site 478,Subject 31439,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,ASIA,THA,Site 478,Subject 31440,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,4,0,0,0,4
Study 22,ASIA,THA,Site 478,Subject 31441,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 478,Subject 31442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 478,Subject 31443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 478,Subject 31444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,ASIA,THA,Site 478,Subject 31445,Unplanned visit (1),On Trial,,,,,,,,,,5,80,0,,,,0,0,0,1,0,0,0,1,4,29,0,0,0,0,2,0,59,2,0,0,2,0
Study 22,ASIA,THA,Site 478,Subject 31446,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 3516,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 3517,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,7,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,ASIA,THA,Site 462,Subject 31451,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31453,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31456,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31458,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31461,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31464,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31465,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 462,Subject 31466,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31467,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31469,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31472,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,THA,Site 1687,Subject 31477,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31478,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31480,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31482,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31484,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31485,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31486,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31488,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31489,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31491,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,78,0,,,,0,0,0,0,0,0,0,0,0,27,0,1,0,0,1,0,62,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31494,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,ASIA,THA,Site 1688,Subject 31495,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 4881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 4882,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 4883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 31496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,16,0,1,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 31497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,8,13,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 31498,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 31499,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 4753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,42,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 4754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 4755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,15,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31502,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31503,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31506,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31509,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31511,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31512,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31513,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 776,Subject 31514,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 3614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 3615,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 3616,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 3617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 31515,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,TUR,Site 479,Subject 31516,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3618,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3619,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3620,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3622,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3623,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3624,Visit 1 (1),Discontinued,,,,,,,,,,2,25,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,23,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 3625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31517,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31518,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31519,Unplanned visit (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31523,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31524,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31525,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31528,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 480,Subject 31529,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 481,Subject 3626,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,TUR,Site 481,Subject 31530,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 481,Subject 31531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,47,6,0,0,0,6
Study 22,EMEA,TUR,Site 481,Subject 31532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,3,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,TUR,Site 481,Subject 31533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,42,1,0,0,1,0
Study 22,EMEA,TUR,Site 481,Subject 31534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 481,Subject 31535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,TUR,Site 482,Subject 3627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 482,Subject 3628,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,TUR,Site 482,Subject 3629,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,TUR,Site 482,Subject 3630,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3632,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3634,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3635,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3636,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,5,14,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 3637,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 31536,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 483,Subject 31537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,1,0,0,0,0,0,1,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 3638,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 3639,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 31538,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 31539,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 31540,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,0,58,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 484,Subject 31541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,TUR,Site 484,Subject 31542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,TUR,Site 484,Subject 31543,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31544,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,7,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31545,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,54,0,0,0,0,0,1,54,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31546,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31547,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,1,61,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31550,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31551,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31552,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31555,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,72,0,,,,0,0,0,3,0,0,0,3,1,21,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 1689,Subject 31558,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 485,Subject 3640,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 485,Subject 3641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,46,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,TUR,Site 485,Subject 3642,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 777,Subject 3646,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,30,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 3648,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,1,0,0,0,1,8,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 3649,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 3650,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,1,0,0,0,0,0,1,0,6,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 3651,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 3652,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31559,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31560,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31563,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31565,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31568,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31571,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,TUR,Site 487,Subject 31574,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31575,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,3,0,62,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31576,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31578,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31579,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31580,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31581,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 1690,Subject 31582,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 3653,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 3654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,7,43,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 3655,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 3656,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 31583,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 31584,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,TUR,Site 488,Subject 31585,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 3657,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,7,10,1,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 3658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 3659,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 3660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 3661,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31587,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31591,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31593,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 489,Subject 31594,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,48,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,TUR,Site 490,Subject 3662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,TUR,Site 490,Subject 3663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,9,35,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,TUR,Site 490,Subject 31595,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,TUR,Site 490,Subject 31596,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,TUR,Site 490,Subject 31597,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,2,0,36,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31598,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31599,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31600,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,12,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31601,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31602,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,0,0,43,3,0,0,3,0
Study 22,ASIA,VNM,Site 1691,Subject 31604,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31605,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31606,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1691,Subject 31607,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31608,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,7,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31609,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31610,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31611,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,3,44,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31613,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31614,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31616,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31618,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31621,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,40,7,0,0,0,7
Study 22,ASIA,VNM,Site 1692,Subject 31625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,7,0,0,0,7
Study 22,ASIA,VNM,Site 1692,Subject 31626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31627,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31629,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31631,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31632,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31633,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31634,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31635,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31636,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31637,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31638,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31639,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31640,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31641,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31642,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31643,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31644,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31645,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31646,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31647,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31648,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31649,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31650,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31651,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31652,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31653,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31654,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31655,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31656,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31657,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31658,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31659,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31660,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31661,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31662,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31663,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31664,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1692,Subject 31665,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,70,0,,,,0,0,0,3,0,0,0,3,21,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31668,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,73,0,,,,0,0,0,2,0,0,0,2,6,26,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31670,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,ASIA,VNM,Site 1693,Subject 31672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31673,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31676,Visit 1 (1),Discontinued,,,,,,,,,,2,33,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31677,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31679,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31683,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31684,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31685,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31688,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31689,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31690,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,4,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31694,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31696,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,7,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31701,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31702,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31703,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31704,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31706,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31708,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,70,1,,,,0,0,0,6,0,0,0,6,6,25,0,0,0,0,0,1,54,2,0,0,2,0
Study 22,ASIA,VNM,Site 1693,Subject 31709,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31710,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31713,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31714,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31716,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31717,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31720,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31722,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,20,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31727,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,2,26,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31730,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31734,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31738,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31739,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31748,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31754,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,VNM,Site 1693,Subject 31758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 17,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 18,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 19,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 853,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 855,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 10,Subject 856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,9,5,0,0,0,0,0,0,45,2,0,0,2,0
Study 22,EMEA,AUT,Site 87,Subject 627,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,9,42,0,0,0,0,0,0,43,2,0,0,1,1
Study 22,EMEA,AUT,Site 87,Subject 628,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,AUT,Site 87,Subject 629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 87,Subject 630,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 87,Subject 631,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 87,Subject 863,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 87,Subject 864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,1,0,44,1,1,0,2,0
Study 22,EMEA,AUT,Site 87,Subject 865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,1,1,0,1,1
Study 22,EMEA,AUT,Site 359,Subject 2870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,7,56,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 2871,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 2872,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 2873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31759,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31761,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31762,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31763,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,64,0,,,,0,0,0,2,0,0,0,2,0,25,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31768,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31769,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31773,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,2,0,0,0,2,1,19,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31775,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31778,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31779,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,AUT,Site 359,Subject 31780,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,15,51,0,0,0,0,3,0,61,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31784,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,2,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31787,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31788,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,EMEA,AUT,Site 1694,Subject 31789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31793,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31796,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31797,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,AUT,Site 1694,Subject 31798,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,BEL,Site 113,Subject 911,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BEL,Site 417,Subject 3227,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,7,50,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,BEL,Site 417,Subject 3228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 417,Subject 3229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BEL,Site 417,Subject 3230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BEL,Site 417,Subject 31799,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BEL,Site 502,Subject 3704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,9,37,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 502,Subject 3705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 502,Subject 6293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3706,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,EMEA,BEL,Site 503,Subject 3707,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,BEL,Site 503,Subject 3708,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3709,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3711,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 3713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,83,0,,,,0,0,0,0,0,0,0,0,0,27,0,1,0,0,0,0,68,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,2,0,0,0,2,10,14,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,2,0,0,0,2,2,28,0,0,0,0,0,0,56,1,0,0,1,0
Study 22,EMEA,BEL,Site 503,Subject 6309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6314,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,BEL,Site 503,Subject 6315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,EMEA,BEL,Site 503,Subject 6316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,9,0,0,2,7
Study 22,EMEA,BEL,Site 504,Subject 3714,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 3715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6341,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6343,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6344,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6345,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6347,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6348,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6351,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6352,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 504,Subject 6353,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,5,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,12,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 3721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BEL,Site 505,Subject 31800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 1067,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 1068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 1069,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 1070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 1071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 6558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,BGR,Site 124,Subject 6559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,BGR,Site 124,Subject 6560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,BGR,Site 124,Subject 31801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,BGR,Site 124,Subject 31802,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31803,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31804,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31805,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,1,0,1,0
Study 22,EMEA,BGR,Site 124,Subject 31806,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31807,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31808,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31809,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 124,Subject 31810,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1072,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,15,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1073,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,8,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1075,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 1077,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1081,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1084,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1085,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1086,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1087,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 1088,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1089,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 1090,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 6561,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 6562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 6563,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31811,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31812,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31816,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,6,6,0,0,0,0,0,0,44,5,0,0,5,0
Study 22,EMEA,BGR,Site 125,Subject 31818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31819,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 31821,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,3,0,0,3,0
Study 22,EMEA,BGR,Site 125,Subject 31822,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 31824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31826,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 31827,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31828,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31830,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31832,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,BGR,Site 125,Subject 31834,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,EMEA,BGR,Site 125,Subject 31835,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,BGR,Site 125,Subject 31837,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,BGR,Site 125,Subject 31838,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,2,0,0,3,6,9,0,0,0,0,0,0,37,5,0,0,5,0
Study 22,EMEA,BGR,Site 125,Subject 31839,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 31840,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31841,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31842,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31843,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31844,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,1,0,0,1,0
Study 22,EMEA,BGR,Site 125,Subject 31845,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31846,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31847,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 125,Subject 31848,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1091,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1092,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,3,57,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1093,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1094,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1095,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1096,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1097,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1098,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1099,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1100,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1101,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1102,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1104,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1105,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1106,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1107,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1108,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1109,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1110,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1111,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1113,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1114,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1115,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 1116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31849,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31850,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31851,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,87,0,,,,0,0,0,9,0,0,0,9,6,30,0,1,0,0,0,0,63,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31855,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31856,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31858,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31860,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31861,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31862,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31863,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31865,Visit 1 (1),Discontinued,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31866,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31867,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31868,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31869,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31871,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31872,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31874,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 126,Subject 31875,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,1,0,0,0,1,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 127,Subject 1117,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 127,Subject 1118,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 127,Subject 1119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 127,Subject 1120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 127,Subject 6564,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31878,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31879,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31880,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31881,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31884,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31885,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31886,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31887,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31888,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31889,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31890,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31893,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31895,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31896,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31898,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31899,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31900,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31902,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31908,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31909,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31910,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31914,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31916,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31917,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1695,Subject 31918,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6566,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6568,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6569,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6570,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6571,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6572,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6573,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 6574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31920,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31923,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31924,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31925,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31926,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31927,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31928,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31929,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31930,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31931,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31932,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31933,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31934,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31935,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31936,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,1,0,0,0,1,2,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31937,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31938,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31939,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31943,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,5,0,0,0,5
Study 22,EMEA,BGR,Site 803,Subject 31954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,EMEA,BGR,Site 803,Subject 31955,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31956,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31957,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31958,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31959,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,BGR,Site 803,Subject 31961,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31963,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31964,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31965,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31966,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31967,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31968,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31969,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31970,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31971,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 803,Subject 31972,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 1124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,6,44,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6575,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,2,0,0,0,0,0,0,2,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6580,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6581,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6582,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6583,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6584,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6585,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 129,Subject 6586,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6588,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6590,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6593,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 6596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 31973,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 31974,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 31975,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 804,Subject 31976,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,65,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31978,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31980,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31982,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,1,0,0,0,0,0,1,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31983,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,2,0,0,0,2,16,4,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31988,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31990,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31991,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31992,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31993,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31994,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31995,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31996,Unplanned visit (1),On Trial,,,,,,,,,,4,67,0,,,,0,0,0,2,0,0,8,10,20,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31997,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31998,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 31999,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,4,2,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,BGR,Site 1696,Subject 32000,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32001,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32002,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32003,Unplanned visit (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32004,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32007,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32008,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32009,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32011,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32013,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32018,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32019,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32020,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32021,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32022,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32023,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1697,Subject 32024,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32025,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,10,53,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32026,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32027,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32028,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32029,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32035,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32037,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32038,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32039,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1698,Subject 32040,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32041,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32042,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32043,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32044,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,54,0,,,,0,0,0,0,0,0,0,0,0,16,1,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32045,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32046,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,BGR,Site 1699,Subject 32048,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,84,0,,,,0,0,0,3,0,0,0,3,6,29,0,0,0,0,0,0,56,8,0,0,3,5
Study 22,EMEA,BGR,Site 1699,Subject 32049,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,1,0,0,0,1,2,6,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,BGR,Site 1699,Subject 32050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32051,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,BGR,Site 1699,Subject 32052,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32053,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32054,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,2,0,0,0,2,2,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,BGR,Site 1699,Subject 32055,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32056,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,1,0,0,0,1,3,6,0,0,0,0,0,0,43,5,0,0,0,5
Study 22,EMEA,BGR,Site 1699,Subject 32057,Visit 1 (1),Discontinued,,,,,,,,,,2,31,0,,,,0,0,0,3,0,0,0,3,0,4,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32058,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,77,0,,,,0,0,0,5,0,0,0,5,21,6,0,0,0,0,2,0,43,15,0,0,7,8
Study 22,EMEA,BGR,Site 1699,Subject 32059,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,43,5,0,0,0,5
Study 22,EMEA,BGR,Site 1699,Subject 32060,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,0,43,5,0,0,0,5
Study 22,EMEA,BGR,Site 1699,Subject 32061,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,58,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1699,Subject 32062,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,1,0,0,0,1
Study 22,EMEA,BGR,Site 1699,Subject 32063,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,2,0,0,0,2,0,6,0,0,0,0,0,0,36,0,2,0,0,2
Study 22,EMEA,BGR,Site 1700,Subject 32064,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32065,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32066,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32067,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32069,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32070,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32071,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32072,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32073,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32078,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32079,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32082,Unplanned visit (3),On Trial,,,,,,,,,,5,75,0,,,,0,0,1,2,0,0,0,3,11,13,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32083,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32084,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,2,0,42,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32085,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32088,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,2,0,0,0,2,0,21,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1700,Subject 32089,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32090,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32091,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32092,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32093,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32094,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32095,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32096,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32097,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32098,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32099,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32100,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32101,End of Study (EOS) (1),Discontinued,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32103,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32104,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32107,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32111,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32112,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32113,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32115,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32116,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32117,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32118,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32119,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1701,Subject 32120,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32121,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32122,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32124,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32125,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32127,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32128,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,BGR,Site 1702,Subject 32129,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32130,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32131,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32134,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32136,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,35,2,0,0,2,0
Study 22,EMEA,BGR,Site 1702,Subject 32137,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,1,0,0,1,0
Study 22,EMEA,BGR,Site 1702,Subject 32138,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1702,Subject 32140,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,1,0,0,1,0
Study 22,EMEA,BGR,Site 1702,Subject 32141,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32142,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32144,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,BGR,Site 1703,Subject 32146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32148,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,81,0,,,,0,0,0,0,0,0,0,0,2,26,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,2,7,0,0,0,0,0,0,45,5,0,0,2,3
Study 22,EMEA,BGR,Site 1703,Subject 32151,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,4,0,0,0,4,0,19,0,0,0,0,0,0,60,1,0,0,1,0
Study 22,EMEA,BGR,Site 1703,Subject 32153,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32154,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,41,9,0,0,2,7
Study 22,EMEA,BGR,Site 1703,Subject 32155,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32156,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,BGR,Site 1703,Subject 32157,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,1,17,0,0,0,0,0,0,53,5,0,0,0,5
Study 22,EMEA,BGR,Site 1703,Subject 32158,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32159,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,EMEA,BGR,Site 1703,Subject 32160,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,BGR,Site 1703,Subject 32161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32164,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32167,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32169,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,5,0,0,0,5
Study 22,EMEA,BGR,Site 1703,Subject 32172,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32173,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32174,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32175,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 1703,Subject 32176,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,BGR,Site 1703,Subject 32177,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,1,0,0,1,0
Study 22,EMEA,BGR,Site 1703,Subject 32178,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1704,Subject 32179,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,5,0,0,0,5,13,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,BGR,Site 1704,Subject 32180,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,BGR,Site 1704,Subject 32181,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1704,Subject 32182,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1704,Subject 32183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32184,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32185,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32186,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32187,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32188,Unplanned visit (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,2,0,0,0,2,4,9,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32190,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32192,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,19,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32194,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32195,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 1705,Subject 32196,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,1,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32197,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,36,0,,,,0,0,0,0,0,0,0,0,1,34,0,0,0,0,1,0,34,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32199,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32200,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32203,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32204,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,3,0,0,0,3,3,12,0,0,0,0,0,0,40,9,0,0,3,6
Study 22,EMEA,BGR,Site 1706,Subject 32205,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32206,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,BGR,Site 1706,Subject 32208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,BGR,Site 1706,Subject 32209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,BGR,Site 1706,Subject 32210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,BGR,Site 1706,Subject 32211,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,BGR,Site 1706,Subject 32213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,BGR,Site 1706,Subject 32214,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32215,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 1706,Subject 32216,Visit 1 (1),On Trial,,,,,,,,,,2,29,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,2,0,27,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 3932,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 3933,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 3934,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32218,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32219,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,3,10,0,0,0,0,0,0,36,24,0,0,0,24
Study 22,EMEA,BGR,Site 568,Subject 32220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32221,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32222,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32223,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,BGR,Site 568,Subject 32224,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32225,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32226,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32227,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,BGR,Site 1707,Subject 32230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 20,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 21,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1126,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1128,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1129,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,CZE,Site 11,Subject 1131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,CZE,Site 11,Subject 1132,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,2,15,0,0,0,0,0,0,51,6,0,0,0,6
Study 22,EMEA,CZE,Site 11,Subject 1133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,6,0,0,0,6
Study 22,EMEA,CZE,Site 11,Subject 1134,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1135,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 1136,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6615,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6616,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6618,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 11,Subject 6621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 1145,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 1146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,10,44,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 1147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,34,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6649,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,7,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6652,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6653,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 131,Subject 6655,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 3730,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6663,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6665,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6666,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6667,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6668,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 6669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 32231,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 32232,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 509,Subject 32233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,9,43,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1149,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1151,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1152,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 1154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6671,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 6675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 132,Subject 32234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 510,Subject 3731,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 510,Subject 3732,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,3,45,0,0,0,0,1,0,45,1,0,0,1,0
Study 22,EMEA,CZE,Site 511,Subject 3733,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,45,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 3734,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 6714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 6715,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 6716,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 6717,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 6718,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32237,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32238,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32239,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32244,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32246,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32248,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32250,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,2,0,0,0,2,7,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32254,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32255,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32256,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32257,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32258,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 511,Subject 32261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 6719,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 6720,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 6721,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 6722,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32262,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32263,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32264,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,44,0,6,0,0,6
Study 22,EMEA,CZE,Site 808,Subject 32266,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,6,0,0,1,5
Study 22,EMEA,CZE,Site 808,Subject 32267,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,CZE,Site 808,Subject 32268,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32269,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32270,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,2,0,0,1,0,0,1,4,7,12,0,0,0,0,1,0,46,12,0,0,6,6
Study 22,EMEA,CZE,Site 808,Subject 32271,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32272,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32275,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 808,Subject 32276,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6723,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6724,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6725,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6726,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6727,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6728,Unplanned visit (2),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6730,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6731,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6732,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,0,22,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,CZE,Site 809,Subject 6737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 809,Subject 6739,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,CZE,Site 809,Subject 6740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,CZE,Site 809,Subject 6741,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6746,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,3,58,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6747,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 6751,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32277,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32278,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32281,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,1,0,0,1,0
Study 22,EMEA,CZE,Site 810,Subject 32282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32283,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 810,Subject 32285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 6752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32286,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,1,0,0,0,0,0,0,1,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,0,0,0,0,1,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32299,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32301,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32304,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32307,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,1,0,0,2,0,0,0,3,0,26,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 811,Subject 32315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6754,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6755,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6756,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6757,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 6758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32316,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32317,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32318,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32319,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32320,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,CZE,Site 812,Subject 32328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,CZE,Site 812,Subject 32329,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 812,Subject 32332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 6759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,9,36,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 6760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 6761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32334,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32338,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32341,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32343,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32344,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32345,Unplanned visit (1),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,2,0,0,0,2,8,14,0,0,0,0,0,0,57,1,0,0,1,0
Study 22,EMEA,CZE,Site 813,Subject 32346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32347,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32348,Unplanned visit (1),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,2,0,0,0,2,10,14,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32349,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32350,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32352,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32353,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32354,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32355,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32356,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32358,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32360,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32362,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32365,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 813,Subject 32366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 814,Subject 6762,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,10,41,0,0,0,0,0,0,37,1,0,7,0,8
Study 22,EMEA,CZE,Site 814,Subject 6763,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 814,Subject 6764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,CZE,Site 814,Subject 6765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,7,0,0,7
Study 22,EMEA,CZE,Site 814,Subject 6766,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 814,Subject 6767,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 814,Subject 6768,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 814,Subject 6769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,7,0,7,0,14
Study 22,EMEA,CZE,Site 814,Subject 6770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,30,7,0,7,0,14
Study 22,EMEA,CZE,Site 814,Subject 6771,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 6779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 6780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 6781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 6782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32367,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32368,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32369,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32370,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32371,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32372,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,50,7,0,0,0,7
Study 22,EMEA,CZE,Site 815,Subject 32375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32377,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32378,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32382,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,EMEA,CZE,Site 815,Subject 32385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32386,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32388,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32389,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32390,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,1,0,0,1,0,0,0,2,0,6,0,0,0,0,0,0,44,2,0,0,2,0
Study 22,EMEA,CZE,Site 815,Subject 32392,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,1,0,0,2,8,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32394,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32395,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32397,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32398,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 815,Subject 32400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 816,Subject 6783,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 816,Subject 6784,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 816,Subject 6785,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 816,Subject 6786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,37,0,0,0,0,0,0,45,2,0,0,1,1
Study 22,EMEA,CZE,Site 816,Subject 6787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,2,0,0,0,2,0,24,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,CZE,Site 816,Subject 6788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6790,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6791,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6792,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,63,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 6795,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32401,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32402,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32404,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32408,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32410,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32412,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32417,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32420,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 817,Subject 32426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6798,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6803,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6805,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6807,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,CZE,Site 818,Subject 6809,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6810,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6811,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6812,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6816,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6817,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 6819,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32427,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32429,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32435,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 818,Subject 32436,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32439,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32443,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 1708,Subject 32444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,2,0,0,0,2,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,4,0,0,0,4,1,8,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6828,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 6831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 807,Subject 32445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32453,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32458,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1709,Subject 32459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 819,Subject 6832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 819,Subject 6833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32462,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32463,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,0,0,0,0,0,2,34,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32464,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32465,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,1,0,0,0,1,0,25,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32466,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32467,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32469,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32470,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32471,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32472,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32473,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32474,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32475,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32476,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32477,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32478,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32480,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32482,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32484,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,1,0,0,0,1,0,23,0,1,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32485,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32486,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32488,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32490,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32499,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32503,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,2,0,0,0,2,0,16,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32507,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32515,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32518,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32522,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32528,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32529,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32530,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32531,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1710,Subject 32535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 820,Subject 6840,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,15,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 820,Subject 6841,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,16,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6843,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6844,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6845,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6846,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6848,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6849,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 6850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 32536,Visit 1 (1),Discontinued,,,,,,,,,,2,41,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,34,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 32537,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,CZE,Site 821,Subject 32538,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,CZE,Site 822,Subject 6851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 822,Subject 6852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1711,Subject 32539,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,9,53,0,0,0,0,0,0,50,0,2,0,1,1
Study 22,EMEA,CZE,Site 1711,Subject 32540,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,CZE,Site 1711,Subject 32541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1711,Subject 32542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1711,Subject 32543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1711,Subject 32544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1711,Subject 32545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,CZE,Site 1712,Subject 32546,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,2,,,,0,0,0,7,0,0,0,7,23,45,0,0,0,0,0,0,27,1,0,17,3,15
Study 22,EMEA,CZE,Site 1712,Subject 32547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,0,0,14,0,14
Study 22,EMEA,CZE,Site 1712,Subject 32548,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,22,0,7,15,1,21
Study 22,EMEA,CZE,Site 1712,Subject 32549,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32550,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32551,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,2,14,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32554,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 1713,Subject 32560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32562,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32563,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32568,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32572,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32574,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32575,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1714,Subject 32576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 1715,Subject 32577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,44,2,0,0,2,0
Study 22,EMEA,CZE,Site 1715,Subject 32578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CZE,Site 1715,Subject 32579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,42,2,7,0,2,7
Study 22,EMEA,CZE,Site 1715,Subject 32580,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 1715,Subject 32581,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,CZE,Site 1715,Subject 32582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,44,0,3,0,3,0
Study 22,EMEA,CZE,Site 1715,Subject 32583,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,2,0,2,0
Study 22,EMEA,CZE,Site 823,Subject 6861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,49,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6862,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 823,Subject 6868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6874,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6880,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6881,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6882,Screening,Discontinued,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6884,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 6885,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 32584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 32585,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 32586,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 32587,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CZE,Site 824,Subject 32588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,CZE,Site 826,Subject 6924,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,16,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CZE,Site 826,Subject 6925,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,14,0,0,0,12,0,0,0,0,0
Study 22,EMEA,CZE,Site 826,Subject 6926,Unplanned visit (1),Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 2844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 2845,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 3735,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 3736,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 3737,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,FRA,Site 353,Subject 32590,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32591,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,EMEA,FRA,Site 353,Subject 32593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,FRA,Site 353,Subject 32594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32596,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32597,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32598,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32600,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32601,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32602,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 353,Subject 32603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,9,0,0,1,8
Study 22,EMEA,FRA,Site 353,Subject 32604,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,FRA,Site 12,Subject 22,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,0,0,44,3,0,0,2,1
Study 22,EMEA,FRA,Site 12,Subject 2846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,7,1,0,1,7
Study 22,EMEA,FRA,Site 512,Subject 3738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,2,0,0,3,0,55,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,FRA,Site 512,Subject 3739,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 513,Subject 3742,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,1,,,,0,0,0,0,0,0,0,1,3,52,0,0,0,0,2,0,46,0,0,7,1,6
Study 22,EMEA,FRA,Site 513,Subject 3743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,1,0,54,1,0,7,1,7
Study 22,EMEA,FRA,Site 513,Subject 3744,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,2,0,7,2,7
Study 22,EMEA,FRA,Site 513,Subject 32605,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,51,0,,,,0,1,0,0,0,0,0,1,0,4,0,0,0,0,0,0,43,6,0,1,2,5
Study 22,EMEA,FRA,Site 513,Subject 32606,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,7,0,7
Study 22,EMEA,FRA,Site 513,Subject 32607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,7,0,7
Study 22,EMEA,FRA,Site 513,Subject 32608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,EMEA,FRA,Site 513,Subject 32609,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 513,Subject 32610,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,0,8,4,2,10
Study 22,EMEA,FRA,Site 513,Subject 32611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,FRA,Site 513,Subject 32612,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,7,0,7,0,14
Study 22,EMEA,FRA,Site 513,Subject 32613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,8,0,8,2,14
Study 22,EMEA,FRA,Site 513,Subject 32614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,7,0,7
Study 22,EMEA,FRA,Site 513,Subject 32615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,7,0,7
Study 22,EMEA,FRA,Site 513,Subject 32616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,8,1,7
Study 22,EMEA,FRA,Site 513,Subject 32617,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,FRA,Site 513,Subject 32618,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,9,0,1,8
Study 22,EMEA,FRA,Site 513,Subject 32619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,1,7,0,1,7
Study 22,EMEA,FRA,Site 513,Subject 32620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,8,0,0,8
Study 22,EMEA,FRA,Site 513,Subject 32621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,FRA,Site 513,Subject 32622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,30,7,0,8,1,14
Study 22,EMEA,FRA,Site 513,Subject 32623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,29,8,0,8,1,15
Study 22,EMEA,FRA,Site 513,Subject 32624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,30,7,0,7,0,14
Study 22,EMEA,FRA,Site 513,Subject 32625,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,29,0,0,9,2,7
Study 22,EMEA,FRA,Site 1716,Subject 32626,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,14,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 514,Subject 3745,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 514,Subject 3746,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 514,Subject 3747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,7,38,0,0,0,0,0,0,37,1,0,0,0,1
Study 22,EMEA,FRA,Site 515,Subject 3748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,FRA,Site 515,Subject 3749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,1,0,0,0,1,0,15,0,1,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,FRA,Site 515,Subject 3750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 515,Subject 3751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 515,Subject 32627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1717,Subject 32628,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,FRA,Site 1717,Subject 32629,Visit 1 (1),On Trial,,,,,,,,,,2,35,0,,,,0,0,0,1,0,0,0,1,2,30,0,0,0,0,1,0,33,0,0,0,0,0
Study 22,EMEA,FRA,Site 1717,Subject 32630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 3752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,4,49,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,FRA,Site 516,Subject 3753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,EMEA,FRA,Site 516,Subject 3754,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 32631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 32632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 32633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 32634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 516,Subject 32635,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32636,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,44,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,FRA,Site 1718,Subject 32638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32640,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32641,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1718,Subject 32645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 3944,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32646,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,FRA,Site 572,Subject 32647,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,7,0,0,0,7
Study 22,EMEA,FRA,Site 572,Subject 32648,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32651,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,2,0,38,1,0,0,0,1
Study 22,EMEA,FRA,Site 572,Subject 32652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32653,Unplanned visit (1),On Trial,,,,,,,,,,3,54,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,44,2,0,0,0,2
Study 22,EMEA,FRA,Site 572,Subject 32654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,36,7,0,0,0,7
Study 22,EMEA,FRA,Site 572,Subject 32655,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 572,Subject 32656,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,FRA,Site 573,Subject 3945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32658,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32659,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,1,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,1,0,43,8,0,0,3,5
Study 22,EMEA,FRA,Site 573,Subject 32660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,1,3,0,0,0,0,0,0,43,9,0,0,2,7
Study 22,EMEA,FRA,Site 573,Subject 32661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,FRA,Site 573,Subject 32664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,9,0,0,0,9
Study 22,EMEA,FRA,Site 573,Subject 32665,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,EMEA,FRA,Site 573,Subject 32666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,36,9,0,0,2,7
Study 22,EMEA,FRA,Site 573,Subject 32667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,36,10,0,0,3,7
Study 22,EMEA,FRA,Site 573,Subject 32668,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,3,12,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,EMEA,FRA,Site 1719,Subject 32669,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,7,56,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32670,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,49,3,1,0,2,2
Study 22,EMEA,FRA,Site 1719,Subject 32671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32674,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,14,1,0,0,1,0
Study 22,EMEA,FRA,Site 1719,Subject 32675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32676,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32677,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1719,Subject 32678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,FRA,Site 1719,Subject 32679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,FRA,Site 1719,Subject 32680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,FRA,Site 1720,Subject 32681,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32684,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32688,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32689,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,FRA,Site 1720,Subject 32690,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1721,Subject 32691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,FRA,Site 1721,Subject 32692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32693,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32694,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32695,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,4,53,0,0,0,0,2,0,56,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32696,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,55,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32698,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,54,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32701,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32702,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32703,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,1,0,50,5,0,0,0,5
Study 22,EMEA,FRA,Site 1722,Subject 32704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32705,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32706,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32707,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,7,10,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32716,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32717,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32718,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32720,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32721,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32722,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,4,13,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32724,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32725,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,FRA,Site 1722,Subject 32726,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,41,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32727,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32728,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32729,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32730,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32731,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,1,0,0,0,1,0,41,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32732,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32733,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32734,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32735,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,1,0,0,0,1,0,22,0,0,0,0,0,0,53,8,0,0,1,7
Study 22,EMEA,FRA,Site 1723,Subject 32736,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32737,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,108,0,,,,0,0,0,0,0,0,0,0,0,47,0,0,0,0,0,0,79,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,85,0,,,,0,0,0,1,0,0,0,1,0,29,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32741,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32743,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32744,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32757,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,92,0,,,,0,0,0,0,0,0,0,0,0,39,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,0,15,1,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32764,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1723,Subject 32765,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,FRA,Site 1724,Subject 32766,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,FRA,Site 1724,Subject 32767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1724,Subject 32768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,1,0,1,0
Study 22,EMEA,FRA,Site 1724,Subject 32769,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,FRA,Site 1724,Subject 32770,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,38,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32771,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32774,Visit 1 (1),On Trial,,,,,,,,,,2,36,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1725,Subject 32777,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,EMEA,FRA,Site 1726,Subject 32778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,10,43,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1726,Subject 32779,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1726,Subject 32780,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1726,Subject 32781,Unplanned visit (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,11,4,0,0,0,0,0,0,53,3,0,0,3,0
Study 22,EMEA,FRA,Site 1726,Subject 32782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,FRA,Site 1726,Subject 32783,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1726,Subject 32784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,FRA,Site 1727,Subject 32785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1727,Subject 32786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32787,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,2,0,44,0,0,8,1,7
Study 22,EMEA,FRA,Site 1728,Subject 32788,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,7,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32789,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32790,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,7,2,2,7
Study 22,EMEA,FRA,Site 1728,Subject 32791,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32792,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,8,3,1,10
Study 22,EMEA,FRA,Site 1728,Subject 32794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32795,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,1,0,8
Study 22,EMEA,FRA,Site 1728,Subject 32797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,7,0,1,0,8
Study 22,EMEA,FRA,Site 1728,Subject 32800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,FRA,Site 1728,Subject 32801,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,1,1,7
Study 22,EMEA,FRA,Site 1728,Subject 32803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,5,0,0,0,5
Study 22,EMEA,FRA,Site 1728,Subject 32804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,8,0,1,2,7
Study 22,EMEA,FRA,Site 1728,Subject 32805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,1,1,7
Study 22,EMEA,FRA,Site 1728,Subject 32806,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32807,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32809,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32810,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,7,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,34,0,7,3,3,7
Study 22,EMEA,FRA,Site 1728,Subject 32812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,9,0,0,1,8
Study 22,EMEA,FRA,Site 1728,Subject 32814,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 1728,Subject 32815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,8,0,1,1,8
Study 22,EMEA,FRA,Site 1728,Subject 32816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,FRA,Site 1728,Subject 32818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,FRA,Site 1728,Subject 32819,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,13,1,0,0,1,0
Study 22,EMEA,FRA,Site 1729,Subject 32820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,43,0,0,0,0,3,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32821,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,14,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,1,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32833,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32835,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32840,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32841,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32842,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32843,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1717,Subject 32845,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32849,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32855,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32859,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32860,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32861,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32862,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32863,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,FRA,Site 1730,Subject 32864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,8,3,0,0,0,0,0,0,36,9,0,0,2,7
Study 22,EMEA,FRA,Site 1731,Subject 32865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,3,52,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,EMEA,FRA,Site 1731,Subject 32866,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,FRA,Site 1731,Subject 32867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,0,0,0,0,0,4,12,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,EMEA,FRA,Site 1731,Subject 32868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,FRA,Site 1731,Subject 32869,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,6,9,0,0,0,0,1,0,51,2,0,0,1,1
Study 22,EMEA,FRA,Site 1732,Subject 32870,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32871,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32872,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32873,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32874,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,41,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,FRA,Site 1732,Subject 32875,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,35,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,FRA,Site 1732,Subject 32877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,EMEA,FRA,Site 1732,Subject 32878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,FRA,Site 1732,Subject 32879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,EMEA,FRA,Site 1732,Subject 32880,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,1,1,0,1,1
Study 22,EMEA,FRA,Site 1732,Subject 32881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,38,7,0,0,3,4
Study 22,EMEA,FRA,Site 1732,Subject 32882,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 1389,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,13,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 1390,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 1391,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,7,19,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,EMEA,GRC,Site 147,Subject 1392,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,GRC,Site 147,Subject 32884,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32885,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GRC,Site 147,Subject 32886,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,GRC,Site 147,Subject 32887,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,GRC,Site 147,Subject 32888,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,EMEA,GRC,Site 147,Subject 32889,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32890,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32891,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,GRC,Site 147,Subject 32893,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32894,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32895,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32896,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32897,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32898,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32900,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32901,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32902,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 147,Subject 32903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1393,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1394,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,31,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1397,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GRC,Site 148,Subject 1398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1401,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 1407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 6975,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32908,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32909,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32914,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32917,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32919,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32920,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32922,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 149,Subject 32924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 3522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,8,36,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 3523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6978,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6982,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6983,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 6984,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 32925,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 32926,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,2,0,0,0,2,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 32927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 32928,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 464,Subject 32929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6994,Screening,Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,18,19,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6995,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6996,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,21,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6998,Visit 1 (1),Discontinued,,,,,,,,,,2,34,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,EMEA,GRC,Site 832,Subject 6999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7016,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7018,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7020,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7022,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7023,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 833,Subject 7025,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 1733,Subject 32930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,1,52,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GRC,Site 1733,Subject 32931,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GRC,Site 834,Subject 7034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,7,36,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 834,Subject 7035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GRC,Site 834,Subject 7036,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 834,Subject 32932,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GRC,Site 834,Subject 32933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 1417,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 1418,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 1419,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 1420,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,0,59,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7186,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7187,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7188,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7189,Visit 1 (1),On Trial,,,,,,,,,,2,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7190,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7191,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7192,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7196,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7197,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7198,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,2,14,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7199,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7200,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7201,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7202,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7203,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7204,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7205,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7206,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7210,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7212,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7214,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7216,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7217,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7218,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 153,Subject 7219,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1421,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,2,62,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1422,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1423,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1424,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 1426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7241,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7244,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,83,0,,,,0,0,0,2,0,0,0,2,3,27,0,0,0,0,1,0,67,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7246,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7248,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7250,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7253,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7254,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7255,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7257,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7258,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7259,Unplanned visit (1),Discontinued,,,,,,,,,,3,82,0,,,,0,0,0,0,0,0,0,0,0,39,1,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7261,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7262,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7263,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7264,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7266,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7267,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7268,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7269,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7270,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,1,0,0,0,1,9,15,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 7275,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32936,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32939,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32940,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32942,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32943,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32945,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32949,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32953,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32956,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32958,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,HUN,Site 154,Subject 32959,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1431,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1432,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1433,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1434,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 1438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 7314,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 7315,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 7316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 156,Subject 7317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1442,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 1447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7408,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7409,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7410,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7412,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,HUN,Site 158,Subject 7413,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7414,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,HUN,Site 158,Subject 7415,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,HUN,Site 158,Subject 7416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,HUN,Site 158,Subject 7417,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7419,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,67,0,,,,0,0,0,2,0,0,0,2,1,23,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7420,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 158,Subject 7423,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7440,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7441,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7442,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7445,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7446,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7447,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7448,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 845,Subject 7450,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 850,Subject 7597,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 850,Subject 7598,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,21,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 850,Subject 7599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 850,Subject 7600,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 850,Subject 7601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7628,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,9,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7629,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,7,43,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7632,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,24,0,0,0,0,1,0,46,7,0,0,0,7
Study 22,EMEA,HUN,Site 851,Subject 7633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7640,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7643,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 851,Subject 7644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 1448,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 1449,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 1450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,0,70,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 1451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 1452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7690,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7693,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7694,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7695,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7696,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7698,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7700,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,HUN,Site 159,Subject 7701,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7702,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,EMEA,HUN,Site 159,Subject 7703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7707,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7708,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 159,Subject 7709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 853,Subject 7747,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,2,60,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,HUN,Site 853,Subject 7748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 853,Subject 7749,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,15,1,0,0,0,1,0,62,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7761,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7762,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,HUN,Site 854,Subject 7763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7764,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 854,Subject 7771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 7869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 857,Subject 7870,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 857,Subject 7871,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HUN,Site 857,Subject 7872,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7894,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7895,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7896,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7897,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7898,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7899,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7900,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7901,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7902,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 849,Subject 7906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32963,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32965,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32966,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32968,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32969,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32970,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32971,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32973,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32974,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32975,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,HUN,Site 1735,Subject 32978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32983,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32985,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32986,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32990,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32991,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32993,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1736,Subject 32994,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 32995,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 32996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 32997,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,1,0,0,0,0,0,0,1,0,2,15,0,0,0,0,0,13,1,0,0,1,0
Study 22,EMEA,HUN,Site 1737,Subject 32998,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 32999,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 33000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,7,0,0,0,7
Study 22,EMEA,HUN,Site 1737,Subject 33001,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 33002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 33003,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1737,Subject 33004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33007,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33008,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33009,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33014,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33015,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33016,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33017,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33018,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33021,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33022,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,HUN,Site 1738,Subject 33023,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33024,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,HUN,Site 1738,Subject 33025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1738,Subject 33027,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33028,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33029,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33030,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33033,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1739,Subject 33036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33037,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33038,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33039,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,35,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33041,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,HUN,Site 1734,Subject 33044,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1734,Subject 33047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33048,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33049,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33050,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33051,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,1,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33052,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33053,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,3,0,0,0,3,9,7,0,0,0,0,0,0,44,7,0,0,1,6
Study 22,EMEA,HUN,Site 1735,Subject 33054,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,HUN,Site 1735,Subject 33055,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,48,6,0,0,0,6
Study 22,EMEA,HUN,Site 1735,Subject 33056,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,HUN,Site 1735,Subject 33057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33058,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33061,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33063,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,9,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33065,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1735,Subject 33066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,HUN,Site 1735,Subject 33067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1740,Subject 33068,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HUN,Site 1740,Subject 33069,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33070,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,5,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33071,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33073,Unplanned visit (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,34,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33074,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33075,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33076,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33078,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33079,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1741,Subject 33082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33083,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33084,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33085,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33087,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33088,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33089,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,48,1,0,0,1,0
Study 22,EMEA,HUN,Site 1742,Subject 33091,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33092,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33093,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33096,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33097,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33099,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HUN,Site 1742,Subject 33100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33104,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1743,Subject 33106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33108,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33110,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33112,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33113,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33116,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HUN,Site 1744,Subject 33120,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33121,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33122,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33124,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,1,0,0,0,0,0,0,1,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33125,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33126,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33127,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33128,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33131,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,6,11,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33134,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33136,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33138,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33139,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33142,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HUN,Site 1745,Subject 33146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 161,Subject 1456,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,7,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 162,Subject 1459,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 162,Subject 1460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,21,0,1,0,0,0,0,49,0,0,7,0,7
Study 22,EMEA,ISR,Site 162,Subject 1461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,1,7,0,1,7
Study 22,EMEA,ISR,Site 162,Subject 1462,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ISR,Site 162,Subject 1463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,35,1,8,0,1,8
Study 22,EMEA,ISR,Site 162,Subject 1464,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,3,0,0,0,3,0,5,0,0,0,0,0,0,28,1,0,9,2,8
Study 22,EMEA,ISR,Site 162,Subject 1465,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8066,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,8,42,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8067,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8068,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 859,Subject 8072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8101,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8102,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8104,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,1,25,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,2,0,36,6,0,0,0,6
Study 22,EMEA,ISR,Site 860,Subject 8107,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 860,Subject 8108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,36,7,0,0,0,7
Study 22,EMEA,ISR,Site 860,Subject 8109,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 783,Subject 4903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,42,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8132,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8133,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8134,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,7,56,0,0,0,0,0,0,55,1,0,0,0,1
Study 22,EMEA,ISR,Site 861,Subject 8135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,1,0,0,0,1,1,28,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8137,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8139,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8140,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,35,8,0,0,1,7
Study 22,EMEA,ISR,Site 861,Subject 8142,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,ISR,Site 861,Subject 8143,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 4905,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,6,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 4906,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8154,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8155,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8156,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8157,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8158,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8159,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8160,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8161,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8162,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8163,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8165,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8166,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8167,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8168,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ISR,Site 784,Subject 8169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8170,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8171,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8173,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8174,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,2,0,0,0,2,14,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 8176,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33147,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33149,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,7,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33151,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,41,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33157,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33158,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33159,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33160,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33161,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 784,Subject 33162,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 4907,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,14,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8177,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,1,0,45,3,0,0,3,0
Study 22,EMEA,ISR,Site 785,Subject 8178,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,3,0,44,5,2,0,5,2
Study 22,EMEA,ISR,Site 785,Subject 8179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,1,0,46,1,0,0,1,0
Study 22,EMEA,ISR,Site 785,Subject 8180,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8181,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8182,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8183,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,19,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,EMEA,ISR,Site 785,Subject 8184,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8185,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8187,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ISR,Site 785,Subject 8188,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8195,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,9,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8196,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8197,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8198,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,1,20,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,EMEA,ISR,Site 862,Subject 8199,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8200,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8201,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8202,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8203,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8204,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 862,Subject 8205,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8221,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,EMEA,ISR,Site 863,Subject 8222,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8223,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,EMEA,ISR,Site 863,Subject 8224,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8225,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8226,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,EMEA,ISR,Site 863,Subject 8227,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8229,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8230,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8231,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8232,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8233,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 8234,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 33163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 33164,Unplanned visit (1),Discontinued,,,,,,,,,,3,58,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 33165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 33166,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ISR,Site 863,Subject 33167,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ISR,Site 575,Subject 3947,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,60,0,1,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ISR,Site 575,Subject 3948,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ISR,Site 575,Subject 3949,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ISR,Site 575,Subject 3950,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 4898,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 8248,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,5,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 8249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 8250,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,ISR,Site 781,Subject 8251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 8252,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,48,0,,,,1,0,0,0,0,0,0,1,0,6,0,0,0,0,0,0,36,2,0,8,0,10
Study 22,EMEA,ISR,Site 781,Subject 8253,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,ISR,Site 781,Subject 8254,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33168,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33170,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33171,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33172,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,EMEA,ITA,Site 1746,Subject 33173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33174,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33176,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33179,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ITA,Site 1746,Subject 33180,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 3758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 3759,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 3760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 3761,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33181,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33182,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,0,8,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,ITA,Site 518,Subject 33183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,1,0,0,1,0
Study 22,EMEA,ITA,Site 518,Subject 33187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,EMEA,ITA,Site 518,Subject 33191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,3,0,0,1,2
Study 22,EMEA,ITA,Site 518,Subject 33192,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 518,Subject 33193,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 3762,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 3763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 3764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 3765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 3766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 33194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 33195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 519,Subject 33196,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,73,0,,,,0,0,0,2,0,0,0,2,3,19,0,0,0,0,0,0,48,11,0,0,4,7
Study 22,EMEA,ITA,Site 1747,Subject 33197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,41,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33198,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,13,0,3,0,2,1
Study 22,EMEA,ITA,Site 1747,Subject 33199,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,14,1,0,0,1,0
Study 22,EMEA,ITA,Site 1747,Subject 33200,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,33,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,28,1,1,0,2,0
Study 22,EMEA,ITA,Site 1747,Subject 33201,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33203,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33204,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,3,0,0,0,0,0,1,37,0,7,0,0,7
Study 22,EMEA,ITA,Site 1747,Subject 33206,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1747,Subject 33207,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,3,0,0,3,0
Study 22,EMEA,ITA,Site 1748,Subject 33208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33209,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33211,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1748,Subject 33217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 3524,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,10,13,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 3525,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 3526,Screening,Discontinued,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 8264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,8,37,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 33218,Unplanned visit (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,3,0,0,0,3,0,10,0,0,0,0,2,0,36,2,0,0,2,0
Study 22,EMEA,ITA,Site 465,Subject 33219,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,2,0,35,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 33220,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 33221,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,EMEA,ITA,Site 465,Subject 33222,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,45,5,0,0,0,5
Study 22,EMEA,ITA,Site 1749,Subject 33225,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33227,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33228,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33229,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33230,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33231,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33232,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33235,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33236,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33237,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33239,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33240,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,7,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33241,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,4,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33242,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,2,0,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33243,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33244,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33245,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,2,0,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33246,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33247,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33248,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33249,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33250,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33251,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33252,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33253,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33254,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33255,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1749,Subject 33256,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 8265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 8266,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33257,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33258,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33259,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,ITA,Site 864,Subject 33261,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33263,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33264,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33267,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 864,Subject 33269,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 8267,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33270,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33271,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33272,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33275,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33280,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 865,Subject 33281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,34,11,0,0,3,8
Study 22,EMEA,ITA,Site 865,Subject 33282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,37,7,0,0,0,7
Study 22,EMEA,ITA,Site 865,Subject 33283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,9,0,0,1,8
Study 22,EMEA,ITA,Site 578,Subject 3958,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,7,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 578,Subject 3959,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 578,Subject 33284,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 578,Subject 33285,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 578,Subject 33286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 578,Subject 33287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 3962,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,13,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 3963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8269,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,1,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,4,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8274,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8275,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8276,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 8277,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 580,Subject 33288,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 3964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,49,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 3965,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 3966,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,EMEA,ITA,Site 581,Subject 3967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,12,12,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 33289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 33290,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,1,1,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 33291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 33292,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 581,Subject 33293,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,1,2,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33294,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33295,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,EMEA,ITA,Site 1750,Subject 33296,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33297,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,0,0,47,8,0,0,1,7
Study 22,EMEA,ITA,Site 1750,Subject 33298,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33299,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,3,0,0,0,3,3,10,0,0,0,0,0,0,47,1,0,0,1,0
Study 22,EMEA,ITA,Site 1750,Subject 33304,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1750,Subject 33307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 8278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,5,40,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 8279,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 8280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,2,0,0,2,2,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 8281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 8282,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33308,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,1,0,0,1,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33312,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33315,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 866,Subject 33318,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1751,Subject 33319,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1751,Subject 33320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1751,Subject 33321,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1751,Subject 33322,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33324,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33325,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33329,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33330,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33331,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33332,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33333,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33334,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33336,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33337,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33338,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33343,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33344,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33345,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33346,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33347,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33348,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33349,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33352,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33353,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33354,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33355,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33356,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33358,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33359,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33360,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33361,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33362,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1752,Subject 33363,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33364,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33365,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,5,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33366,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,49,0,0,0,0,0,0,44,0,5,0,0,5
Study 22,EMEA,ITA,Site 1753,Subject 33367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,7,0,7
Study 22,EMEA,ITA,Site 1753,Subject 33368,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,36,0,0,7,0,7
Study 22,EMEA,ITA,Site 1753,Subject 33370,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33371,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33372,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33373,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,7,0,7
Study 22,EMEA,ITA,Site 1753,Subject 33374,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,8,0,8
Study 22,EMEA,ITA,Site 1753,Subject 33376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,41,6,0,0,0,6
Study 22,EMEA,ITA,Site 1753,Subject 33377,Screening,Discontinued,,,,,,,,,,1,23,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,ITA,Site 1753,Subject 33379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,8,0,1,7
Study 22,EMEA,ITA,Site 1753,Subject 33380,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,7,1,1,7
Study 22,EMEA,ITA,Site 1753,Subject 33382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,ITA,Site 1753,Subject 33383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,ITA,Site 1753,Subject 33384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,2,0,0,5,0,0,0,7,20,6,0,0,0,0,1,0,27,10,0,8,2,16
Study 22,EMEA,ITA,Site 1753,Subject 33385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,28,8,0,8,1,15
Study 22,EMEA,ITA,Site 1753,Subject 33386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,29,7,0,7,0,14
Study 22,EMEA,ITA,Site 1753,Subject 33387,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33388,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33389,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1753,Subject 33390,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,30,0,0,7,0,7
Study 22,EMEA,ITA,Site 1753,Subject 33391,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,28,0,0,8,1,7
Study 22,EMEA,ITA,Site 1754,Subject 33392,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,58,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33393,Unplanned visit (1),Discontinued,,,,,,,,,,3,63,0,,,,0,0,0,0,0,0,0,0,0,19,1,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,2,0,0,0,2,0,22,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33397,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33398,Visit 1 (1),Discontinued,,,,,,,,,,2,48,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1754,Subject 33399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,2,0,0,1,0,0,0,3,12,5,0,0,0,0,0,0,42,4,0,0,2,2
Study 22,EMEA,ITA,Site 1754,Subject 33400,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,63,0,,,,0,0,0,2,0,0,0,2,9,17,0,0,0,0,1,0,45,2,0,0,1,1
Study 22,EMEA,ITA,Site 1754,Subject 33401,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33402,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33403,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,51,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1755,Subject 33417,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,2,50,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33419,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33420,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33422,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33424,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33426,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,4,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33429,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,2,0,0,0,2,10,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1756,Subject 33431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33433,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33435,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33436,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33437,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,EMEA,ITA,Site 1757,Subject 33438,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33442,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33443,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1757,Subject 33444,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,1,1,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33448,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33450,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33451,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33452,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1758,Subject 33453,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33454,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,42,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33456,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,1,0,37,1,0,0,1,0
Study 22,EMEA,ITA,Site 1759,Subject 33457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33458,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33461,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,1,1,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33464,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33465,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,1,0,0,0,1
Study 22,EMEA,ITA,Site 1759,Subject 33466,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,1,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33468,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33469,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33470,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33473,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33474,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33475,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33476,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33477,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33478,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33479,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33480,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,2,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1759,Subject 33481,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,37,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33483,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33485,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33486,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33488,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33489,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1760,Subject 33490,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33491,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33492,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33493,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33495,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,32,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,EMEA,ITA,Site 1761,Subject 33496,Visit 1 (1),On Trial,,,,,,,,,,2,30,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,29,0,0,0,0,0
Study 22,EMEA,ITA,Site 1762,Subject 33497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,18,27,0,0,0,0,0,0,37,0,0,5,0,5
Study 22,EMEA,ITA,Site 1762,Subject 33498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,38,0,0,8,1,7
Study 22,EMEA,ITA,Site 1762,Subject 33499,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1762,Subject 33500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,37,0,0,8,1,7
Study 22,EMEA,ITA,Site 1762,Subject 33501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,8,1,7
Study 22,EMEA,ITA,Site 1762,Subject 33502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,35,0,0,10,3,7
Study 22,EMEA,ITA,Site 1762,Subject 33503,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1762,Subject 33504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,8,1,7
Study 22,EMEA,ITA,Site 1762,Subject 33505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,34,9,0,3,3,9
Study 22,EMEA,ITA,Site 1762,Subject 33506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,30,7,0,8,1,14
Study 22,EMEA,ITA,Site 1762,Subject 33507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,30,8,0,8,2,14
Study 22,EMEA,ITA,Site 1762,Subject 33508,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,2,0,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1762,Subject 33509,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,29,1,0,8,2,7
Study 22,EMEA,ITA,Site 1763,Subject 33510,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,49,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33512,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33515,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33518,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33519,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1763,Subject 33522,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33527,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33528,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33530,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33531,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,0,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ITA,Site 1764,Subject 33532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,1,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33533,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,8,0,1,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33534,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33539,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33543,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,8,5,0,0,0,0,0,0,41,1,0,0,1,0
Study 22,EMEA,ITA,Site 1765,Subject 33546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33548,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,5,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ITA,Site 1765,Subject 33549,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,6,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ITA,Site 1766,Subject 33550,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ITA,Site 1767,Subject 33551,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33552,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33553,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33554,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33555,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,20,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33557,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33558,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33559,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33560,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33562,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33563,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ITA,Site 1768,Subject 33569,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,1,7,0,1,7
Study 22,EMEA,ITA,Site 1768,Subject 33571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,ITA,Site 1768,Subject 33574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,ITA,Site 1768,Subject 33575,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33576,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ITA,Site 1768,Subject 33577,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1769,Subject 33578,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1769,Subject 33579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,54,0,0,0,0,1,0,29,0,8,16,3,21
Study 22,EMEA,NLD,Site 1769,Subject 33580,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,28,0,7,19,5,21
Study 22,EMEA,NLD,Site 1769,Subject 33581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,1,0,0,1,0,0,0,2,8,7,0,0,0,0,0,0,27,7,0,17,3,21
Study 22,EMEA,NLD,Site 1769,Subject 33582,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1770,Subject 33583,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,18,0,0,0,0,0
Study 22,EMEA,NLD,Site 1770,Subject 33584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,50,6,0,0,0,6
Study 22,EMEA,NLD,Site 1770,Subject 33585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,50,6,0,0,0,6
Study 22,EMEA,NLD,Site 1770,Subject 33586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,NLD,Site 1770,Subject 33587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,NLD,Site 1770,Subject 33588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,77,0,,,,0,0,0,2,0,0,0,2,2,25,0,0,0,0,0,0,50,8,0,0,6,2
Study 22,EMEA,NLD,Site 1770,Subject 33589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1770,Subject 33590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,33,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1770,Subject 33591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,NLD,Site 1770,Subject 33592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1770,Subject 33593,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33595,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33599,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33600,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33601,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,NLD,Site 1771,Subject 33602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,NLD,Site 1771,Subject 33604,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33606,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33607,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33609,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33613,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33618,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1771,Subject 33619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1772,Subject 33620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,3,37,0,0,0,0,1,0,42,0,0,4,4,0
Study 22,EMEA,NLD,Site 1772,Subject 33621,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1772,Subject 33622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,9,2,7
Study 22,EMEA,NLD,Site 1772,Subject 33623,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1772,Subject 33624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,34,1,6,3,4,6
Study 22,EMEA,NLD,Site 1773,Subject 33625,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,9,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33626,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33627,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33628,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33629,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33632,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,NLD,Site 1773,Subject 33633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,58,1,0,0,1,0
Study 22,EMEA,NLD,Site 1773,Subject 33634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33635,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33636,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33640,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33641,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33642,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33643,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33644,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,9,8,0,0,0,0,0,0,52,3,0,0,3,0
Study 22,EMEA,NLD,Site 1773,Subject 33645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33647,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,2,0,48,1,0,0,1,0
Study 22,EMEA,NLD,Site 1773,Subject 33652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,4,13,0,0,0,0,2,0,48,1,0,0,1,0
Study 22,EMEA,NLD,Site 1773,Subject 33653,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33658,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33659,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33660,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,16,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33661,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33663,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33665,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33669,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33672,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33673,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33675,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,4,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1773,Subject 33679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33680,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33681,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33682,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33683,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,2,0,0,0,2,10,16,0,0,0,0,0,0,52,5,0,0,4,1
Study 22,EMEA,NLD,Site 1774,Subject 33684,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,19,1,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33685,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,53,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33687,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33690,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,53,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33691,Unplanned visit (1),Discontinued,,,,,,,,,,3,59,0,,,,0,0,0,0,0,0,0,0,0,19,3,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33693,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,45,6,0,0,0,6
Study 22,EMEA,NLD,Site 1774,Subject 33694,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,NLD,Site 1774,Subject 33695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,1,0,0,0,0,0,0,1,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,2,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33704,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,2,0,0,0,2,0,24,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33712,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,0,0,0,0,0,1,16,1,0,0,0,0,0,46,2,0,2,4,0
Study 22,EMEA,NLD,Site 1774,Subject 33713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33717,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33718,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33720,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,7,15,0,0,0,0,1,0,46,3,0,0,2,1
Study 22,EMEA,NLD,Site 1774,Subject 33727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,NLD,Site 1774,Subject 33728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33730,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1774,Subject 33735,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33736,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,13,1,0,0,1,0
Study 22,EMEA,NLD,Site 1775,Subject 33737,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,8,13,0,0,0,0,0,0,42,2,0,0,1,1
Study 22,EMEA,NLD,Site 1775,Subject 33739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,42,8,0,0,2,6
Study 22,EMEA,NLD,Site 1775,Subject 33740,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,NLD,Site 1775,Subject 33741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,NLD,Site 1775,Subject 33742,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,NLD,Site 1775,Subject 33744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33746,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33747,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,4,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,NLD,Site 1775,Subject 33750,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,11,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,2,0,0,0,2,1,14,0,0,0,0,0,0,47,1,0,0,1,0
Study 22,EMEA,NLD,Site 1775,Subject 33755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,NLD,Site 1775,Subject 33757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33758,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,NLD,Site 1775,Subject 33760,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,43,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,36,5,0,0,3,2
Study 22,EMEA,NLD,Site 1775,Subject 33761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33763,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1775,Subject 33765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,EMEA,NLD,Site 582,Subject 3968,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,NLD,Site 582,Subject 3969,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,1,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 582,Subject 3970,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 582,Subject 3971,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 582,Subject 33766,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,43,8,0,0,1,7
Study 22,EMEA,NLD,Site 582,Subject 33767,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,NLD,Site 582,Subject 33768,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 582,Subject 33769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,1,1,0,2,0
Study 22,EMEA,NLD,Site 582,Subject 33770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,1,0,0,1,0
Study 22,EMEA,NLD,Site 582,Subject 33771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 582,Subject 33772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 3972,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 3973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33773,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,3,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33776,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33780,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33781,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33784,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33787,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33788,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33789,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33790,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33796,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33798,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33799,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33802,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33805,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,47,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33806,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33807,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33809,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33810,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33812,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33813,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,1,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,1,48,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 583,Subject 33818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33819,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,1,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33820,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33821,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,2,0,0,0,2,3,21,0,0,0,0,1,2,60,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,2,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,2,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33827,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,1,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,1,0,0,0,0,0,0,1,1,5,0,0,0,0,0,1,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33830,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,1,1,48,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33832,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,1,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33834,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33835,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,1,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33837,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,1,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,2,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33839,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,3,0,0,0,0,0,1,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33840,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,1,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1776,Subject 33841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33842,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33843,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33844,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,4,0,0,5,3,13,0,0,0,0,1,0,46,4,0,0,4,0
Study 22,EMEA,NLD,Site 1777,Subject 33845,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33849,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,1,0,0,2,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33855,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33856,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1777,Subject 33858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,NLD,Site 1778,Subject 33859,Unplanned visit (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,2,0,0,0,2,5,59,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,EMEA,NLD,Site 1778,Subject 33860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,1,50,1,0,0,1,0
Study 22,EMEA,NLD,Site 1778,Subject 33861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1778,Subject 33862,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1778,Subject 33863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1778,Subject 33864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1778,Subject 33865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,NLD,Site 1778,Subject 33866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,2,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,NLD,Site 1778,Subject 33868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,NLD,Site 1778,Subject 33870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1778,Subject 33875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,3,0,0,0,3,1,19,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,NLD,Site 1779,Subject 33876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1779,Subject 33877,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33878,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33880,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33885,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1779,Subject 33887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33888,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33889,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,44,6,0,0,0,6
Study 22,EMEA,NLD,Site 1780,Subject 33890,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,NLD,Site 1780,Subject 33891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,2,5
Study 22,EMEA,NLD,Site 1780,Subject 33892,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,8,8,0,0,0,0,0,0,43,2,0,0,1,1
Study 22,EMEA,NLD,Site 1780,Subject 33895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33898,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33899,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33900,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33901,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33902,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33903,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,5,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33908,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33909,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,36,7,0,0,1,6
Study 22,EMEA,NLD,Site 1780,Subject 33910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1780,Subject 33911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,EMEA,NLD,Site 1781,Subject 33912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,28,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33916,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1781,Subject 33918,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33919,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33920,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,8,0,0,0,8
Study 22,EMEA,NLD,Site 1781,Subject 33921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,NLD,Site 1781,Subject 33923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,NLD,Site 1781,Subject 33924,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,NLD,Site 1781,Subject 33925,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33926,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33928,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33931,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33932,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1781,Subject 33934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33935,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33936,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,NLD,Site 1782,Subject 33937,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33938,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33939,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33940,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33941,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,58,2,0,0,2,0
Study 22,EMEA,NLD,Site 1782,Subject 33942,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33943,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33944,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,NLD,Site 1782,Subject 33945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,NLD,Site 1782,Subject 33946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,8,0,0,1,7
Study 22,EMEA,NLD,Site 1782,Subject 33947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33953,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1782,Subject 33954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1783,Subject 33955,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,9,41,0,0,0,0,0,0,42,0,2,0,1,1
Study 22,EMEA,NLD,Site 1783,Subject 33956,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1783,Subject 33957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1783,Subject 33958,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1783,Subject 33959,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,50,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,39,1,3,0,1,3
Study 22,EMEA,NLD,Site 1783,Subject 33960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,7,0,0,7
Study 22,EMEA,NLD,Site 1784,Subject 33961,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33962,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,84,0,,,,0,0,0,3,0,0,0,3,7,26,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33963,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33965,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33966,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33967,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33968,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33969,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33970,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33971,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33973,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33975,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33976,Unplanned visit (2),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,3,15,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33977,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1784,Subject 33984,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33986,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33987,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33988,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,1,0,0,1,0
Study 22,EMEA,NLD,Site 1785,Subject 33989,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33990,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,NLD,Site 1785,Subject 33991,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,NLD,Site 1785,Subject 33992,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33993,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33994,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33995,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33996,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1785,Subject 33999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,NLD,Site 1785,Subject 34000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34001,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,3,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34003,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,2,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34004,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,54,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34007,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34008,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,1,0,0,0,1,1,24,0,0,0,0,2,0,60,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34009,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,3,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,46,6,0,0,0,6
Study 22,EMEA,NLD,Site 1786,Subject 34014,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,44,6,0,0,0,6
Study 22,EMEA,NLD,Site 1786,Subject 34015,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,NLD,Site 1786,Subject 34016,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,EMEA,NLD,Site 1786,Subject 34017,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,3,0,49,4,0,0,0,4
Study 22,EMEA,NLD,Site 1786,Subject 34018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,1,0,46,10,0,0,4,6
Study 22,EMEA,NLD,Site 1786,Subject 34019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,NLD,Site 1786,Subject 34020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,3,0,44,7,0,0,1,6
Study 22,EMEA,NLD,Site 1786,Subject 34021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34022,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34028,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34031,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34039,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34040,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1786,Subject 34042,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34044,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34045,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,1,4,0,0,0,0,2,0,45,1,0,0,1,0
Study 22,EMEA,NLD,Site 1787,Subject 34047,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,EMEA,NLD,Site 1787,Subject 34049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,4,0,0,0,0,1,0,42,2,0,0,2,0
Study 22,EMEA,NLD,Site 1787,Subject 34050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34051,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34052,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,NLD,Site 1787,Subject 34053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,1,1,0,2,0
Study 22,EMEA,NLD,Site 1788,Subject 34054,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,0,0,0,0,0,6,65,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34055,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34056,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34057,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34058,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34061,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34062,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,3,14,1,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34063,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34064,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,NLD,Site 1788,Subject 34068,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 13,Subject 23,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,41,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 13,Subject 24,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 13,Subject 637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 25,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 26,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 27,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 28,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 29,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 30,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 31,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 32,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 33,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 34,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,9,0,2,7
Study 22,EMEA,POL,Site 14,Subject 35,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 36,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 37,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,1,2,0,0,3,6,8,0,0,0,0,0,0,55,0,5,0,5,0
Study 22,EMEA,POL,Site 14,Subject 38,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8284,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8285,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8286,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8287,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,2,0,0,0,2,0,4,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,8,0,0,8
Study 22,EMEA,POL,Site 14,Subject 8291,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,EMEA,POL,Site 14,Subject 8292,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,POL,Site 14,Subject 8293,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8294,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,POL,Site 14,Subject 8295,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,1,0,0,0,2,0,3,0,0,0,0,0,0,43,9,0,0,1,8
Study 22,EMEA,POL,Site 14,Subject 8296,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8297,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8298,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8299,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8301,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,13,0,1,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8307,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 14,Subject 8310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,8,0,0,1,7
Study 22,EMEA,POL,Site 14,Subject 8311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,POL,Site 14,Subject 8312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,36,9,0,0,1,8
Study 22,EMEA,POL,Site 14,Subject 8313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,POL,Site 14,Subject 8314,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 39,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 40,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 41,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 42,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 43,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 44,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 45,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 46,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 47,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 48,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 49,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 50,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 15,Subject 51,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 55,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 56,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 57,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 58,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,123,0,,,,0,0,0,1,0,0,0,1,11,52,0,0,0,0,0,0,82,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 59,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 8365,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,8,0,0,4,0,0,0,12,18,6,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,POL,Site 16,Subject 8366,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 8367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 8368,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 16,Subject 8369,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 638,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 639,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 640,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8387,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8388,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8389,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8390,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8391,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8392,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,97,0,,,,0,0,0,0,0,0,0,0,0,40,0,0,0,0,0,0,73,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8393,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8394,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8395,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 8397,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34069,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34070,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34071,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34072,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34073,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34074,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34077,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34078,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34079,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34080,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34081,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34084,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34085,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34086,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34087,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34088,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34089,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34090,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34091,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34092,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34093,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34095,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34096,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34097,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34098,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34100,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,1,0,0,0,1,0,20,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34101,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34102,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34104,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34105,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34106,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34107,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34109,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34110,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34111,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34113,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,7,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34116,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34117,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34118,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34119,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34120,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34121,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34122,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34124,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34126,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34127,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34128,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34131,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,1,0,0,0,1,0,21,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34134,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34136,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34138,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34142,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34144,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34147,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34149,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34152,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 89,Subject 34155,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 641,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 642,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,EMEA,POL,Site 90,Subject 643,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 644,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 645,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 646,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,POL,Site 90,Subject 8398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,POL,Site 90,Subject 8399,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8400,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,POL,Site 90,Subject 8402,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 8406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34158,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 90,Subject 34161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 60,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 61,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 62,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8408,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8409,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,POL,Site 17,Subject 8410,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,9,0,0,2,7
Study 22,EMEA,POL,Site 17,Subject 8411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,POL,Site 17,Subject 8412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,POL,Site 17,Subject 8413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8414,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,3,11,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,4,9,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,POL,Site 17,Subject 8417,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8418,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 8420,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34163,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34165,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34166,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34167,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34169,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,POL,Site 17,Subject 34172,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34176,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34177,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 17,Subject 34179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 650,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,49,1,0,1,2,0
Study 22,EMEA,POL,Site 92,Subject 651,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,4,0,0,0,4
Study 22,EMEA,POL,Site 92,Subject 652,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 653,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,14,0,0,1,1,0
Study 22,EMEA,POL,Site 92,Subject 654,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 655,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,POL,Site 92,Subject 656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 657,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,14,1,0,0,1,0
Study 22,EMEA,POL,Site 92,Subject 658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 659,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 92,Subject 661,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 163,Subject 1496,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1498,Unplanned visit (2),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,5,54,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1499,Unplanned visit (6),On Trial,,,,,,,,,,5,78,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1500,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,1,12,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1501,Unplanned visit (2),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1502,Unplanned visit (2),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1503,Unplanned visit (5),On Trial,,,,,,,,,,5,85,0,,,,0,0,0,4,0,0,0,4,5,20,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1504,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1505,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1506,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 164,Subject 1507,Unplanned visit (2),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,2,0,0,0,2,2,13,0,0,0,0,0,1,54,0,0,0,0,0
Study 22,EMEA,POL,Site 354,Subject 2848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 354,Subject 2849,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 354,Subject 2850,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 354,Subject 2851,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 2852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,37,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34180,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34186,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34187,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,POL,Site 355,Subject 34188,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,POL,Site 1789,Subject 34189,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,18,35,0,0,0,0,0,0,45,2,0,0,1,1
Study 22,EMEA,POL,Site 1789,Subject 34190,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,1,0,0,1,0
Study 22,EMEA,POL,Site 1789,Subject 34191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,35,8,0,0,1,7
Study 22,EMEA,POL,Site 867,Subject 8510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,2,0,0,0,2,3,56,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8512,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8513,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8516,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8521,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8522,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,POL,Site 867,Subject 8524,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 678,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 679,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 680,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 681,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,27,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8560,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,EMEA,POL,Site 94,Subject 8561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8563,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8566,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,EMEA,POL,Site 94,Subject 8567,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,POL,Site 94,Subject 8569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 94,Subject 8574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,47,3,0,0,3,0
Study 22,EMEA,POL,Site 94,Subject 8575,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 682,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 683,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 684,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 685,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,43,2,0,0,1,1
Study 22,EMEA,POL,Site 95,Subject 687,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,POL,Site 95,Subject 688,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 689,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 692,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 8576,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 8577,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 8578,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 95,Subject 8579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 694,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 695,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,6,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 696,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 698,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 699,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 700,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 701,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 702,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 703,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 704,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8583,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8586,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8587,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8588,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,56,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,2,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 8591,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34192,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34196,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34198,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,1,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34199,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34203,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,54,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34205,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34207,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 96,Subject 34210,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 97,Subject 705,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,3,49,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 97,Subject 706,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 97,Subject 707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 97,Subject 708,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 97,Subject 709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,24,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8613,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8615,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 8617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 868,Subject 34211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,4,9,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,EMEA,POL,Site 868,Subject 34212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 711,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,61,0,,,,0,0,0,0,0,0,0,0,0,57,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8618,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,POL,Site 98,Subject 8619,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8620,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8622,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8623,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8624,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8625,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8626,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8627,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8628,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8629,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,34,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 8630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 34213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,2,0,0,1,1
Study 22,EMEA,POL,Site 98,Subject 34214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 34215,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 98,Subject 34216,Visit 1 (1),Discontinued,,,,,,,,,,2,29,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,28,0,0,0,0,0
Study 22,EMEA,POL,Site 869,Subject 8631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,POL,Site 869,Subject 8632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 869,Subject 8633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 869,Subject 8634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 869,Subject 8635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34217,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34218,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34219,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34220,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34221,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,2,0,0,0,2,20,42,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34225,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34226,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34228,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34231,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34232,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,46,0,,,,1,0,0,1,0,0,0,2,1,4,0,0,0,0,0,0,41,1,3,0,4,0
Study 22,EMEA,POL,Site 1790,Subject 34233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 1790,Subject 34234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,POL,Site 99,Subject 712,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 713,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 715,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 716,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 717,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 719,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 721,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 722,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 723,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 724,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 726,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 34235,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 34236,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 34237,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 34238,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 99,Subject 34239,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 730,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 731,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 732,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 733,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34242,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34244,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34245,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34246,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,2,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34247,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34248,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34249,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34250,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34251,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34252,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34253,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34254,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34257,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34258,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34259,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34263,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34266,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34267,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34268,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 100,Subject 34269,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 734,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 735,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 736,Unplanned visit (5),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8672,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8679,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 8680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 34270,Unplanned visit (6),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 34271,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 34272,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 34273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 101,Subject 34274,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8681,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8685,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,EMEA,POL,Site 870,Subject 8687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,POL,Site 870,Subject 8690,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8691,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 870,Subject 8693,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,1,0,0,1,0
Study 22,EMEA,POL,Site 870,Subject 8694,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,POL,Site 870,Subject 8695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,9,0,0,2,7
Study 22,EMEA,POL,Site 871,Subject 8709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,1,1,0
Study 22,EMEA,POL,Site 871,Subject 8711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8712,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8713,Screening,Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,20,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8714,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8715,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8716,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8718,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8720,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,1,1,0
Study 22,EMEA,POL,Site 871,Subject 8722,Unplanned visit (6),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8723,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8724,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8725,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,POL,Site 871,Subject 8726,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 873,Subject 8831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,PRT,Site 873,Subject 8832,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,PRT,Site 873,Subject 8833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 873,Subject 8834,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,PRT,Site 520,Subject 3767,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,PRT,Site 520,Subject 3768,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,PRT,Site 520,Subject 3769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,PRT,Site 520,Subject 8867,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 3770,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 3771,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 3772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 3773,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,PRT,Site 521,Subject 8892,Unplanned visit (1),On Trial,,,,,,,,,,4,99,1,,,,0,0,0,14,0,0,0,14,18,33,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8898,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8899,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8900,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8902,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8903,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8904,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 8905,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,3,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 34275,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 34276,Unplanned visit (1),On Trial,,,,,,,,,,2,28,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,27,0,0,0,0,0
Study 22,EMEA,PRT,Site 521,Subject 34277,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 522,Subject 3774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,PRT,Site 522,Subject 8927,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,PRT,Site 522,Subject 8928,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,PRT,Site 522,Subject 8929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 522,Subject 8930,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 875,Subject 8964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,PRT,Site 875,Subject 8965,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 875,Subject 8966,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,PRT,Site 875,Subject 8967,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,PRT,Site 875,Subject 8968,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8989,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8992,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8993,Unplanned visit (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8994,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8995,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8997,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,3,41,0,,,,1,0,0,0,0,0,0,1,0,5,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 8999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9000,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9001,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9003,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9004,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,1,0,47,7,0,0,1,6
Study 22,EMEA,PRT,Site 876,Subject 9006,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9007,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 876,Subject 9013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 3775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 3776,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 3777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9043,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9044,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,PRT,Site 523,Subject 9046,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9047,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9048,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 523,Subject 9049,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9060,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,4,47,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,PRT,Site 877,Subject 9061,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9062,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9063,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9064,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,4,0,0,0,4
Study 22,EMEA,PRT,Site 877,Subject 9065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9069,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 877,Subject 9070,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9093,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9094,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9095,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9096,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9100,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 878,Subject 9103,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 9110,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 9111,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,32,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,EMEA,PRT,Site 879,Subject 9112,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 9113,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 9114,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34278,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34279,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,7,7,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34282,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34284,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34286,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34288,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,EMEA,PRT,Site 879,Subject 34290,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34291,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,PRT,Site 879,Subject 34292,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 3778,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 3779,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 3780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 3781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34293,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34294,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34295,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34296,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34297,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34298,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34299,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34300,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34301,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34302,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34303,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34304,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,ROU,Site 524,Subject 34305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34317,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34318,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,52,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34322,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 524,Subject 34323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3783,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3784,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,23,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3786,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3787,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 3788,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34324,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34326,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34327,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34328,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34334,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34335,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 526,Subject 34336,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34337,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34338,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34340,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34341,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34342,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34343,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,1,17,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34345,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34346,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34352,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34355,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34357,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34358,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34359,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34360,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34361,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1791,Subject 34362,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 3789,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34363,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,1,0,0,0,1,2,17,0,0,0,0,1,0,63,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34364,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ROU,Site 527,Subject 34365,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34366,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,83,0,,,,0,2,0,1,0,0,0,3,2,29,0,0,0,0,0,0,61,4,0,0,4,0
Study 22,EMEA,ROU,Site 527,Subject 34368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34369,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ROU,Site 527,Subject 34371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ROU,Site 527,Subject 34372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ROU,Site 527,Subject 34373,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34374,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 527,Subject 34375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1792,Subject 34376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1793,Subject 34377,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1793,Subject 34378,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1793,Subject 34379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1794,Subject 34380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,6,37,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1794,Subject 34381,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1795,Subject 34382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1795,Subject 34383,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1795,Subject 34384,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34385,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34387,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34388,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34390,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1796,Subject 34392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 292,Subject 2417,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,2,0,0,0,2,12,51,0,0,0,0,1,1,56,0,0,0,0,0
Study 22,EMEA,ROU,Site 292,Subject 2418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 292,Subject 2419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 292,Subject 2420,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 292,Subject 34393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34394,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34398,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34399,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34400,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34402,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34403,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34406,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34407,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34408,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34410,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34411,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34413,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34414,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34417,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34418,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34419,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34420,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34421,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1797,Subject 34422,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34424,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34427,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34428,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34429,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34430,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34431,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34433,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34434,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34436,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34437,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34438,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34443,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34446,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34447,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34448,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34450,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ROU,Site 1798,Subject 34451,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 2421,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,6,55,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34452,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34453,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34454,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,83,0,,,,0,0,0,2,0,0,0,2,0,31,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34457,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34458,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34460,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34461,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34462,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34464,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34466,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34467,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34472,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 293,Subject 34473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34474,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34475,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34476,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34477,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34479,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34480,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34481,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34485,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34491,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34493,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1799,Subject 34495,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,ROU,Site 294,Subject 2422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 294,Subject 2423,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 294,Subject 2424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,EMEA,ROU,Site 295,Subject 2425,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2431,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2432,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 295,Subject 2433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 297,Subject 2436,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 297,Subject 2437,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 297,Subject 2438,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 297,Subject 2439,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ROU,Site 297,Subject 2440,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34496,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,ROU,Site 1800,Subject 34497,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,ROU,Site 1800,Subject 34498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,ROU,Site 1800,Subject 34499,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34501,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34502,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34503,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1800,Subject 34504,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34505,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34506,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34507,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34508,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34509,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34510,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34511,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34512,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34513,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34514,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34515,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34520,Unplanned visit (2),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1801,Subject 34523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34525,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34527,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34528,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 1802,Subject 34529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34530,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34531,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34534,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34535,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34536,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34537,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34538,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34539,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34540,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1803,Subject 34546,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34547,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34549,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34550,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34551,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1804,Subject 34552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,44,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,EMEA,ROU,Site 1805,Subject 34554,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,EMEA,ROU,Site 1805,Subject 34556,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34558,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,36,0,1,0,1,0
Study 22,EMEA,ROU,Site 1805,Subject 34559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34561,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1805,Subject 34562,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,7,19,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34568,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1806,Subject 34571,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34574,Unplanned visit (13),On Trial,,,,,,,,,,5,97,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,96,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34575,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34576,Unplanned visit (11),On Trial,,,,,,,,,,5,87,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,2,0,85,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34579,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34580,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34581,Unplanned visit (13),On Trial,,,,,,,,,,5,92,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,91,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34582,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34583,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34586,Unplanned visit (3),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,4,0,0,0,4,9,11,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34587,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,42,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34590,Unplanned visit (9),On Trial,,,,,,,,,,5,83,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,82,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34591,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34592,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34593,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,77,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,75,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34594,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34596,Unplanned visit (8),On Trial,,,,,,,,,,5,76,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,75,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34597,Unplanned visit (5),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34598,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34600,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34601,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34602,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,2,10,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34604,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34606,Unplanned visit (8),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,0,0,0,0,0,5,11,0,0,0,0,0,0,74,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34607,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,74,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34608,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34609,Unplanned visit (2),On Trial,,,,,,,,,,4,46,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34610,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,76,0,,,,0,0,0,1,0,0,0,1,4,13,0,0,0,0,1,0,74,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,85,0,,,,0,0,0,1,0,0,0,1,3,15,0,0,0,0,0,0,83,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34613,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,0,21,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,2,10,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34615,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34616,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34617,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1807,Subject 34618,Unplanned visit (6),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34619,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,47,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34622,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34628,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34629,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34631,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34633,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34638,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34640,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,9,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34644,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34645,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34646,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34650,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1808,Subject 34651,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34653,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34657,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34659,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,ROU,Site 1809,Subject 34663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,ROU,Site 1809,Subject 34664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,ROU,Site 1809,Subject 34665,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34666,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,ROU,Site 1809,Subject 34668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,14,1,0,0,0,1,0,46,6,0,0,0,6
Study 22,EMEA,ROU,Site 1809,Subject 34669,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34670,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1809,Subject 34671,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34673,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34674,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34679,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34680,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34682,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34683,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34694,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1810,Subject 34699,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34701,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34702,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34703,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34705,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34706,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34707,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34709,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34711,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34713,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,41,2,0,0,2,0
Study 22,EMEA,ROU,Site 1811,Subject 34715,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1811,Subject 34716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1812,Subject 34717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1812,Subject 34718,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34719,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34720,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34722,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34730,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34737,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34739,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34740,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ROU,Site 1813,Subject 34741,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34748,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34749,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34750,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34754,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34759,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34761,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,18,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34762,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34763,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34766,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ROU,Site 1814,Subject 34768,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ROU,Site 1815,Subject 34769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ROU,Site 1815,Subject 34770,Unplanned visit (1),Discontinued,,,,,,,,,,1,23,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,EMEA,ROU,Site 1815,Subject 34771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,10,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 585,Subject 3978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,34,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 585,Subject 34772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 585,Subject 34773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 585,Subject 34774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 585,Subject 34775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 4020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34776,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,96,0,,,,0,0,0,6,0,0,0,6,22,16,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34779,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34780,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34782,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,1,13,1,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34785,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34786,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34787,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34788,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 598,Subject 34791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34792,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34793,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34795,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34802,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34810,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34812,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34815,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34816,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34820,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34821,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34822,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34823,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1816,Subject 34825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 2578,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,0,66,0,0,0,0,2,0,61,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34827,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34828,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34837,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34839,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34840,End of Study (EOS) (1),Discontinued,,,,,,,,,,6,68,0,,,,0,0,0,3,0,0,0,3,1,13,0,1,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 308,Subject 34843,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34844,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34845,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34847,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,5,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34848,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34850,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34851,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34852,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,4,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34854,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34855,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1817,Subject 34859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 2579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34862,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34865,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34866,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34869,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34870,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 309,Subject 34872,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34877,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1818,Subject 34884,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34886,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34887,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34890,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34891,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34892,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34898,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34900,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1819,Subject 34901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34902,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34903,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34904,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34905,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34906,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34909,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34910,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34911,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,1,0,0,0,1,0,26,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34918,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34920,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34923,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34924,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34925,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34926,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34928,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34932,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,1,,,,0,0,0,1,0,0,0,1,8,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34939,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34941,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34943,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34946,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1820,Subject 34947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34948,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,8,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34951,Visit 1 (1),Discontinued,,,,,,,,,,2,49,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,78,0,,,,0,0,0,3,0,0,0,3,9,21,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34956,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,6,0,0,0,6,9,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1821,Subject 34957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34958,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34959,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34960,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34962,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1822,Subject 34965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1823,Subject 34966,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,9,43,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,EMEA,SVK,Site 1823,Subject 34967,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1823,Subject 34968,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1823,Subject 34969,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1823,Subject 34970,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1823,Subject 34971,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34972,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,62,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34974,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34975,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34976,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34978,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34980,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34982,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34983,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,1,0,0,0,1,0,22,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,85,0,,,,0,1,0,4,0,0,0,5,0,39,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,EMEA,SVK,Site 1824,Subject 34987,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34990,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34991,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,47,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34993,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34994,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34995,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34996,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34997,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 34999,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 35000,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 35001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 35002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1824,Subject 35003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35004,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,23,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35007,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35012,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35013,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1825,Subject 35016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,3,0,0,0,3,3,43,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35018,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,1,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35022,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,1,3,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35023,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35024,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35025,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1826,Subject 35026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,7,0,0,7
Study 22,EMEA,SVK,Site 1827,Subject 35027,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35028,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,24,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35029,Unplanned visit (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35030,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35031,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35032,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35035,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35036,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35040,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1827,Subject 35042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35043,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35045,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35048,Unplanned visit (2),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35050,Unplanned visit (3),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35051,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,46,2,0,0,2,0
Study 22,EMEA,SVK,Site 1828,Subject 35052,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35054,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35055,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35056,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35058,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35060,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1828,Subject 35061,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,41,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35063,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,1,,,,0,0,0,6,0,0,0,6,3,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35072,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,SVK,Site 1829,Subject 35073,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35077,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1830,Subject 35081,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1831,Subject 35082,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,16,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1831,Subject 35083,Screening,Discontinued,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,19,0,19,0,1,0,17,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35084,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35085,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35086,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,33,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35087,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35089,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,75,0,,,,0,0,0,2,0,0,0,2,1,24,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35091,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35092,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35093,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35096,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35104,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1832,Subject 35110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35111,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35113,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35115,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35117,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35121,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,1,,,,0,0,0,2,0,0,0,2,9,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35122,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1833,Subject 35123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35125,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35126,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35128,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35129,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35131,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35132,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35133,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35134,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35135,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35138,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35139,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35140,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35142,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35145,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1834,Subject 35147,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35148,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,13,38,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35151,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,3,9,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1835,Subject 35155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 2584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35156,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,SVK,Site 313,Subject 35157,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,SVK,Site 313,Subject 35158,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,SVK,Site 313,Subject 35159,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,7,0,0,0,7
Study 22,EMEA,SVK,Site 313,Subject 35160,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35162,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,SVK,Site 313,Subject 35163,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35166,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35167,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35169,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35170,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35174,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35176,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 313,Subject 35184,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35186,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35187,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,3,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35188,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35189,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35190,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35192,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35193,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,5,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35196,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35197,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,3,0,0,0,0,0,0,3,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35198,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35199,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35200,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35201,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35202,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35204,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35205,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35216,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35218,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1836,Subject 35220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35221,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35225,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35226,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35228,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35231,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1837,Subject 35234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35237,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35238,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35239,Visit 1 (1),Discontinued,,,,,,,,,,2,48,0,,,,0,0,0,0,0,0,0,0,0,14,1,1,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35242,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35243,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35244,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35245,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35247,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35248,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1838,Subject 35250,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,6,56,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35253,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35254,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35257,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35258,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35259,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,3,13,1,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35261,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,1,0,0,5,0,0,0,6,7,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35263,Unplanned visit (2),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35269,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SVK,Site 1839,Subject 35273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1840,Subject 35274,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1840,Subject 35275,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,37,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,1,0,35,0,0,0,0,0
Study 22,EMEA,SVK,Site 1840,Subject 35276,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1840,Subject 35277,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SVK,Site 1840,Subject 35278,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,41,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35280,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35285,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1841,Subject 35287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,54,0,0,0,0,0,0,50,0,0,1,1,0
Study 22,EMEA,SVK,Site 1842,Subject 35289,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35292,Unplanned visit (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1842,Subject 35300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35301,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35304,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35306,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35309,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35311,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35314,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1843,Subject 35315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,4,11,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35318,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,2,0,49,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35320,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35322,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SVK,Site 1844,Subject 35325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,103,1,,,,4,0,0,9,0,0,0,13,5,90,0,0,0,0,0,0,65,8,0,0,8,0
Study 22,EMEA,ESP,Site 1845,Subject 35327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35329,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35331,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35332,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35333,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35334,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35336,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1845,Subject 35338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,0,0,0,0,0,2,22,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2830,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2831,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 2835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35340,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35341,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35342,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35343,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35345,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35346,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,1,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35355,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35356,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35357,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35365,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35368,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 349,Subject 35369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 2836,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,9,29,0,0,0,0,2,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 350,Subject 35376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35377,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35378,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35379,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35382,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35383,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35384,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35385,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35386,Screening,Screen Failure,,,,,,,,,,1,27,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,63,0,,,,0,0,0,2,0,0,0,2,0,22,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1846,Subject 35388,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 3798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,50,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35389,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35390,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35391,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35392,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,2,0,0,0,2,0,10,0,0,0,0,1,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35393,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,3,17,0,0,0,0,1,0,57,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,5,14,0,0,0,0,1,0,54,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,49,3,0,0,2,1
Study 22,EMEA,ESP,Site 529,Subject 35398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,2,0,0,0,2,5,23,0,0,0,0,2,0,59,1,0,0,1,0
Study 22,EMEA,ESP,Site 529,Subject 35399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,1,0,0,2,0,0,1,4,9,8,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,ESP,Site 529,Subject 35400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35401,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35404,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,59,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,3,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35406,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35407,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35408,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 529,Subject 35412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 3799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35413,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35414,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35415,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35417,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35419,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35420,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,5,0,0,0,5
Study 22,EMEA,ESP,Site 530,Subject 35421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35422,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,1,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 530,Subject 35424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35427,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,1,0,0,0,1,1,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35428,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35429,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35430,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1847,Subject 35434,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35435,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35437,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35439,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,1,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35440,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35441,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35442,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,2,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 1848,Subject 35446,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35448,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1848,Subject 35453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35454,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1848,Subject 35455,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,1,0,0,0,0,0,0,1,0,6,0,0,0,0,0,0,36,7,0,0,4,3
Study 22,EMEA,ESP,Site 1848,Subject 35458,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35459,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35461,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35464,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35465,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35472,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35474,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35477,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35480,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35481,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35490,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ESP,Site 1848,Subject 35494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,14,0,1,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35498,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,56,0,,,,0,0,0,0,0,0,0,0,0,17,1,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35502,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35503,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1848,Subject 35506,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35507,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35508,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35509,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35510,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35511,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35512,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35513,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35514,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35515,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35516,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1849,Subject 35517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35519,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,ESP,Site 1849,Subject 35520,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35521,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1849,Subject 35522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1849,Subject 35525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35526,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35527,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35529,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35530,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1850,Subject 35533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1850,Subject 35534,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35535,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35539,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1850,Subject 35545,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35546,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35547,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35550,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,50,0,,,,0,0,0,1,0,0,0,1,0,15,1,0,0,0,1,0,42,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35551,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35552,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35553,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35554,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35555,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35556,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35557,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,61,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,49,4,0,0,4,0
Study 22,EMEA,ESP,Site 1851,Subject 35558,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35559,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35560,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35562,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,49,5,0,0,5,0
Study 22,EMEA,ESP,Site 1851,Subject 35563,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,4,0,0,4,0
Study 22,EMEA,ESP,Site 1851,Subject 35564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35566,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35568,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35569,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35570,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35572,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,ESP,Site 1851,Subject 35573,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,1,1,8
Study 22,EMEA,ESP,Site 1851,Subject 35575,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35576,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1851,Subject 35577,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,50,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35578,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,5,12,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35580,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,ESP,Site 1851,Subject 35581,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35583,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,1,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35587,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,ESP,Site 1851,Subject 35589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1851,Subject 35590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ESP,Site 1852,Subject 35591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35595,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35596,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35598,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35600,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1852,Subject 35602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35604,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35605,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35606,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35608,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35609,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35610,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35612,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35614,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35615,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35616,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35617,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35618,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,2,0,0,0,0,0,2,0,6,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35619,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35620,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35622,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1853,Subject 35624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1854,Subject 35625,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,3,53,0,0,0,0,2,0,51,3,0,0,3,0
Study 22,EMEA,ESP,Site 1854,Subject 35626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1854,Subject 35627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1854,Subject 35628,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1854,Subject 35629,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,3,9,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35632,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35634,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35635,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35636,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,ESP,Site 1855,Subject 35638,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35640,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35641,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35642,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35643,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35644,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35647,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35650,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1855,Subject 35652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35653,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35654,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35655,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35656,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35658,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35659,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35661,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35662,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35663,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1856,Subject 35664,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1857,Subject 35665,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,15,45,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1857,Subject 35666,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1857,Subject 35667,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1857,Subject 35668,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,82,0,,,,0,0,0,0,0,0,0,0,3,23,2,0,0,0,1,0,60,7,0,0,0,7
Study 22,EMEA,ESP,Site 1857,Subject 35669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1857,Subject 35670,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1857,Subject 35671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35672,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,43,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35673,Visit 1 (1),Discontinued,,,,,,,,,,2,27,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,25,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35674,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,69,0,,,,0,0,0,0,0,0,0,0,0,23,1,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35675,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35676,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35677,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,1,0,1,0,0,0,2,10,3,0,0,0,0,0,1,58,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35678,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35679,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35680,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35681,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35682,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35683,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35684,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35685,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35687,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35694,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,6,16,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1858,Subject 35704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35705,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35706,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35707,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35708,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35709,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35710,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35711,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35712,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35713,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,9,3,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35715,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35716,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35717,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35718,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35719,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35720,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35721,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35722,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35723,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35724,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35725,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35726,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35727,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35728,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35730,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,1,12,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35735,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35739,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,1,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35744,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35745,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1859,Subject 35746,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35747,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35749,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35751,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35754,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35755,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35756,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35757,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1860,Subject 35760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35761,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35762,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35763,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35764,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35765,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35766,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35767,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35768,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35769,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35770,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35771,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35772,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35773,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,41,7,0,0,0,7
Study 22,EMEA,ESP,Site 1861,Subject 35775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1861,Subject 35778,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,48,1,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35779,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35780,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35781,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35782,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,2,44,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1862,Subject 35787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35788,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35789,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,90,1,,,,0,0,0,1,0,0,0,1,6,79,0,0,0,0,2,0,72,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35790,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35791,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,86,0,,,,0,0,0,3,0,0,0,3,2,34,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35792,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,2,0,0,0,2,2,4,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1863,Subject 35797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35798,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35799,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,4,0,1,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35800,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,8,55,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,EMEA,ESP,Site 1864,Subject 35802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1864,Subject 35804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35809,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35810,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35817,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1865,Subject 35819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35820,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35821,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35822,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35827,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35832,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35834,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 35835,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35836,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1866,Subject 35837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1866,Subject 35838,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1868,Subject 35839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1868,Subject 35840,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,ESP,Site 1868,Subject 35841,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1868,Subject 35842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1868,Subject 35843,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35845,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,1,0,0,0,1,2,16,0,1,0,0,0,0,66,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35847,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,ESP,Site 1869,Subject 35848,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,ESP,Site 1869,Subject 35850,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,96,0,,,,0,0,0,1,0,0,0,1,1,44,0,0,0,0,1,0,67,4,0,0,4,0
Study 22,EMEA,ESP,Site 1869,Subject 35851,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35854,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1869,Subject 35855,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35856,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35858,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35859,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35862,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,ESP,Site 1870,Subject 35863,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35864,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,3,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35868,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1870,Subject 35872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35874,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35875,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35876,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35877,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35879,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35880,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35883,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35884,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1871,Subject 35889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35890,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,10,42,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35892,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35893,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1872,Subject 35896,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1873,Subject 35897,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1873,Subject 35898,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1873,Subject 35899,Unplanned visit (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,10,0,0,0,10
Study 22,EMEA,ESP,Site 1873,Subject 35900,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,ESP,Site 1873,Subject 35901,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,ESP,Site 1873,Subject 35902,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1873,Subject 35903,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1873,Subject 35904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,ESP,Site 1874,Subject 35905,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35906,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35908,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35909,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1874,Subject 35912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,2,61,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35917,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1875,Subject 35919,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35920,Screening,Discontinued,,,,,,,,,,1,18,0,,,,1,0,0,0,0,0,0,1,0,13,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,34,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35924,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35925,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35926,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35927,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35928,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35929,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35930,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35931,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35932,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35933,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35934,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35935,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35936,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,2,0,0,0,2,9,17,0,0,0,0,0,1,60,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35937,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35938,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35939,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1876,Subject 35948,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35949,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35950,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35951,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35952,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35953,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35954,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35955,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35956,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35957,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35958,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35959,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35960,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35961,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,ESP,Site 1877,Subject 35962,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35963,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1877,Subject 35964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,9,0,0,2,7
Study 22,EMEA,ESP,Site 1877,Subject 35965,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35966,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35968,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35969,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35970,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,1,17,1,1,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35971,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1877,Subject 35972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,10,42,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35974,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35975,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35976,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35978,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35979,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35980,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35982,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35983,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35984,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35985,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35986,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35987,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35988,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35989,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35990,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,47,0,,,,1,0,0,0,0,0,0,1,0,3,0,0,0,0,0,0,45,0,0,1,1,0
Study 22,EMEA,ESP,Site 1878,Subject 35993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,55,9,0,0,2,7
Study 22,EMEA,ESP,Site 1878,Subject 35994,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ESP,Site 1878,Subject 35995,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35996,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35998,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 35999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1878,Subject 36009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1879,Subject 36010,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1879,Subject 36011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1879,Subject 36012,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1879,Subject 36013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1879,Subject 36014,Unplanned visit (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,2,0,0,0,2,16,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36015,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36016,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,2,0,0,0,2,1,24,0,0,0,0,2,0,62,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36017,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36021,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36022,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36023,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36024,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36025,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,EMEA,ESP,Site 1880,Subject 36026,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,0,0,44,7,0,0,1,6
Study 22,EMEA,ESP,Site 1880,Subject 36027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36028,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1880,Subject 36037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36038,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,54,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,EMEA,ESP,Site 1881,Subject 36039,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36041,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36042,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1881,Subject 36043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,1,5,0,0,0,0,0,1,44,8,0,0,1,7
Study 22,EMEA,ESP,Site 1881,Subject 36044,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36045,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1881,Subject 36046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36047,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36048,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36049,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36050,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36051,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36052,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36053,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,8,0,0,0,8
Study 22,EMEA,ESP,Site 1882,Subject 36054,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1882,Subject 36055,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36056,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,1,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36058,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,1,0,0,0,1,0,24,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36061,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1882,Subject 36062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36063,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36064,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36065,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36066,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36067,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36069,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36070,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36072,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36073,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36077,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36081,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36082,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,111,0,,,,0,0,0,1,0,0,0,1,5,38,1,0,0,0,1,0,74,8,0,0,1,7
Study 22,EMEA,ESP,Site 1883,Subject 36084,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1883,Subject 36085,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36086,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36088,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36089,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36091,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,1,22,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36092,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36093,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36096,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1883,Subject 36098,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36100,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36101,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36102,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,7,5,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36104,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36105,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36106,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36107,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36109,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36110,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36112,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36113,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36115,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36118,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36121,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36122,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36123,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1884,Subject 36124,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36126,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36128,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36129,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36130,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36132,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1885,Subject 36134,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1885,Subject 36135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1886,Subject 36136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1886,Subject 36137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1886,Subject 36138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,3,0,53,2,0,0,2,0
Study 22,EMEA,ESP,Site 1886,Subject 36139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1886,Subject 36140,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,46,8,0,0,1,7
Study 22,EMEA,ESP,Site 1886,Subject 36141,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1886,Subject 36142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 1887,Subject 36150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36151,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,ESP,Site 1887,Subject 36152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1887,Subject 36153,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36154,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1887,Subject 36155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36158,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1887,Subject 36159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36160,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36161,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36162,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36163,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36165,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36166,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 1888,Subject 36167,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 1888,Subject 36168,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 1888,Subject 36170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36173,Visit 1 (1),Discontinued,,,,,,,,,,2,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36176,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,EMEA,ESP,Site 1888,Subject 36179,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1888,Subject 36183,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1889,Subject 36184,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1889,Subject 36185,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,ESP,Site 1889,Subject 36186,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,2,0,0,0,2,0,24,0,0,0,0,0,0,54,7,0,0,0,7
Study 22,EMEA,ESP,Site 1889,Subject 36187,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,ESP,Site 1889,Subject 36188,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,ESP,Site 1889,Subject 36189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1889,Subject 36190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36192,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36193,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 1890,Subject 36194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 1890,Subject 36196,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36197,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36198,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36199,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,ESP,Site 1890,Subject 36200,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36201,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,47,9,0,0,2,7
Study 22,EMEA,ESP,Site 1890,Subject 36202,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36203,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1890,Subject 36204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,2,20,0,0,0,0,1,0,47,7,0,0,0,7
Study 22,EMEA,ESP,Site 1890,Subject 36209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36210,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,ESP,Site 1890,Subject 36212,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1890,Subject 36214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36215,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36216,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,2,0,43,1,0,1,1,1
Study 22,EMEA,ESP,Site 1891,Subject 36217,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36218,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,3,0,43,0,0,1,1,0
Study 22,EMEA,ESP,Site 1891,Subject 36220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1891,Subject 36222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,2,0,47,0,0,2,2,0
Study 22,EMEA,ESP,Site 1891,Subject 36223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,ESP,Site 1891,Subject 36224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,ESP,Site 1891,Subject 36225,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,ESP,Site 1891,Subject 36226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,37,0,0,7,0,7
Study 22,EMEA,ESP,Site 1892,Subject 36227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,43,1,0,1,1,1
Study 22,EMEA,ESP,Site 1892,Subject 36228,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,1,1,7
Study 22,EMEA,ESP,Site 1892,Subject 36229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1892,Subject 36230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1892,Subject 36231,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1892,Subject 36232,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,48,1,0,0,1,0
Study 22,EMEA,ESP,Site 1892,Subject 36233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,ESP,Site 1893,Subject 36234,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,8,51,0,0,0,0,0,0,48,7,0,0,7,0
Study 22,EMEA,ESP,Site 1893,Subject 36235,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1893,Subject 36236,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,4,11,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1893,Subject 36237,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1893,Subject 36238,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,5,0,0,0,0,2,0,43,1,1,0,1,1
Study 22,EMEA,ESP,Site 1893,Subject 36239,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36240,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,EMEA,ESP,Site 1894,Subject 36243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36244,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36246,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36249,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36250,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1894,Subject 36254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36255,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36257,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36258,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,7,0,0,0,7
Study 22,EMEA,ESP,Site 1895,Subject 36259,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1895,Subject 36260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,10,0,0,3,7
Study 22,EMEA,ESP,Site 1895,Subject 36261,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1895,Subject 36263,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36266,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1895,Subject 36269,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36270,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36272,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,EMEA,ESP,Site 1896,Subject 36273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,ESP,Site 1896,Subject 36274,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,1,0,0,0,0,0,1,0,14,0,0,0,0,0,0,49,0,8,0,1,7
Study 22,EMEA,ESP,Site 1896,Subject 36275,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,ESP,Site 1896,Subject 36276,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,7,0,0,7
Study 22,EMEA,ESP,Site 1896,Subject 36277,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,1,0,0,1,0
Study 22,EMEA,ESP,Site 1896,Subject 36278,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,ESP,Site 1896,Subject 36279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,ESP,Site 1896,Subject 36280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,1,0,1,0,0,0,2,11,5,0,0,0,0,0,1,43,10,0,0,3,7
Study 22,EMEA,ESP,Site 1896,Subject 36281,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,8,0,0,1,7
Study 22,EMEA,ESP,Site 1896,Subject 36282,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36283,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,4,9,0,0,0,0,0,0,48,2,0,0,2,0
Study 22,EMEA,ESP,Site 1896,Subject 36285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,EMEA,ESP,Site 1896,Subject 36288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36289,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1896,Subject 36292,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36293,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36294,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36295,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36296,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36297,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36298,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36299,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36300,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36301,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36302,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36303,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,1,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36304,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36305,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36306,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36307,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36308,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36309,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36310,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36311,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36312,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36313,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36314,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36315,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,3,0,0,3,0,3,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,ESP,Site 1897,Subject 36316,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36317,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36318,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36319,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36320,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36321,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,84,0,,,,0,0,0,11,0,0,0,11,11,17,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36325,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36326,Screening,Screen Failure,,,,,,,,,,1,24,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,ESP,Site 1897,Subject 36328,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36329,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36331,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36332,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36333,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36334,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,3,0,0,0,3,1,9,0,0,0,0,0,0,58,3,0,0,3,0
Study 22,EMEA,ESP,Site 1897,Subject 36336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,3,0,0,0,3,6,3,0,0,0,0,0,0,44,9,0,0,1,8
Study 22,EMEA,ESP,Site 1897,Subject 36337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,2,9,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,2,0,0,0,2,1,11,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,EMEA,ESP,Site 1897,Subject 36342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36343,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36344,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36345,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36346,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36347,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36348,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36350,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,3,0,0,0,3,2,9,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,EMEA,ESP,Site 1897,Subject 36352,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36353,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,EMEA,ESP,Site 1897,Subject 36354,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36355,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36356,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36358,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1897,Subject 36361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1898,Subject 36362,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,12,41,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1898,Subject 36363,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1898,Subject 36364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36365,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,48,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36366,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1899,Subject 36370,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,ESP,Site 1867,Subject 36373,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1867,Subject 36375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,43,0,14,0,1,13
Study 22,EMEA,ESP,Site 1867,Subject 36376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,1,43,7,0,0,0,7
Study 22,EMEA,ESP,Site 1867,Subject 36377,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36378,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,7,0,0,7
Study 22,EMEA,ESP,Site 1867,Subject 36379,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1867,Subject 36380,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,ESP,Site 1867,Subject 36382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36383,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,48,2,0,0,2,0
Study 22,EMEA,ESP,Site 1867,Subject 36387,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,ESP,Site 1867,Subject 36390,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1867,Subject 36395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,46,4,0,0,4,0
Study 22,EMEA,ESP,Site 1867,Subject 36396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36400,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36402,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,EMEA,ESP,Site 1900,Subject 36405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 1900,Subject 36406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,ESP,Site 1900,Subject 36408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36409,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1900,Subject 36410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36411,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36412,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36413,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36414,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36415,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36417,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36419,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36420,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36421,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36424,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,9,4,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1901,Subject 36429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36430,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,10,42,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36431,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36432,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36433,Screening,Discontinued,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,18,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36434,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36439,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,1,0,0,0,0,0,0,1,1,5,0,0,0,0,1,0,39,2,0,0,0,2
Study 22,EMEA,ESP,Site 1902,Subject 36440,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36441,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,ESP,Site 1902,Subject 36442,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,10,0,0,2,8
Study 22,EMEA,ESP,Site 1902,Subject 36443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36444,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,ESP,Site 1902,Subject 36446,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36447,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36448,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1902,Subject 36449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36453,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36454,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36456,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36457,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36458,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36459,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36460,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36462,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36463,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36464,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36465,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1903,Subject 36466,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,42,7,0,0,2,5
Study 22,EMEA,ESP,Site 1903,Subject 36467,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1903,Subject 36469,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36470,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,ESP,Site 1903,Subject 36471,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1903,Subject 36472,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36473,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36474,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36475,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36476,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36477,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36478,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36479,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36480,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,4,18,0,0,0,0,0,0,58,3,0,0,3,0
Study 22,EMEA,ESP,Site 1904,Subject 36481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,EMEA,ESP,Site 1904,Subject 36482,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,9,0,0,0,9
Study 22,EMEA,ESP,Site 1904,Subject 36483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,44,7,0,0,0,7
Study 22,EMEA,ESP,Site 1904,Subject 36484,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,8,0,0,0,8
Study 22,EMEA,ESP,Site 1904,Subject 36485,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,44,7,0,0,1,6
Study 22,EMEA,ESP,Site 1904,Subject 36486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,5,0,0,0,5
Study 22,EMEA,ESP,Site 1904,Subject 36487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,EMEA,ESP,Site 1904,Subject 36490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,ESP,Site 1904,Subject 36491,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36492,Visit 1 (1),Discontinued,,,,,,,,,,2,46,0,,,,0,0,0,0,0,0,0,0,1,39,1,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36493,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36494,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36495,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36496,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36497,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36498,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,43,10,0,0,3,7
Study 22,EMEA,ESP,Site 1905,Subject 36499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36503,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36504,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36505,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,3,10,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,ESP,Site 1905,Subject 36508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 3979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 3980,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 36509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 36510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 36511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 36512,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 586,Subject 36513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,8,0,0,1,7
Study 22,EMEA,CHE,Site 587,Subject 3981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,51,1,0,0,1,0
Study 22,EMEA,CHE,Site 587,Subject 3982,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36514,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,CHE,Site 587,Subject 36515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,3,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 587,Subject 36521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,EMEA,CHE,Site 1906,Subject 36522,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36523,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36524,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36525,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36526,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,1,0,1,0,0,0,2,1,13,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,EMEA,CHE,Site 1906,Subject 36528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36529,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36530,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36531,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36534,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36535,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36537,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1906,Subject 36538,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36539,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,16,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36540,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36541,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,13,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36542,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36543,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36544,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36545,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36546,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36547,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,EMEA,CHE,Site 1907,Subject 36549,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36550,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,EMEA,CHE,Site 1907,Subject 36551,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,2,0,0,0,2,3,19,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,EMEA,CHE,Site 1907,Subject 36553,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36555,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1907,Subject 36556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36557,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36558,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36559,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36560,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36563,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,CHE,Site 1908,Subject 36566,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36570,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36575,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36576,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36577,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,CHE,Site 1908,Subject 36578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36579,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36580,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36582,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36583,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36584,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36588,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36590,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36595,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36600,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36601,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36602,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36604,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,36,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,34,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36605,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36606,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36607,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36610,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36611,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36612,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,GBR,Site 1909,Subject 36613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,GBR,Site 1909,Subject 36614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36618,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36620,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36622,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36626,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36627,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,1,0,0,0,1,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36630,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36631,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36634,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,5,0,0,0,5,1,15,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36640,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36641,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,32,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36646,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GBR,Site 1909,Subject 36647,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 3983,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,3,32,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36648,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36649,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36652,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36653,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36656,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36657,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36658,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,2,0,0,0,2,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 588,Subject 36659,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,EMEA,GBR,Site 589,Subject 3984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 3985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 3986,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 3987,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 3988,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36661,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36662,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36663,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36665,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,GBR,Site 589,Subject 36666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36667,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,1,1,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36669,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36671,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36674,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36676,Unplanned visit (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,1,0,0,0,1,9,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36679,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36682,Unplanned visit (1),On Trial,,,,,,,,,,4,56,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36688,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,GBR,Site 589,Subject 36689,Visit 1 (1),On Trial,,,,,,,,,,2,30,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,29,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3989,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3990,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,38,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3992,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3993,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3994,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3995,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 3996,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36690,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,GBR,Site 590,Subject 36691,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 590,Subject 36693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36694,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,7,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36702,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36704,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36706,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36708,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36709,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36712,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 590,Subject 36713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,EMEA,GBR,Site 590,Subject 36714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 3997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,15,37,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,EMEA,GBR,Site 592,Subject 3998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,GBR,Site 592,Subject 3999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,GBR,Site 592,Subject 4000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4003,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4004,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,38,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 4009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36715,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36722,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,4,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36726,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,54,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,0,46,2,0,0,0,2
Study 22,EMEA,GBR,Site 592,Subject 36727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,5,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36730,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36735,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36737,Unplanned visit (1),On Trial,,,,,,,,,,3,50,0,,,,0,0,0,1,0,0,0,1,6,9,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,GBR,Site 592,Subject 36738,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 4010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 4011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 4012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36740,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36742,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36744,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36746,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36747,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36749,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36750,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36751,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36754,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 591,Subject 36766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36767,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36768,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,70,0,,,,0,0,0,2,0,0,0,2,0,26,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36769,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,51,0,0,1,1,0
Study 22,EMEA,GBR,Site 1910,Subject 36771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36776,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36779,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36780,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36781,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36782,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36785,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36795,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1910,Subject 36797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1911,Subject 36798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1911,Subject 36799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1911,Subject 36800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,1,0,0,0,0,0,1,1,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1911,Subject 36801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,EMEA,GBR,Site 1912,Subject 36802,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1912,Subject 36803,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1912,Subject 36804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1912,Subject 36805,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1912,Subject 36806,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1912,Subject 36807,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,2,0,0,2,0
Study 22,EMEA,GBR,Site 1912,Subject 36808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,GBR,Site 1912,Subject 36809,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1913,Subject 36810,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,3,0,1,0,4
Study 22,EMEA,GBR,Site 1914,Subject 36811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36812,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,1,0,0,1,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36814,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36815,Unplanned visit (1),Discontinued,,,,,,,,,,3,57,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36816,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36817,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,2,0,0,0,2,0,14,0,0,0,0,1,0,45,5,0,0,1,4
Study 22,EMEA,GBR,Site 1914,Subject 36818,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36819,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36820,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36823,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36824,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,81,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,69,0,0,1,1,0
Study 22,EMEA,GBR,Site 1914,Subject 36826,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,48,6,0,0,0,6
Study 22,EMEA,GBR,Site 1914,Subject 36829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,GBR,Site 1914,Subject 36830,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36831,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,12,1,0,0,1,0
Study 22,EMEA,GBR,Site 1914,Subject 36832,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36833,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,2,0,0,0,2
Study 22,EMEA,GBR,Site 1914,Subject 36834,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36835,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 1914,Subject 36837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36839,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36840,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 1914,Subject 36841,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36842,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36843,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,1,0,0,1,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36844,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36845,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,2,0,0,0,2,0,4,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36847,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36848,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36850,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,39,2,0,0,0,2
Study 22,EMEA,GBR,Site 1914,Subject 36851,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36852,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36853,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36854,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,49,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36855,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36857,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36858,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36859,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36860,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36861,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36862,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36864,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,14,1,0,0,1,0
Study 22,EMEA,GBR,Site 1914,Subject 36865,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36868,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36869,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36870,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36872,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36877,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36879,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36880,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36881,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36882,Unplanned visit (2),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36883,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36884,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36885,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36886,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36887,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36888,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36889,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36890,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36891,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36892,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36897,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36898,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36899,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36900,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36901,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36902,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36906,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36907,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36908,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36909,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36911,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36912,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,2,0,0,0,2,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36914,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36915,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36917,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36919,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36920,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36921,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36922,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36923,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36924,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36925,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36926,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36927,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36928,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36929,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36930,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36931,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,2,0,0,0,2
Study 22,EMEA,GBR,Site 1914,Subject 36932,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,2,0,0,0,2,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36933,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36935,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,1,0,0,1,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36937,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,1,0,0,1,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,3,0,0,3,0,5,0,0,0,0,0,0,43,2,0,0,1,1
Study 22,EMEA,GBR,Site 1914,Subject 36941,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36942,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36948,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36949,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36950,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36951,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36952,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,1,0,0,2,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36955,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36956,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36957,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36958,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,1,0,0,1,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36959,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36962,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36964,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,48,2,0,0,2,0
Study 22,EMEA,GBR,Site 1914,Subject 36966,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36967,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36968,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36969,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,70,0,,,,0,0,0,6,0,0,0,6,0,27,0,0,0,0,0,0,49,3,0,0,2,1
Study 22,EMEA,GBR,Site 1914,Subject 36970,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36971,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,9,0,0,2,7
Study 22,EMEA,GBR,Site 1914,Subject 36973,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,2,2,0,0,4,1,22,0,0,0,0,0,0,52,8,0,0,4,4
Study 22,EMEA,GBR,Site 1914,Subject 36975,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36980,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36985,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36986,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36987,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1914,Subject 36991,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,GBR,Site 1914,Subject 36992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1914,Subject 36993,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1915,Subject 36994,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1915,Subject 36995,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1915,Subject 36996,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 36997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 36998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 36999,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37001,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,2,0,2,0
Study 22,EMEA,GBR,Site 1916,Subject 37008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1916,Subject 37010,Screening,Discontinued,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1916,Subject 37012,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1916,Subject 37013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,GBR,Site 1916,Subject 37014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1917,Subject 37015,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,11,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37016,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37017,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37018,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37019,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,1,0,0,1,0
Study 22,EMEA,GBR,Site 1917,Subject 37021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37022,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37023,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37024,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37028,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37029,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37031,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37032,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37033,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37036,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37038,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37040,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,1,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37043,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37044,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37045,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37046,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,34,2,0,0,2,0
Study 22,EMEA,GBR,Site 1917,Subject 37047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,GBR,Site 1917,Subject 37048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,EMEA,GBR,Site 1917,Subject 37050,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37051,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37052,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37054,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37055,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37056,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,84,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37058,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37061,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37062,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37063,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,GBR,Site 1917,Subject 37066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,EMEA,GBR,Site 1917,Subject 37067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,GBR,Site 1917,Subject 37070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,46,3,0,0,3,0
Study 22,EMEA,GBR,Site 1917,Subject 37071,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37074,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37075,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37076,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37077,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37078,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37079,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37080,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,5,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,GBR,Site 1917,Subject 37083,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,GBR,Site 1917,Subject 37084,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,39,8,0,0,2,6
Study 22,EMEA,GBR,Site 1917,Subject 37085,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,62,0,,,,0,0,0,3,0,0,0,3,12,12,0,0,0,0,0,0,37,7,0,0,6,1
Study 22,EMEA,GBR,Site 1917,Subject 37086,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,42,7,0,0,1,6
Study 22,EMEA,GBR,Site 1917,Subject 37088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37089,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37090,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37091,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,1,0,0,0,1,7,0,0,0,0,0,0,0,40,8,0,0,2,6
Study 22,EMEA,GBR,Site 1917,Subject 37092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,1,,,,0,0,0,1,0,0,0,1,3,13,0,0,0,0,0,0,41,8,0,0,2,6
Study 22,EMEA,GBR,Site 1917,Subject 37093,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37095,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,EMEA,GBR,Site 1917,Subject 37096,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,GBR,Site 1918,Subject 37097,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,1,0,0,0,1,0,57,1,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1918,Subject 37098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1918,Subject 37099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1918,Subject 37100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,1,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1918,Subject 37101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1918,Subject 37102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,9,43,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37104,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1919,Subject 37109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37110,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,1,8,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37111,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37112,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,24,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37113,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37116,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1920,Subject 37119,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,1,2,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1921,Subject 37120,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1921,Subject 37121,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1921,Subject 37122,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,17,2,0,0,2,0
Study 22,EMEA,GBR,Site 1921,Subject 37123,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,1,0,0,0,1,0,2,15,0,0,0,0,0,13,2,0,0,1,1
Study 22,EMEA,GBR,Site 1921,Subject 37124,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,1,0,0,0,1
Study 22,EMEA,GBR,Site 1922,Subject 37125,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,9,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37126,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37127,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37128,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37129,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37130,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37131,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,8,0,0,0,8,3,21,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37132,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37134,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37136,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,1,0,1,0,0,0,2,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37138,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1922,Subject 37139,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37140,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37141,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37143,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,12,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37147,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37149,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,9,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37154,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1923,Subject 37155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,3,14,0,0,0,0,0,0,46,8,0,0,1,7
Study 22,EMEA,GBR,Site 1924,Subject 37156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37157,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37158,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37159,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1924,Subject 37164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,GBR,Site 1924,Subject 37165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1924,Subject 37166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,GBR,Site 1924,Subject 37167,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37168,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,14,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37169,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37170,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37171,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37172,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37173,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37174,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37175,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37176,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,EMEA,GBR,Site 1925,Subject 37177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37178,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37180,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,47,5,0,0,0,5
Study 22,EMEA,GBR,Site 1925,Subject 37181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37183,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,1,0,0,0,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37185,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37187,Unplanned visit (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37189,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37191,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37192,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37193,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,56,0,,,,0,0,0,1,0,0,0,1,10,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37196,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37197,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37199,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37200,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37203,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37206,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37209,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37210,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37213,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37217,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37218,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37219,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37221,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,10,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37223,Screening,Screen Failure,,,,,,,,,,1,41,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,27,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37224,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37225,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37226,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37227,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1925,Subject 37229,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1926,Subject 37230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,GBR,Site 1927,Subject 37231,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1927,Subject 37232,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1927,Subject 37233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,8,20,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1927,Subject 37234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1927,Subject 37235,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,44,2,0,0,1,1
Study 22,EMEA,GBR,Site 1928,Subject 37237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1928,Subject 37238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37239,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37240,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37241,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37242,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,8,0,1,7
Study 22,EMEA,GBR,Site 1928,Subject 37243,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1929,Subject 37244,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,44,0,,,,0,0,0,1,0,0,0,1,10,21,0,0,0,0,0,0,38,0,4,0,0,4
Study 22,EMEA,GBR,Site 1929,Subject 37245,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1929,Subject 37246,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1929,Subject 37247,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,21,6,0,0,0,0,0,0,43,0,1,0,0,1
Study 22,EMEA,GBR,Site 1929,Subject 37248,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1929,Subject 37249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1929,Subject 37250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,37,5,0,0,0,5
Study 22,EMEA,GBR,Site 1930,Subject 37251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,2,0,0,0,2,2,66,0,0,0,0,1,0,42,7,8,0,1,14
Study 22,EMEA,GBR,Site 1930,Subject 37252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37255,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37256,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37257,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37258,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37263,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,3,49,0,,,,0,0,0,2,0,0,0,2,3,13,0,0,0,0,1,0,39,1,0,0,1,0
Study 22,EMEA,GBR,Site 1930,Subject 37264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37265,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1930,Subject 37266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1930,Subject 37267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1931,Subject 37268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,GBR,Site 1931,Subject 37269,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1931,Subject 37270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,1,1,0
Study 22,EMEA,GBR,Site 1931,Subject 37271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,EMEA,GBR,Site 1931,Subject 37272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1931,Subject 37273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,8,0,1,7
Study 22,EMEA,GBR,Site 1931,Subject 37274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,EMEA,GBR,Site 1931,Subject 37275,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,GBR,Site 1931,Subject 37276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,EMEA,GBR,Site 1931,Subject 37277,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,54,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,45,0,1,1,1,1
Study 22,EMEA,GBR,Site 1932,Subject 37278,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,15,35,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37281,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 1932,Subject 37283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37284,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,1,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37290,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37293,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37300,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,0,0,0,0,0,11,5,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37304,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37305,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1932,Subject 37307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,40,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37309,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1933,Subject 37314,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37315,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37316,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37317,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,1,,,,0,0,0,0,0,0,0,0,2,29,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37318,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37319,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37320,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37321,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,EMEA,GBR,Site 1934,Subject 37324,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37326,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37329,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37331,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,8,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37332,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37333,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37334,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37335,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37337,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37338,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37340,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37342,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37343,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37345,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37347,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37348,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37352,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37353,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37354,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37355,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37356,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37357,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37360,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37361,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37362,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37363,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37364,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37365,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,1,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37367,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37368,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37370,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37371,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37373,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37374,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37376,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37377,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37378,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,11,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37381,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37382,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1934,Subject 37383,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37384,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37385,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,21,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37387,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37388,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37389,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,33,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37392,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37395,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37397,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37399,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37400,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37401,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37402,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37403,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37405,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37406,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37408,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37410,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37411,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,48,1,0,0,0,1
Study 22,EMEA,GBR,Site 1935,Subject 37414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37417,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37419,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37420,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37423,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37424,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37425,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37427,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37428,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37435,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37436,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37437,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37438,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37440,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37441,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37444,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,2,0,0,1,1
Study 22,EMEA,GBR,Site 1935,Subject 37446,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37447,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37448,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37450,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37451,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37452,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,3,0,0,1,2
Study 22,EMEA,GBR,Site 1935,Subject 37453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37454,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37455,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37456,Visit 1 (1),Discontinued,,,,,,,,,,2,73,0,,,,0,0,0,0,0,0,0,0,0,37,1,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37458,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37461,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37462,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37463,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1935,Subject 37464,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,37,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,3,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37468,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37469,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37471,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37472,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37473,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1936,Subject 37475,Visit 1 (1),Discontinued,,,,,,,,,,2,45,0,,,,0,0,0,2,0,0,0,2,9,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GBR,Site 1937,Subject 37476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1937,Subject 37477,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,1,0,6,0,7
Study 22,EMEA,GBR,Site 1937,Subject 37478,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,9,44,0,0,0,0,0,0,43,3,0,0,1,2
Study 22,EMEA,GBR,Site 1938,Subject 37480,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37481,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37484,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37486,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1938,Subject 37494,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37499,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37502,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37503,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1939,Subject 37504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1940,Subject 37505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,28,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1940,Subject 37506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1940,Subject 37507,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1941,Subject 37508,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1941,Subject 37509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,8,39,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1941,Subject 37510,Screening,Discontinued,,,,,,,,,,1,22,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,19,1,0,0,1,0
Study 22,EMEA,GBR,Site 1941,Subject 37511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1941,Subject 37512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,EMEA,GBR,Site 1942,Subject 37513,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,39,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37514,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,1,0,1,0,0,0,2,0,15,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37518,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37519,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,3,0,0,3,0
Study 22,EMEA,GBR,Site 1942,Subject 37527,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37528,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37530,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37531,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1942,Subject 37532,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,7,38,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37534,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37535,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37538,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,GBR,Site 1943,Subject 37539,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,GBR,Site 1944,Subject 37540,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37541,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37542,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37543,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37544,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37545,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37546,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 1944,Subject 37547,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37548,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37550,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37551,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,3,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37553,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37555,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37556,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37561,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,GBR,Site 1944,Subject 37564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,45,0,1,0,0,1
Study 22,EMEA,GBR,Site 1945,Subject 37566,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,8,0,2,6
Study 22,EMEA,GBR,Site 1945,Subject 37567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,47,10,0,0,3,7
Study 22,EMEA,GBR,Site 1945,Subject 37568,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,1,6,0,0,7
Study 22,EMEA,GBR,Site 1945,Subject 37569,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37570,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,GBR,Site 1945,Subject 37571,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,EMEA,GBR,Site 1945,Subject 37572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37573,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,GBR,Site 1945,Subject 37574,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37575,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37576,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,EMEA,GBR,Site 1945,Subject 37577,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,0,6,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,EMEA,GBR,Site 1945,Subject 37580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37581,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37582,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,47,0,7,0,4,3
Study 22,EMEA,GBR,Site 1945,Subject 37583,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37584,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,1,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,47,0,2,0,2,0
Study 22,EMEA,GBR,Site 1945,Subject 37587,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37588,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,48,0,4,0,4,0
Study 22,EMEA,GBR,Site 1945,Subject 37591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,EMEA,GBR,Site 1945,Subject 37593,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37594,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,1,0,1,0
Study 22,EMEA,GBR,Site 1945,Subject 37596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,7,0,1,6
Study 22,EMEA,GBR,Site 1945,Subject 37597,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,0,0,0,0,0,2,22,0,0,0,0,0,0,46,0,8,0,2,6
Study 22,EMEA,GBR,Site 1945,Subject 37598,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1945,Subject 37599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,8,0,0,2,6
Study 22,EMEA,GBR,Site 1945,Subject 37600,Unplanned visit (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,11,0,0,0,11,10,6,0,0,0,0,0,0,37,12,0,0,1,11
Study 22,EMEA,GBR,Site 1945,Subject 37601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,EMEA,GBR,Site 1945,Subject 37602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,8,0,0,2,6
Study 22,EMEA,GBR,Site 1945,Subject 37603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,GBR,Site 1945,Subject 37604,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,GBR,Site 1946,Subject 37605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,2,0,0,0,2,15,45,0,0,0,0,0,0,45,0,1,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37606,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1946,Subject 37607,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,GBR,Site 1946,Subject 37609,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37610,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37613,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37618,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37619,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37622,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37628,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,1,0,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,42,1,0,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37631,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37635,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37637,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37640,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,GBR,Site 1946,Subject 37642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,GBR,Site 1946,Subject 37644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,GBR,Site 1946,Subject 37646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,1,6,0,1,6
Study 22,EMEA,GBR,Site 1946,Subject 37647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1946,Subject 37648,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37649,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,GBR,Site 1946,Subject 37651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,7,0,1,6
Study 22,EMEA,GBR,Site 1946,Subject 37652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,7,0,0,1,6
Study 22,EMEA,GBR,Site 1946,Subject 37653,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1946,Subject 37654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,GBR,Site 1946,Subject 37655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,EMEA,GBR,Site 1946,Subject 37656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,GBR,Site 1947,Subject 37657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37658,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37659,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,10,0,3,7
Study 22,EMEA,GBR,Site 1947,Subject 37660,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37661,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37662,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37663,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,1,0,1,0
Study 22,EMEA,GBR,Site 1947,Subject 37664,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37665,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,8,0,1,7
Study 22,EMEA,GBR,Site 1947,Subject 37666,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37667,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37668,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,8,0,0,1,7
Study 22,EMEA,GBR,Site 1947,Subject 37669,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37670,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37671,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,1,0,1,7
Study 22,EMEA,GBR,Site 1947,Subject 37672,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37673,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37675,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37676,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,47,7,0,0,0,7
Study 22,EMEA,GBR,Site 1947,Subject 37677,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,GBR,Site 1947,Subject 37678,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,0,0,0,0,1,1,8,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,GBR,Site 1947,Subject 37679,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37682,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,GBR,Site 1947,Subject 37683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37687,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1928,Subject 37689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,GBR,Site 1947,Subject 37690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37694,Unplanned visit (2),Discontinued,,,,,,,,,,4,49,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,38,0,7,0,1,6
Study 22,EMEA,GBR,Site 1947,Subject 37696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,36,0,7,0,1,6
Study 22,EMEA,GBR,Site 1947,Subject 37698,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37699,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,GBR,Site 1947,Subject 37700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,35,8,0,0,2,6
Study 22,EMEA,GBR,Site 1947,Subject 37701,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37702,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,9,52,0,0,0,0,0,0,48,2,0,1,1,2
Study 22,EMEA,GBR,Site 1948,Subject 37703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,1,0,0,0,0,0,0,1,0,6,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1948,Subject 37708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1948,Subject 37709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1948,Subject 37710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,GBR,Site 1948,Subject 37714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,1,0,0,0,0,0,0,1,1,14,0,0,0,0,0,0,42,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37716,Unplanned visit (2),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,4,8,1,11
Study 22,EMEA,GBR,Site 1948,Subject 37717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,7,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,41,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,1,0,1
Study 22,EMEA,GBR,Site 1948,Subject 37727,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,38,1,0,7,0,8
Study 22,EMEA,GBR,Site 1948,Subject 37728,Screening,Discontinued,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37729,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37730,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,7,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,8,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37732,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,0,37,0,0,9,1,8
Study 22,EMEA,GBR,Site 1948,Subject 37734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,7,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,1,0,7,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,8,0,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37739,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,0,0,0,0,0,15,7,1,0,0,0,2,0,51,8,0,0,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,1,7,0,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37742,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,7,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,7,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,EMEA,GBR,Site 1948,Subject 37747,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,33,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,GBR,Site 1948,Subject 37749,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,GBR,Site 1948,Subject 37750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,GBR,Site 1948,Subject 37751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,9,6,0,0,0,0,0,0,42,6,0,0,0,6
Study 22,EMEA,GBR,Site 1948,Subject 37752,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,1,0,1
Study 22,EMEA,GBR,Site 1948,Subject 37753,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37756,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37757,Visit 1 (1),Discontinued,,,,,,,,,,2,31,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37761,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,GBR,Site 1949,Subject 37762,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,GBR,Site 1950,Subject 37763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,4,0,0,0,4,0,46,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,EMEA,GBR,Site 1950,Subject 37764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,4,0,0,0,4,0,4,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,AMERICA,ARG,Site 435,Subject 3284,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,57,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3285,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3286,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 3291,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9784,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9787,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9788,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9789,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9790,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9791,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9792,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9795,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9797,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9803,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9805,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9809,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9812,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9816,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9817,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9818,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9819,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9820,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9822,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9829,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9830,Visit 1 (1),Discontinued,,,,,,,,,,2,48,0,,,,0,0,0,0,0,0,0,0,0,16,1,0,0,0,1,0,40,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,ARG,Site 435,Subject 9835,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9836,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9837,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9839,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9840,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9841,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9843,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9844,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9845,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9846,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9849,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9851,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9853,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9855,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9857,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9858,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9859,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9860,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9861,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9862,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 9867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37768,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37770,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37773,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37776,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37779,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37780,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37781,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37782,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37785,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37786,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,AMERICA,ARG,Site 435,Subject 37788,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37789,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37790,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37791,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37792,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37793,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37794,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 435,Subject 37795,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 2592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 2593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 2594,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9944,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9945,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9947,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9948,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,ARG,Site 315,Subject 9949,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9950,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9951,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9952,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9953,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9954,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9955,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,7,0,0,0,7
Study 22,AMERICA,ARG,Site 315,Subject 9956,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,7,0,0,1,6
Study 22,AMERICA,ARG,Site 315,Subject 9957,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,AMERICA,ARG,Site 315,Subject 9958,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,ARG,Site 315,Subject 9959,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,AMERICA,ARG,Site 315,Subject 9960,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 315,Subject 9965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 1514,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,54,0,0,0,0,1,0,53,1,0,0,1,0
Study 22,AMERICA,ARG,Site 166,Subject 1515,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 1516,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 1517,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 1518,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9970,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9971,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9972,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,1,19,0,0,0,0,0,0,57,6,0,0,0,6
Study 22,AMERICA,ARG,Site 166,Subject 9974,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9975,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,44,8,0,0,2,6
Study 22,AMERICA,ARG,Site 166,Subject 9976,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9977,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9978,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9982,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 9985,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,ARG,Site 166,Subject 9986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37799,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37800,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,1,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,ARG,Site 166,Subject 37805,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,5,12,0,0,0,0,0,0,45,6,0,0,6,0
Study 22,AMERICA,ARG,Site 166,Subject 37806,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37807,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37808,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37809,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37810,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,1,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,ARG,Site 166,Subject 37813,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 166,Subject 37814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,ARG,Site 316,Subject 2595,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,7,57,0,0,0,0,0,0,57,1,0,0,0,1
Study 22,AMERICA,ARG,Site 316,Subject 2596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 2597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 2598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 2599,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 2600,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 3311,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 3312,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 3313,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9987,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9988,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,1,0,0,2,2,7,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,AMERICA,ARG,Site 316,Subject 9989,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9990,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,1,0,47,2,0,0,0,2
Study 22,AMERICA,ARG,Site 316,Subject 9991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9992,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9994,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9995,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9998,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 9999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,ARG,Site 316,Subject 10000,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10009,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10014,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 316,Subject 10015,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10080,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10081,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,7,47,0,0,0,0,0,0,47,1,0,0,0,1
Study 22,AMERICA,ARG,Site 910,Subject 10082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10083,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10084,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10085,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 910,Subject 10087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,2,0,0,0,2,1,7,0,0,0,0,0,0,38,5,0,0,0,5
Study 22,AMERICA,ARG,Site 910,Subject 10088,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,AMERICA,ARG,Site 910,Subject 10089,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,AMERICA,ARG,Site 910,Subject 10090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,AMERICA,ARG,Site 168,Subject 1520,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1521,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1522,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1523,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1524,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1525,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1526,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1527,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1529,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1530,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1532,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1534,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1535,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 1536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,50,6,0,0,0,6
Study 22,AMERICA,ARG,Site 168,Subject 37816,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,ARG,Site 168,Subject 37817,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,5,0,0,0,5
Study 22,AMERICA,ARG,Site 168,Subject 37818,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37821,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37822,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37826,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37827,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37828,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37831,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37832,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,39,4,0,0,0,4
Study 22,AMERICA,ARG,Site 168,Subject 37833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,39,5,0,1,2,4
Study 22,AMERICA,ARG,Site 168,Subject 37834,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,37,4,0,0,0,4
Study 22,AMERICA,ARG,Site 168,Subject 37835,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37836,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,62,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37837,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37838,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37839,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,56,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 168,Subject 37840,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,33,5,0,0,1,4
Study 22,AMERICA,ARG,Site 356,Subject 2853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10157,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10158,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10160,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10162,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,AMERICA,ARG,Site 356,Subject 10167,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 356,Subject 10168,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 1537,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 1538,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10347,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10349,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10352,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10354,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10355,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10356,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10360,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10363,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10364,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 169,Subject 10365,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1539,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,11,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1542,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1544,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1545,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 1546,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 37841,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 170,Subject 37842,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1547,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,7,54,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,ARG,Site 171,Subject 1548,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1549,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1550,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1551,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1552,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1553,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1554,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1555,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 171,Subject 1556,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 1566,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 1567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 1568,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 1569,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10390,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10391,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,0,0,0,0,0,1,25,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10392,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10393,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10394,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,1,0,0,0,0,0,0,1,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10398,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10399,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10400,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10401,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10403,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10405,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10409,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10414,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 172,Subject 10415,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1570,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1571,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1573,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1575,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 1576,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 37843,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,1,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 37844,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 37845,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 173,Subject 37846,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,37,1,0,0,1,0
Study 22,AMERICA,ARG,Site 436,Subject 3314,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3315,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3316,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,ARG,Site 436,Subject 3317,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3318,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3319,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3320,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 3321,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10525,Unplanned visit (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,6,0,0,0,6,10,6,0,0,0,0,0,0,61,1,0,0,1,0
Study 22,AMERICA,ARG,Site 436,Subject 10526,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,1,41,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10527,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10529,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10530,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10531,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10533,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10534,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10535,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10536,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,2,0,0,0,2,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10537,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10539,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10540,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10541,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 436,Subject 10543,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1577,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,0,0,59,0,0,1,1,0
Study 22,AMERICA,ARG,Site 174,Subject 1578,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1579,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1580,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,6,0,0,0,6
Study 22,AMERICA,ARG,Site 174,Subject 1581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1582,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1583,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1584,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1588,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1589,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 1590,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10673,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10674,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10675,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10676,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10677,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10679,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 174,Subject 10680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 174,Subject 10681,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 3329,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,52,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10876,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10877,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10879,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10880,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10881,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,2,0,0,0,2,8,9,0,0,0,0,1,0,54,1,0,0,0,1
Study 22,AMERICA,ARG,Site 438,Subject 10883,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10884,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10885,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10886,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10887,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10888,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10889,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10890,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10891,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 438,Subject 10892,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10900,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10901,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10902,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10903,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10904,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10905,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10906,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10907,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10908,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10910,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10913,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10914,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10917,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10919,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10920,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10922,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10923,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 911,Subject 10924,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,36,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10975,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10978,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,3,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10981,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10983,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10986,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10989,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 10990,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 912,Subject 37847,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10991,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10992,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,7,62,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,ARG,Site 913,Subject 10993,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10994,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,ARG,Site 913,Subject 10995,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10996,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,ARG,Site 913,Subject 10997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10998,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,52,0,,,,0,0,0,0,0,0,0,0,0,16,1,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 10999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11001,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11002,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11003,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11004,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11005,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11007,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11008,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11009,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11011,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11012,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 11013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37848,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37850,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37851,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37852,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37854,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37855,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37856,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37858,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37862,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37863,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37864,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37868,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37869,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,2,15,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37871,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37872,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37874,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,ARG,Site 913,Subject 37876,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,AMERICA,ARG,Site 913,Subject 37878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,ARG,Site 913,Subject 37880,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37881,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,ARG,Site 913,Subject 37883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37885,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37888,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37890,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37891,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37892,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37894,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37898,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37900,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37902,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37903,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37904,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37908,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37909,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 913,Subject 37910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 914,Subject 11014,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,3,0,0,0,3,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11015,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11016,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11017,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11018,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11019,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 11021,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37911,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,3,0,0,0,3,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37916,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37917,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37918,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37920,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37924,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37925,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37926,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37928,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37929,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37932,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37935,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37941,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37945,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37949,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,1,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37955,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37956,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37958,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37959,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37963,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37966,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,1,0,0,0,0,0,0,1,0,6,0,0,0,0,0,0,40,6,0,0,0,6
Study 22,AMERICA,ARG,Site 914,Subject 37968,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 914,Subject 37969,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3330,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,8,53,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,ARG,Site 439,Subject 3331,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3332,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3333,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,1,0,0,1,0
Study 22,AMERICA,ARG,Site 439,Subject 3334,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3336,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3337,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3338,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 3339,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 37970,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 37971,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,ARG,Site 439,Subject 37972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,ARG,Site 439,Subject 37973,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 37974,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 439,Subject 37975,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 3346,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 3347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 3348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 3349,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37976,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37977,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37978,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37979,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37980,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37982,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37983,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37985,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37986,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37987,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37988,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37989,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37990,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37992,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37994,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37995,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37996,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 37999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38002,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,2,0,0,0,2,2,17,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38013,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,5,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,4,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38018,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,4,2,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38022,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38025,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38026,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38027,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38028,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38030,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 441,Subject 38031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11022,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,0,53,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11023,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11024,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11025,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,1,0,56,1,0,0,1,0
Study 22,AMERICA,ARG,Site 915,Subject 11026,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11027,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11028,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11029,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 915,Subject 11031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11071,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,10,47,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11072,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11074,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11075,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11076,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11078,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,1,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11079,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11081,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11082,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11083,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 916,Subject 11084,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11270,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,7,47,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11272,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11273,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11274,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11275,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11276,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11277,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11278,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,2,0,0,0,2,19,7,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11281,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11284,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11286,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,1,0,0,0,1,12,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 11289,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38035,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38036,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38038,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38039,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38040,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38043,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38049,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38050,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38051,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38052,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38053,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38054,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38055,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38056,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38057,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38058,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 917,Subject 38059,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,47,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11291,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11300,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11301,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11302,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11303,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11305,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11306,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11307,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,41,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11309,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11311,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11312,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,ARG,Site 918,Subject 11313,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11318,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11319,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11320,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,4,6,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11322,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11323,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11324,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11325,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11326,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11328,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,9,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11329,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11331,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11332,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11333,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11334,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11337,Screening,Screen Failure,,,,,,,,,,1,21,0,,,,0,0,0,0,0,0,0,0,0,8,19,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11338,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,2,0,0,0,2,1,25,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11342,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11343,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,AMERICA,ARG,Site 919,Subject 11344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,ARG,Site 919,Subject 11345,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,8,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11346,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,2,0,46,6,0,0,0,6
Study 22,AMERICA,ARG,Site 919,Subject 11347,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11348,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11349,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11350,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11352,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11353,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11354,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,8,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11355,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,2,28,0,0,0,0,0,0,28,4,0,0,1,3
Study 22,AMERICA,ARG,Site 919,Subject 11356,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11358,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11359,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11361,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 919,Subject 11362,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2601,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2602,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2604,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2605,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2606,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2609,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2610,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 2611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,ARG,Site 317,Subject 38060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38061,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38063,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38064,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38065,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38066,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38067,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38069,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38070,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38072,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38074,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38075,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38076,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38077,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38078,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38079,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,69,0,,,,0,0,0,1,0,0,0,1,0,24,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38080,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38081,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38083,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38084,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,7,0,0,0,7
Study 22,AMERICA,ARG,Site 317,Subject 38085,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38086,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38087,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 317,Subject 38088,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 2612,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,1,0,0,0,0,0,1,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 2613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 2614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 2615,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 2616,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 3350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11387,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11388,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11389,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11390,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,0,18,1,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11391,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11392,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11393,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11394,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11395,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11399,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11400,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11401,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11402,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11404,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11405,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11408,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11409,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11410,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,3,0,0,0,3
Study 22,AMERICA,ARG,Site 318,Subject 11411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11412,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11415,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11416,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11417,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11418,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11419,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11420,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11421,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11422,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11423,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11425,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11427,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,61,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11428,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,AMERICA,ARG,Site 318,Subject 11430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 318,Subject 11432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 318,Subject 11433,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 318,Subject 11434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 321,Subject 2623,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,11,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 2624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,35,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 2625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,3,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38089,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38090,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38091,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,1,0,0,1,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38093,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38096,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38103,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38104,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38107,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38108,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 321,Subject 38109,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3351,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3352,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3353,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,0,17,1,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3354,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3355,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3356,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3357,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3358,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3359,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 3360,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38110,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38111,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38112,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38113,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38114,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38115,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38116,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38117,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38118,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38119,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38120,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38121,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,59,0,0,1,1,0
Study 22,AMERICA,ARG,Site 442,Subject 38122,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38123,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38124,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38127,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38128,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38129,Unplanned visit (1),On Trial,,,,,,,,,,6,77,0,,,,0,0,0,1,0,0,0,1,0,24,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38132,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38134,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38138,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38139,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38140,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38141,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38142,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38146,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,58,0,,,,0,0,0,0,0,0,0,0,0,18,1,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38150,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38151,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38153,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38154,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38155,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38157,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38158,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38159,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38160,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38161,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38162,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38163,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38165,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38166,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38167,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38168,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,58,0,,,,0,0,0,1,0,0,0,1,1,19,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38169,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38170,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38171,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38172,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38173,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38174,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,3,0,0,0,3,9,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38175,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38176,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38178,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,70,0,,,,0,0,0,2,0,0,0,2,0,24,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38179,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,ARG,Site 442,Subject 38180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38181,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38182,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38188,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38191,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38192,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38195,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38196,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38201,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38204,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38205,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38210,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38213,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 442,Subject 38214,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 2637,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,14,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 3361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38216,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38218,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,37,5,0,0,0,5
Study 22,AMERICA,ARG,Site 323,Subject 38224,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38225,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38226,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 323,Subject 38227,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38228,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38230,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38231,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38232,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38233,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38235,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38237,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38238,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38239,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,54,6,0,0,6,0
Study 22,AMERICA,ARG,Site 1951,Subject 38240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,5,0,0,0,5,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38241,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38243,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38244,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,46,1,0,0,1,0
Study 22,AMERICA,ARG,Site 1951,Subject 38245,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38246,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38247,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38250,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,5,0,0,0,5,0,19,0,0,0,0,0,0,52,8,0,0,1,7
Study 22,AMERICA,ARG,Site 1951,Subject 38251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,53,1,0,0,1,0
Study 22,AMERICA,ARG,Site 1951,Subject 38253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38255,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38256,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38257,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38258,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38261,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38263,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38269,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38270,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38271,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38273,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38275,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38282,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38284,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38287,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38290,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38293,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38294,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1951,Subject 38297,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38298,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,1,0,0,1,6,63,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38299,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38300,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,2,15,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38301,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38302,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38303,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38304,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38306,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38307,Unplanned visit (1),Discontinued,,,,,,,,,,4,63,0,,,,0,0,0,4,0,0,0,4,2,16,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38308,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38309,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38310,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38311,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38312,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38313,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,2,17,1,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38314,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38315,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,1,1,0,0,0,2,3,16,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38316,Unplanned visit (4),Screen Failure,,,,,,,,,,1,26,0,,,,0,0,0,0,0,0,0,0,0,2,12,1,0,0,0,0,25,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38318,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1952,Subject 38320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 3362,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 3363,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38321,Unplanned visit (2),On Trial,,,,,,,,,,6,93,0,,,,0,0,0,0,0,0,0,0,0,36,1,0,0,0,0,0,74,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38322,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38327,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38328,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38329,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38331,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38332,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,2,0,0,0,2,15,44,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38333,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38334,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38335,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38336,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38337,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38338,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38340,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38341,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38342,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38343,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38344,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38345,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38346,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38348,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38349,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38350,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38351,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38355,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38356,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38357,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38358,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38360,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38363,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38365,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38368,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38369,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38370,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38371,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38373,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38374,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38375,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38376,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38377,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38378,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38379,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38380,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38381,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 443,Subject 38382,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 3364,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 3365,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,35,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38385,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38386,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38388,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,AMERICA,ARG,Site 444,Subject 38390,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38391,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38392,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38393,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38394,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38395,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38396,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 444,Subject 38397,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 3366,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,2,0,0,0,2,5,56,0,1,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 3367,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,2,0,0,0,2,2,14,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38399,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38400,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,2,17,0,1,0,0,0,0,51,6,0,0,0,6
Study 22,AMERICA,ARG,Site 445,Subject 38402,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 445,Subject 38404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,ARG,Site 1953,Subject 38405,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,1,61,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38406,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,2,16,0,0,0,0,0,0,55,6,0,0,0,6
Study 22,AMERICA,ARG,Site 1953,Subject 38408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38409,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38411,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38412,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,0,17,1,1,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38414,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38417,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38420,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,ARG,Site 1953,Subject 38426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,ARG,Site 1953,Subject 38427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38428,Unplanned visit (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1953,Subject 38429,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38430,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38431,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38433,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38434,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38439,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38440,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38441,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38442,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38445,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38451,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38453,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38454,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,ARG,Site 1954,Subject 38456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38457,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38458,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38461,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38464,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38465,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38469,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1954,Subject 38470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38471,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,82,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,1,0,72,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38472,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,8,14,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38473,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,1,0,0,0,0,0,0,1,0,6,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,ARG,Site 1955,Subject 38474,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38475,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38476,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38477,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38478,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38480,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1955,Subject 38486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 1592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 3368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,2,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 3369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,ARG,Site 176,Subject 3370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,5,0,0,0,5
Study 22,AMERICA,ARG,Site 176,Subject 3371,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38488,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,3,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38491,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38494,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 176,Subject 38495,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 3372,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,10,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 3373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,2,38,0,0,0,0,0,0,45,0,6,0,0,6
Study 22,AMERICA,ARG,Site 446,Subject 38496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38497,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38498,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38499,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38501,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38503,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,1,1,0
Study 22,AMERICA,ARG,Site 446,Subject 38504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38505,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,1,0,0,1,0
Study 22,AMERICA,ARG,Site 446,Subject 38506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,0,0,1,1,0
Study 22,AMERICA,ARG,Site 446,Subject 38507,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38508,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38509,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38510,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,3,0,0,0,3,1,7,0,0,0,0,0,0,34,0,0,9,2,7
Study 22,AMERICA,ARG,Site 446,Subject 38512,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38513,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,33,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,AMERICA,ARG,Site 446,Subject 38515,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 446,Subject 38516,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,1,0,0,1,0
Study 22,AMERICA,ARG,Site 447,Subject 3374,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 3375,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 3376,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 3377,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 3378,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 38517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,AMERICA,ARG,Site 447,Subject 38518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,41,6,0,0,0,6
Study 22,AMERICA,ARG,Site 447,Subject 38519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,AMERICA,ARG,Site 447,Subject 38520,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 447,Subject 38521,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 3379,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 3380,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 3381,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38522,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38523,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,58,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38524,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38525,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38526,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38527,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38528,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38529,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38530,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,0,17,0,1,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38533,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38534,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38535,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,13,2,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38536,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38537,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38539,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38540,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38542,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38543,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38544,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38545,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38548,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38551,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38552,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,ARG,Site 448,Subject 38553,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,ARG,Site 449,Subject 3382,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,ARG,Site 449,Subject 3383,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,55,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,ARG,Site 449,Subject 3384,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 449,Subject 3385,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 449,Subject 3386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 449,Subject 3387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 449,Subject 3388,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,29,0,0,7,0,7
Study 22,AMERICA,ARG,Site 1956,Subject 38554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,AMERICA,ARG,Site 1956,Subject 38558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,ARG,Site 1956,Subject 38559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,AMERICA,ARG,Site 1956,Subject 38560,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38561,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38562,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38563,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38564,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38565,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38566,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38567,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,ARG,Site 1956,Subject 38568,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11580,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11582,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11583,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,BRA,Site 921,Subject 11584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11587,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11588,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11590,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11591,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11593,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11595,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11597,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 921,Subject 11598,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,1,0,0,1,2,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11754,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11756,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11757,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11759,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,1,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11762,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 923,Subject 11765,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 925,Subject 11912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,1,0,0,1,2,51,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,AMERICA,BRA,Site 925,Subject 11913,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 925,Subject 11914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 925,Subject 11915,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 925,Subject 11916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,47,7,0,0,1,6
Study 22,AMERICA,BRA,Site 925,Subject 11917,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12212,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12213,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12214,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12215,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12216,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12217,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12218,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12219,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12220,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12221,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12223,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12225,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12228,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,2,4,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12231,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12233,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12236,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12238,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12239,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12240,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12241,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12244,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12246,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12248,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12250,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12251,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12253,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12254,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12255,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12256,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12257,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12258,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,7,0,0,0,7
Study 22,AMERICA,BRA,Site 927,Subject 12259,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12261,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,76,0,,,,0,0,0,3,1,0,1,5,2,23,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12263,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12269,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12272,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12273,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12275,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12276,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12278,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12279,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12283,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12289,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12292,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,16,1,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,14,0,1,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12299,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 927,Subject 12300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,1,1,0
Study 22,AMERICA,BRA,Site 927,Subject 12301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12318,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12319,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12320,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12323,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,1,0,1,0,0,1,3,4,13,0,0,0,0,1,0,58,2,0,0,2,0
Study 22,AMERICA,BRA,Site 928,Subject 12325,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12327,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12328,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12330,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,1,0,0,0,1,0,0,2,1,13,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,BRA,Site 928,Subject 12332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,1,0,0,2,1,18,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12333,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12334,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12337,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 928,Subject 12339,Screening,Screen Failure,,,,,,,,,,1,24,0,,,,0,0,0,0,0,0,0,0,0,9,22,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 929,Subject 12368,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,BRA,Site 929,Subject 12369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,51,0,0,0,0,1,0,42,0,7,1,1,7
Study 22,AMERICA,BRA,Site 929,Subject 12370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,43,3,5,0,1,7
Study 22,AMERICA,BRA,Site 929,Subject 12371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,0,7,0,0,7
Study 22,AMERICA,BRA,Site 929,Subject 12372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,7,0,0,7
Study 22,AMERICA,BRA,Site 929,Subject 12373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,BRA,Site 929,Subject 12374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,7,0,1,1,7
Study 22,AMERICA,BRA,Site 929,Subject 12375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,36,7,0,9,1,15
Study 22,AMERICA,BRA,Site 929,Subject 12376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,35,7,0,8,1,14
Study 22,AMERICA,BRA,Site 930,Subject 12450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12454,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12455,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 930,Subject 12456,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12597,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,2,30,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12599,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12600,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,2,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12601,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,2,50,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12602,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,1,0,0,1,2,6,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12604,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,1,0,0,1,1,6,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12605,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12606,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,3,0,0,3,0,7,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12609,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12613,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,AMERICA,BRA,Site 931,Subject 12615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12616,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 931,Subject 12617,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,BRA,Site 931,Subject 12618,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 931,Subject 12619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12625,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 931,Subject 12629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12733,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12734,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,53,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12735,Unplanned visit (2),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12736,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12737,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12738,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,3,8,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12740,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12741,Unplanned visit (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12742,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,1,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12743,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12744,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12745,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12747,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12750,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12751,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 932,Subject 12757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12807,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,14,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12812,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,2,0,0,2,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12814,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12816,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12817,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12818,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12819,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12820,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,1,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12833,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,1,0,0,0,1
Study 22,AMERICA,BRA,Site 933,Subject 12840,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,1,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 933,Subject 12841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12843,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,48,7,0,0,0,7
Study 22,AMERICA,BRA,Site 933,Subject 12845,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12849,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12850,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12854,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12855,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12860,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12861,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 12862,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38575,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38576,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38580,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38581,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 933,Subject 38583,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12863,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12864,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12865,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12866,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,BRA,Site 934,Subject 12868,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12869,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,1,0,46,7,0,0,0,7
Study 22,AMERICA,BRA,Site 934,Subject 12871,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12874,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12876,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12877,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12879,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12880,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12883,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12884,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 934,Subject 12885,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,3,0,0,0,3
Study 22,AMERICA,BRA,Site 935,Subject 12946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12947,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12948,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12950,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12951,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12952,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12953,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12954,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12955,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12956,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12957,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12958,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12959,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12960,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12961,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12962,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12963,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12965,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12966,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12967,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12968,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12969,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12970,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12971,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12972,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12974,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12975,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12976,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 12977,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38584,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38586,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38587,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38589,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38590,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38592,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38593,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38595,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38596,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38597,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38598,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38600,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38603,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38604,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38606,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38607,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38609,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38610,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38612,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38613,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38614,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38615,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38616,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38617,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38618,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38621,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38623,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 935,Subject 38626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 936,Subject 12978,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 936,Subject 12979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 936,Subject 12980,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,1,0,0,0,0,0,0,1,1,4,0,0,0,0,2,0,41,9,0,0,2,7
Study 22,AMERICA,BRA,Site 936,Subject 12981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 936,Subject 12982,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 12998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 12999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13000,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13001,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,3,9,0,0,0,0,0,1,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13004,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13005,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13006,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13008,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13010,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13012,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13013,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13014,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13015,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13018,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13020,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 937,Subject 13021,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38627,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,62,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38628,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38629,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,50,7,0,0,1,6
Study 22,AMERICA,BRA,Site 1957,Subject 38630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38631,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38632,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38635,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38636,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38637,Visit 1 (1),Discontinued,,,,,,,,,,2,42,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,34,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38638,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38640,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38641,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38642,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38643,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38644,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38646,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38647,Unplanned visit (2),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38648,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38649,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38650,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38651,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38652,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38653,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38654,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38656,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38658,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38659,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38660,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38661,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38662,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38663,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38664,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38665,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38666,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38667,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,BRA,Site 1957,Subject 38668,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38669,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38670,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38671,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,77,0,,,,0,0,0,2,0,0,0,2,0,31,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38673,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38674,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38675,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38676,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,3,19,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38677,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38678,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38679,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38680,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38681,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38682,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38683,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38684,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38685,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38687,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38690,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38692,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38693,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38694,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38695,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38696,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38702,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,35,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38703,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38706,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38707,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1957,Subject 38713,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13081,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13084,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13085,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13086,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13087,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13088,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,2,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13089,Unplanned visit (1),Screen Failure,,,,,,,,,,1,21,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13090,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13091,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 13092,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38715,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38716,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38717,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38718,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38719,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38720,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38721,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38722,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38723,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38724,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38725,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38727,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,3,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38728,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38729,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38730,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,87,0,,,,0,0,0,2,0,0,0,2,11,23,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38731,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38732,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38733,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38734,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38735,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,1,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38736,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38737,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38740,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38742,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,AMERICA,BRA,Site 938,Subject 38744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38746,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38747,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38748,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38752,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38754,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38756,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38757,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38758,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38760,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38761,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38763,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38764,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38765,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38767,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38769,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,90,0,,,,0,0,0,2,0,0,0,2,5,32,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38773,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38774,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38775,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 938,Subject 38776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13093,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13094,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,4,48,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13095,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13096,Screening,Screen Failure,,,,,,,,,,1,27,0,,,,0,0,0,0,0,0,0,0,0,10,25,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13097,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13098,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13099,Unplanned visit (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13100,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13101,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13102,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13104,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13105,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13106,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13107,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13108,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13109,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13110,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13111,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13113,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,19,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13117,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13118,Unplanned visit (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,2,0,0,0,2
Study 22,AMERICA,BRA,Site 939,Subject 13119,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13120,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13121,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13122,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13124,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13125,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 13127,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38777,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,1,5
Study 22,AMERICA,BRA,Site 939,Subject 38779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,AMERICA,BRA,Site 939,Subject 38780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,BRA,Site 939,Subject 38781,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,AMERICA,BRA,Site 939,Subject 38783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38784,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38788,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38789,Unplanned visit (2),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38793,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38797,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38798,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,3,0,0,0,3
Study 22,AMERICA,BRA,Site 939,Subject 38799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38801,Visit 1 (1),On Trial,,,,,,,,,,2,30,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,25,4,0,0,0,4
Study 22,AMERICA,BRA,Site 939,Subject 38802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38803,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38804,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38805,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38806,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38807,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38809,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38810,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 939,Subject 38813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13128,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13129,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13131,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,1,1,0
Study 22,AMERICA,BRA,Site 940,Subject 13132,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13134,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13135,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13136,Unplanned visit (8),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,72,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13137,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13141,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13142,Unplanned visit (7),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13145,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13146,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13147,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13148,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13149,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13151,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13152,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13153,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13154,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13155,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13156,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13157,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13158,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13160,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13161,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13163,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13164,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 940,Subject 13165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13177,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,3,39,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13178,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13179,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13180,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13183,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13184,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13185,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13186,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13187,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13188,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13190,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13192,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,2,0,32,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13194,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13195,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13196,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13198,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13200,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13201,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13202,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13205,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13206,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13207,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13210,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 941,Subject 13211,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13231,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13232,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13233,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,78,0,,,,0,0,0,1,0,0,0,1,2,70,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13234,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13236,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13238,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13239,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,3,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13242,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13244,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13246,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13248,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,85,0,,,,0,0,0,0,0,0,0,0,0,20,0,0,0,0,1,0,72,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13250,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13253,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13254,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13255,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13257,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13258,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13259,Visit 1 (1),On Trial,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,1,0,30,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13260,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13261,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13262,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13263,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13265,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13267,Unplanned visit (2),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13268,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13269,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13271,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 13272,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 38814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 38815,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 38816,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 942,Subject 38817,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,5,0,0,1,4
Study 22,AMERICA,BRA,Site 943,Subject 13273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13274,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13275,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13276,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13277,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13278,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13279,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13281,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13283,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13284,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13285,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13286,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13289,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13290,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13292,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13294,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13296,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13297,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 943,Subject 13298,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13317,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,1,0,0,0,1,2,63,0,0,0,0,0,0,72,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13318,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13319,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13320,Unplanned visit (3),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,63,1,0,0,1,0
Study 22,AMERICA,BRA,Site 944,Subject 13321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13326,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13327,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13329,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13330,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13331,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13332,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13333,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13334,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13336,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13337,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13341,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13343,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13344,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13345,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 13346,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38818,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38819,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38820,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38821,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38822,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 944,Subject 38824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 945,Subject 13347,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 945,Subject 13348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 945,Subject 13349,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,BRA,Site 945,Subject 13350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13366,Unplanned visit (5),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,4,59,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13368,Unplanned visit (2),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13374,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 13375,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38825,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38828,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38829,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38831,Unplanned visit (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,1,0,0,0,1,2,15,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38833,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38835,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38840,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38841,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38842,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38843,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38845,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38846,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38847,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38848,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38850,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38851,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38852,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38853,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38854,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38855,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38856,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38857,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38858,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,BRA,Site 946,Subject 38859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,AMERICA,BRA,Site 946,Subject 38860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38861,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38862,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38863,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38865,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38871,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38874,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38875,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 946,Subject 38876,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38877,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38878,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38879,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38880,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38881,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 1958,Subject 38882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,BRA,Site 1958,Subject 38883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38884,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38885,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38886,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38887,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38888,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38889,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1958,Subject 38890,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13376,Unplanned visit (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13377,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,1,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 947,Subject 13381,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,11,0,0,0,11
Study 22,AMERICA,BRA,Site 948,Subject 13438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,BRA,Site 948,Subject 13439,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13440,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,BRA,Site 948,Subject 13444,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,3,0,0,0,3
Study 22,AMERICA,BRA,Site 948,Subject 13445,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,7,10,0,0,0,0,0,0,49,2,0,0,0,2
Study 22,AMERICA,BRA,Site 949,Subject 13462,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,14,49,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13463,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13464,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13465,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13466,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13467,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13468,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13469,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13475,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13476,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13477,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 949,Subject 13480,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13503,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,14,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13504,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13505,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13506,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13507,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13508,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13509,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13510,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13511,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13512,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13513,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13514,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13515,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13516,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,BRA,Site 950,Subject 13517,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13518,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13519,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13520,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,1,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13521,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 950,Subject 13522,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,BRA,Site 950,Subject 13523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,2,0,0,0,2,1,18,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,AMERICA,BRA,Site 950,Subject 13525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13526,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13528,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13530,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13531,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 950,Subject 13535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,91,0,,,,0,0,0,0,0,0,0,0,0,29,1,0,0,0,2,0,73,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38893,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38896,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38898,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1959,Subject 38899,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38900,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38901,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38902,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38904,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1960,Subject 38905,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,BRA,Site 1961,Subject 38906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,1,52,0,0,0,0,0,0,43,0,0,10,2,8
Study 22,AMERICA,BRA,Site 1961,Subject 38907,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13628,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13629,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13631,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13632,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 13634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38910,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38911,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38912,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38913,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38915,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38916,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38918,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38920,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,CAN,Site 951,Subject 38923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38924,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38925,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38926,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38927,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,AMERICA,CAN,Site 951,Subject 38928,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,9,0,0,2,7
Study 22,AMERICA,CAN,Site 951,Subject 38929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38930,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38932,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38933,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38934,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 951,Subject 38935,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38936,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38937,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38938,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38939,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38942,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1962,Subject 38943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13635,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13636,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,30,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13639,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13640,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,5,0,0,0,5,0,5,0,0,0,0,0,0,40,4,0,0,4,0
Study 22,AMERICA,CAN,Site 952,Subject 13641,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,21,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13644,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13645,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 952,Subject 13646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,CAN,Site 952,Subject 13649,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13657,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13658,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13659,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,9,43,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13661,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13662,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13663,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13664,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13665,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 13666,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38944,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38947,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,CAN,Site 954,Subject 38948,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38949,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 954,Subject 38950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13667,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13668,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13669,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13670,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13671,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,50,1,0,0,1,0
Study 22,AMERICA,CAN,Site 955,Subject 38951,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 38952,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 38953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 13672,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 13673,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13674,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,34,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 13675,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13676,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 13677,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 38954,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 38955,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 38956,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 38957,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 38958,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,16,0,1,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 38959,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 956,Subject 38960,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 955,Subject 38961,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,CAN,Site 956,Subject 38962,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 957,Subject 13678,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,CAN,Site 957,Subject 13679,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 957,Subject 13680,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13700,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13701,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13702,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,53,0,,,,0,0,0,0,0,0,0,0,0,15,1,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13703,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13704,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13705,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13706,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13707,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,84,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,73,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13708,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13709,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13710,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13711,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13712,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13713,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13714,Unplanned visit (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13715,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,1,18,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13716,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13718,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,57,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,50,5,0,0,0,5
Study 22,AMERICA,CAN,Site 958,Subject 13719,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13720,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13721,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13722,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13723,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13724,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13725,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,CAN,Site 958,Subject 13726,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13727,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13728,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13729,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13730,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13732,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13733,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 958,Subject 13737,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38963,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,2,60,0,0,0,0,0,0,61,1,0,0,1,0
Study 22,AMERICA,CAN,Site 1963,Subject 38964,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,7,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38965,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,7,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38966,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,57,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38967,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38968,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38969,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38970,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,8,0,0,1,7
Study 22,AMERICA,CAN,Site 1963,Subject 38971,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,4,58,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,2,0,39,11,0,0,3,8
Study 22,AMERICA,CAN,Site 1963,Subject 38972,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38973,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38974,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38975,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38976,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38978,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38979,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38980,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38982,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38983,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38984,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 38985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,CAN,Site 1963,Subject 38986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,AMERICA,CAN,Site 1963,Subject 38987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,8,0,0,0,8,8,5,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,AMERICA,CAN,Site 959,Subject 13744,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,1,,,,0,0,0,0,0,0,0,0,5,65,0,0,0,0,0,0,65,1,0,0,1,0
Study 22,AMERICA,CAN,Site 959,Subject 13745,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13746,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13747,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13748,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13749,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13750,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13751,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13752,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13753,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13754,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13756,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 38988,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,36,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 38989,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 38990,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 38991,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38992,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38993,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38994,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38995,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,3,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38997,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 38999,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 39000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 39001,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 39002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13757,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13758,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,0,0,61,2,0,0,1,1
Study 22,AMERICA,CAN,Site 960,Subject 13759,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13760,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,1,0,0,1,0
Study 22,AMERICA,CAN,Site 960,Subject 13761,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,65,1,0,0,1,0
Study 22,AMERICA,CAN,Site 960,Subject 13762,Visit 6 (Month 27) (1),Discontinued,,,,,,,,,,7,61,0,,,,3,1,0,0,0,0,0,4,0,9,0,0,0,0,1,0,53,6,0,0,2,4
Study 22,AMERICA,CAN,Site 960,Subject 13763,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13764,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,70,0,,,,0,0,0,0,0,0,0,0,0,7,0,1,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13765,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 960,Subject 13767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13790,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,1,0,0,0,1,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13791,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13792,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13793,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13794,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13795,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13796,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13797,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13799,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,0,0,0,0,0,6,14,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13800,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,2,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13801,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13802,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13803,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13804,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 959,Subject 13805,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13806,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,2,0,0,1,1
Study 22,AMERICA,CAN,Site 961,Subject 13808,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 13809,Visit 1 (1),On Trial,,,,,,,,,,2,36,0,,,,0,0,0,4,0,0,0,4,0,6,0,0,0,0,0,0,32,2,0,0,0,2
Study 22,AMERICA,CAN,Site 961,Subject 39003,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39004,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,4,0,0,0,4,1,10,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,AMERICA,CAN,Site 961,Subject 39006,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39007,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39008,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39009,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39010,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39011,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39012,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39014,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 961,Subject 39015,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1963,Subject 39016,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,7,0,0,1,6
Study 22,AMERICA,CAN,Site 963,Subject 13826,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,8,55,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13827,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,62,0,0,1,1,0
Study 22,AMERICA,CAN,Site 963,Subject 13828,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,84,0,,,,0,0,0,0,0,0,0,0,2,22,0,0,0,0,1,0,69,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13829,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,96,0,,,,0,0,0,1,0,0,0,1,1,32,0,0,0,0,0,0,74,0,0,1,1,0
Study 22,AMERICA,CAN,Site 963,Subject 13830,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13831,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13832,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 13839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,2,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39017,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39019,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39021,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39022,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39023,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39024,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39027,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39028,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39030,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39032,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 963,Subject 39036,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13840,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,7,52,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13841,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13842,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13843,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13844,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 13845,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39037,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39038,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39039,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39041,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39042,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39043,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39044,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39045,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 964,Subject 39048,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13846,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,62,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13847,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13848,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13849,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13850,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13851,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 13852,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,1,0,0,0,1,6,13,0,0,0,0,1,0,60,1,0,0,1,0
Study 22,AMERICA,CAN,Site 965,Subject 13853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 39049,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 39050,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 39051,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 965,Subject 39052,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13854,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13855,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,7,54,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13856,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,60,2,0,0,2,0
Study 22,AMERICA,CAN,Site 966,Subject 13857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13858,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 13860,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39053,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39054,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39055,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39056,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39057,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39058,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39059,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39060,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39061,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39062,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39063,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39064,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39065,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39066,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39067,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,43,9,0,0,2,7
Study 22,AMERICA,CAN,Site 1965,Subject 39069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39071,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 13873,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 13874,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,67,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 13875,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 13876,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,1,1,0
Study 22,AMERICA,CAN,Site 967,Subject 13877,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 13878,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39073,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39074,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39075,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39076,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39077,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,61,0,0,1,1,0
Study 22,AMERICA,CAN,Site 967,Subject 39078,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39079,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39080,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39081,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,1,0,0,0,1,2,8,0,0,0,0,0,0,53,9,0,0,3,6
Study 22,AMERICA,CAN,Site 967,Subject 39082,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39083,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39084,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39085,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,57,7,0,0,0,7
Study 22,AMERICA,CAN,Site 967,Subject 39086,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,57,7,0,0,0,7
Study 22,AMERICA,CAN,Site 967,Subject 39087,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,54,7,0,1,1,7
Study 22,AMERICA,CAN,Site 967,Subject 39088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39089,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39090,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,7,0,0,0,7
Study 22,AMERICA,CAN,Site 967,Subject 39091,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,CAN,Site 967,Subject 39092,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39093,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39094,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39095,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,CAN,Site 967,Subject 39096,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,CAN,Site 967,Subject 39097,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39098,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39100,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,57,6,0,0,0,6
Study 22,AMERICA,CAN,Site 967,Subject 39101,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39102,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39103,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,57,6,0,0,0,6
Study 22,AMERICA,CAN,Site 967,Subject 39104,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,53,6,0,1,1,6
Study 22,AMERICA,CAN,Site 967,Subject 39105,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39106,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39107,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39109,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39110,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39113,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39114,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39116,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39117,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39118,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39119,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39120,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39121,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39122,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39123,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39126,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39127,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39128,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39129,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,2,0,1,2,1
Study 22,AMERICA,CAN,Site 967,Subject 39130,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 967,Subject 39131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,CAN,Site 968,Subject 13879,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,10,17,0,17,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 968,Subject 13880,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,19,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 13881,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13882,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,3,42,0,0,0,0,0,0,46,0,4,0,0,4
Study 22,AMERICA,CAN,Site 966,Subject 13883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 968,Subject 39132,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1965,Subject 39133,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 39134,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 966,Subject 39135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,79,0,,,,0,0,0,3,0,0,0,3,7,15,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 39136,Visit 5 (Month 21) (1),Discontinued,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,4,4,2,1,9
Study 22,AMERICA,CAN,Site 968,Subject 39137,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,16,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1964,Subject 39138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,AMERICA,CAN,Site 968,Subject 39139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,17,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 968,Subject 39140,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,20,0,20,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 13884,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,8,38,0,0,0,0,0,0,52,2,0,0,1,1
Study 22,AMERICA,CAN,Site 969,Subject 13885,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 13886,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 13887,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 13888,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 13889,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39141,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39142,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39147,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39149,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39151,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39153,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39158,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,CAN,Site 969,Subject 39162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13890,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13891,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13892,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,2,0,37,0,3,7,0,10
Study 22,AMERICA,CAN,Site 970,Subject 13893,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13894,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13895,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 970,Subject 13896,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13910,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13911,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13913,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13914,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 13915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39163,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39165,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39166,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39167,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39168,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39170,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 971,Subject 39172,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13916,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,0,68,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13917,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13918,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13919,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13920,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13921,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13922,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,13,0,0,1,1,0
Study 22,AMERICA,CAN,Site 972,Subject 13923,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13924,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13925,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13926,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,7,0,0,0,7
Study 22,AMERICA,CAN,Site 972,Subject 13927,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13928,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13929,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 13930,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 972,Subject 39173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13931,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,8,51,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13932,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13933,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13934,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13935,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13936,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13937,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13938,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13939,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13940,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13941,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13942,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13943,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13944,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,0,0,0,0,0,2,22,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 13946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39174,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39175,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,1,6,0,0,0,0,0,0,45,7,0,0,1,6
Study 22,AMERICA,CAN,Site 973,Subject 39176,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,CAN,Site 973,Subject 39177,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,94,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39179,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,3,13,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39184,Unplanned visit (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39188,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39189,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39190,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,9,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,CAN,Site 973,Subject 39192,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13947,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,5,59,0,0,0,0,0,0,59,3,0,0,3,0
Study 22,AMERICA,CAN,Site 974,Subject 13948,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13949,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,63,3,0,0,3,0
Study 22,AMERICA,CAN,Site 974,Subject 13950,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13951,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13952,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13953,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13954,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13955,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13956,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13957,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13958,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13959,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13962,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 974,Subject 13963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13979,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13981,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,42,0,0,0,0,0,0,45,8,0,7,0,15
Study 22,AMERICA,CAN,Site 975,Subject 13982,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13983,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,1,17,0,0,0,0,0,0,38,4,3,16,5,18
Study 22,AMERICA,CAN,Site 975,Subject 13984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,7,0,7
Study 22,AMERICA,CAN,Site 975,Subject 13985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,7,0,7
Study 22,AMERICA,CAN,Site 975,Subject 13986,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13987,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13988,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13989,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13990,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13991,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13992,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,7,0,0,7
Study 22,AMERICA,CAN,Site 975,Subject 13993,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 13994,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,56,0,,,,0,0,0,2,0,0,0,2,2,14,0,0,0,0,3,0,30,0,6,11,4,13
Study 22,AMERICA,CAN,Site 975,Subject 39193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,36,0,0,7,0,7
Study 22,AMERICA,CAN,Site 975,Subject 39194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,33,0,1,10,3,8
Study 22,AMERICA,CAN,Site 975,Subject 39195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,0,0,8,0,8
Study 22,AMERICA,CAN,Site 975,Subject 39196,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 975,Subject 39197,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39198,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,8,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39199,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39200,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39201,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39202,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39203,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,18,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39204,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,17,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39205,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39206,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39207,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39208,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1966,Subject 39209,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 13995,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 13996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 13997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 13998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 39210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,38,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 39211,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,CAN,Site 976,Subject 39212,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 39213,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 39214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 976,Subject 39215,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 13999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 14000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 14001,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 14002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 14003,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 14004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 39216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 977,Subject 39217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39218,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39219,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39220,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39221,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39223,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39224,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39225,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,1,18,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39226,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39228,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39229,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39231,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39233,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39234,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39235,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39236,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39238,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39239,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39240,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39241,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39242,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39244,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,AMERICA,CAN,Site 1967,Subject 39245,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39246,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39247,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39248,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39249,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39250,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39254,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39256,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39257,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39258,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39263,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39265,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39269,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39270,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39273,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39275,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39276,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39280,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39281,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39284,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,CAN,Site 1967,Subject 39288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,CAN,Site 978,Subject 14005,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,5,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 978,Subject 14006,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,1,0,0,1,1,60,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,CAN,Site 978,Subject 14007,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,CAN,Site 978,Subject 14008,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,CAN,Site 978,Subject 14009,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,CAN,Site 978,Subject 14010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14548,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14551,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14555,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14556,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 995,Subject 14557,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14571,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,10,43,0,0,0,0,0,0,44,3,0,0,2,1
Study 22,AMERICA,COL,Site 996,Subject 14572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14575,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 14578,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39289,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39291,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39295,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39296,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 996,Subject 39303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,9,42,0,0,0,0,0,0,42,0,2,0,1,1
Study 22,AMERICA,COL,Site 997,Subject 14580,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14581,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,114,0,,,,0,0,0,4,0,0,0,4,1,55,0,0,0,0,1,0,68,7,2,0,2,7
Study 22,AMERICA,COL,Site 997,Subject 14582,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14583,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,1,0,0,1,0
Study 22,AMERICA,COL,Site 997,Subject 14584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,AMERICA,COL,Site 997,Subject 14587,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14588,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14590,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,7,1,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,9,0,0,2,7
Study 22,AMERICA,COL,Site 997,Subject 14594,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14595,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14597,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,47,7,1,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14598,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14599,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14600,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14602,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,34,0,9,0,1,8
Study 22,AMERICA,COL,Site 997,Subject 14604,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,COL,Site 997,Subject 14606,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14607,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14609,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 14610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,35,0,8,0,1,7
Study 22,AMERICA,COL,Site 997,Subject 14611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,COL,Site 997,Subject 39304,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 997,Subject 39305,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,0,0,35,1,0,0,1,0
Study 22,AMERICA,COL,Site 997,Subject 39306,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,1,0,35,1,0,0,1,0
Study 22,AMERICA,COL,Site 998,Subject 14612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 14613,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 14614,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 14615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 14616,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39309,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39310,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39312,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 998,Subject 39315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14617,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14618,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14620,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,19,1,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14624,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14626,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14630,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14631,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14632,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 999,Subject 14633,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,6,33,0,0,0,0,0,0,42,1,1,0,2,0
Study 22,AMERICA,COL,Site 1001,Subject 14659,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14662,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14665,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14666,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,1,5,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,AMERICA,COL,Site 1001,Subject 14668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,AMERICA,COL,Site 1001,Subject 14669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 14670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,7,0,0,7
Study 22,AMERICA,COL,Site 1001,Subject 39316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,36,0,7,0,0,7
Study 22,AMERICA,COL,Site 1001,Subject 39317,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1001,Subject 39318,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 14671,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 14672,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 14673,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39319,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,69,0,,,,0,0,0,1,0,0,0,1,1,30,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,36,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39322,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39326,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39327,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39328,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,47,3,0,0,3,0
Study 22,AMERICA,COL,Site 1002,Subject 39331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39333,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39334,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1002,Subject 39337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39338,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39339,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39343,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39344,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39345,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39346,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39347,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39348,Unplanned visit (2),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39350,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39352,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39353,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39354,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39355,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39356,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39358,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39365,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39366,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39368,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39369,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39370,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39371,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39373,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39374,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39375,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39376,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39377,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39378,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1968,Subject 39379,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,2,58,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39382,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39383,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39386,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39387,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1969,Subject 39389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39390,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39391,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39392,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39393,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39394,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39395,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39398,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39400,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39402,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39403,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39405,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39406,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,8,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39408,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39409,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39412,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39413,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39416,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39417,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39419,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39420,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39421,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39423,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39425,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39426,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,69,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39427,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39428,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39435,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39436,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39437,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39438,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39441,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39445,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39446,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39447,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1970,Subject 39448,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39449,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39450,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39451,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39453,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,1,21,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39457,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39458,Unplanned visit (2),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,COL,Site 1971,Subject 39459,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39460,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39461,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39462,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39463,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1971,Subject 39464,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39473,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1972,Subject 39474,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39476,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39477,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39479,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39480,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39481,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39482,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39487,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39488,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39489,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,1,0,0,1,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39497,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1973,Subject 39499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39500,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39502,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,45,5,0,0,1,4
Study 22,AMERICA,COL,Site 1974,Subject 39503,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39505,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,COL,Site 1974,Subject 39506,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,45,6,0,0,0,6
Study 22,AMERICA,COL,Site 1974,Subject 39507,Visit 1 (1),Discontinued,,,,,,,,,,2,31,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39509,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39510,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39511,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39514,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39515,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39516,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39517,Visit 1 (1),Discontinued,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39518,Visit 1 (1),Discontinued,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39519,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,6,11,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,COL,Site 1974,Subject 39520,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39522,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1974,Subject 39527,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39528,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39529,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39530,Unplanned visit (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,1,19,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39531,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39533,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39536,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,0,0,0,0,0,2,22,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39539,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39540,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,2,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39543,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39544,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,COL,Site 1975,Subject 39547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,COL,Site 1975,Subject 39548,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39550,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39551,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39553,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39554,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39555,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39556,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39557,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39558,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39559,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39560,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,COL,Site 1976,Subject 39561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,COL,Site 1976,Subject 39562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,COL,Site 1976,Subject 39563,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,COL,Site 1976,Subject 39564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39567,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39568,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39569,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39570,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39571,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39572,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39573,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39575,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,41,1,0,0,1,0
Study 22,AMERICA,COL,Site 1976,Subject 39577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39578,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,AMERICA,COL,Site 1976,Subject 39581,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39582,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39583,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39584,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1976,Subject 39585,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39587,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39588,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39590,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39591,Unplanned visit (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,1,18,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39592,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39593,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39597,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39598,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39600,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39602,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39604,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39605,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39606,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 1977,Subject 39607,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,8,49,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39610,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39611,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39612,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,8,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39613,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39615,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39616,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39617,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39618,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39619,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,COL,Site 1978,Subject 39620,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,7,0,0,1,6
Study 22,AMERICA,COL,Site 1978,Subject 39622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39623,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,AMERICA,COL,Site 1978,Subject 39624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39625,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39628,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39630,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39631,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39634,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39636,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39637,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39638,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39640,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39643,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39644,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39645,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39651,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39653,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1978,Subject 39655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39656,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,31,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39659,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39660,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1979,Subject 39662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39665,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39666,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39667,Unplanned visit (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,5,0,0,0,5,0,17,0,0,0,0,0,0,50,5,0,0,5,0
Study 22,AMERICA,COL,Site 1980,Subject 39668,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39669,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39670,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39671,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39672,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39673,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39674,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,2,0,0,1,1
Study 22,AMERICA,COL,Site 1980,Subject 39678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39679,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39680,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39684,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39685,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,COL,Site 1980,Subject 39686,Unplanned visit (1),On Trial,,,,,,,,,,4,53,0,,,,1,0,0,2,0,0,0,3,0,14,0,0,0,0,0,0,44,2,0,0,2,0
Study 22,AMERICA,COL,Site 1980,Subject 39687,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39689,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39694,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39695,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1981,Subject 39696,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14782,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1008,Subject 14784,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,22,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14786,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14787,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14788,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1008,Subject 14790,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14792,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14794,Unplanned visit (2),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14797,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14799,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,1,0,0,0,1
Study 22,AMERICA,MEX,Site 1008,Subject 14802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1008,Subject 14803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14824,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14825,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14826,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14827,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14828,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,1,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14832,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1009,Subject 14833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,33,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39698,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,2,43,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39700,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,4,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39701,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39702,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39703,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39704,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39705,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39706,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39707,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39708,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39709,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39710,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39711,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,4,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39715,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39716,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,2,0,0,0,2,15,11,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39718,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39719,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39727,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39730,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39731,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39733,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39739,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39742,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39743,Unplanned visit (1),Screen Failure,,,,,,,,,,1,22,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,12,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39747,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39748,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39749,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,8,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39758,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39760,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39761,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39762,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39763,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,4,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39765,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1982,Subject 39767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39769,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39770,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39771,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39772,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39779,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39780,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39781,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39782,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39785,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39789,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39791,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39792,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39796,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1983,Subject 39798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39804,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39807,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1984,Subject 39811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1984,Subject 39812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,AMERICA,MEX,Site 1984,Subject 39814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1984,Subject 39815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1984,Subject 39816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39821,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39822,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39825,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1984,Subject 39826,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39828,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39830,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39831,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39832,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39834,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39835,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39837,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39839,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39840,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1985,Subject 39841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39842,Unplanned visit (4),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,27,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39843,Unplanned visit (3),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,40,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39844,Unplanned visit (3),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39845,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39846,Unplanned visit (3),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39847,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39849,Unplanned visit (3),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39850,Unplanned visit (3),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39852,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,65,0,,,,0,0,0,0,0,0,0,0,0,17,1,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39853,Unplanned visit (2),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39854,Unplanned visit (2),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39855,Unplanned visit (3),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39856,Unplanned visit (3),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39857,Unplanned visit (3),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39858,Unplanned visit (3),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,52,0,1,0,1,0
Study 22,AMERICA,MEX,Site 1986,Subject 39859,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39860,Unplanned visit (3),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39861,Unplanned visit (3),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39862,Unplanned visit (3),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39863,Unplanned visit (3),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39864,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,1,0,0,0,0,0,0,1,1,5,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1986,Subject 39866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39867,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1986,Subject 39868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39870,Unplanned visit (2),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39871,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,2,0,0,0,2,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39877,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39878,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39880,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39886,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,1,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39888,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39889,Unplanned visit (2),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39890,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39891,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39892,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1986,Subject 39893,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1986,Subject 39894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,AMERICA,MEX,Site 1987,Subject 39895,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39896,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39897,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39898,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39899,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39900,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39901,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39902,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39907,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39908,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39914,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39917,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39919,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39920,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,1,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39922,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39925,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1987,Subject 39926,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39927,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39928,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39930,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,1,0,0,0,1,4,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39932,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39934,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39936,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39940,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1988,Subject 39943,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39944,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39945,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39946,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39947,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,1,,,,0,0,0,1,0,0,0,1,9,52,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39952,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39955,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1989,Subject 39956,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39957,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39958,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39959,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39960,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39961,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39962,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39963,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39964,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39965,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39966,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39967,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39968,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39969,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1990,Subject 39970,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39971,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39973,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39975,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39985,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39990,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,1,12,0,0,0,0,0,0,46,3,0,0,2,1
Study 22,AMERICA,MEX,Site 1990,Subject 39991,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39993,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39994,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1990,Subject 39995,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 39996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,1,0,0,0,1,0,55,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 39997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 39998,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 39999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40000,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40002,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40003,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40006,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40007,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40008,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,38,5,0,0,0,5
Study 22,AMERICA,MEX,Site 1991,Subject 40013,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1991,Subject 40014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40017,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40018,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40019,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40021,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40022,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40026,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40028,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40029,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40030,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,1,0,0,1,1,6,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1992,Subject 40032,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,32,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1992,Subject 40033,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40034,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40035,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,44,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40036,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40037,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40040,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40042,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40043,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40048,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40050,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1993,Subject 40051,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40052,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40053,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40054,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40055,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,50,3,0,0,0,3
Study 22,AMERICA,MEX,Site 1994,Subject 40056,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,49,4,0,0,4,0
Study 22,AMERICA,MEX,Site 1994,Subject 40057,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40058,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40059,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40061,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40063,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40064,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40066,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40074,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1994,Subject 40075,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40076,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40077,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40078,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1995,Subject 40080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,MEX,Site 1995,Subject 40081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40083,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40084,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40085,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1995,Subject 40086,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40087,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40088,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40089,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40091,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40093,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40096,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40099,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40101,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40103,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40104,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40106,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1996,Subject 40109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40110,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40111,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,1,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40112,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40113,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40116,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40120,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40121,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40122,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40124,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40125,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,1,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40126,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,1,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40127,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40128,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40131,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40133,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1997,Subject 40134,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,43,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40136,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40137,Unplanned visit (8),On Trial,,,,,,,,,,5,72,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40138,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40139,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40141,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40142,Unplanned visit (1),Discontinued,,,,,,,,,,4,67,0,,,,0,0,0,0,0,0,0,0,0,24,1,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40145,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40146,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40147,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,1,20,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40149,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40151,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,46,1,0,0,1,0
Study 22,AMERICA,MEX,Site 1998,Subject 40154,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40155,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40156,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40157,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40158,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40159,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40161,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40162,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40163,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,4,17,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40167,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,58,0,,,,0,0,0,2,0,0,0,2,11,8,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,AMERICA,MEX,Site 1998,Subject 40168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40169,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1998,Subject 40175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40176,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40177,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40178,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40181,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 1999,Subject 40189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2000,Subject 40190,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2000,Subject 40191,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2000,Subject 40192,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40193,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,MEX,Site 2001,Subject 40195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,8,46,0,0,0,0,1,0,45,2,0,0,1,1
Study 22,AMERICA,MEX,Site 2001,Subject 40196,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,MEX,Site 2001,Subject 40198,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40201,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2001,Subject 40204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,MEX,Site 2001,Subject 40205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,54,1,0,0,1,0
Study 22,AMERICA,MEX,Site 2002,Subject 40206,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40207,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40208,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40209,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40210,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40211,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40212,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40213,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40214,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40215,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40216,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40217,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40218,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,1,0,0,0,0,0,1,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40220,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40221,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40225,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40226,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40227,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40228,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40231,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40235,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40236,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40237,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40239,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40240,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40241,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40242,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40243,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40244,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40245,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40247,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40255,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40256,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40257,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40258,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40263,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40268,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40269,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40272,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40275,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40281,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2002,Subject 40285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,44,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,9,12,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40293,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40302,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40304,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40305,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40306,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40307,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40308,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40309,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40310,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40313,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40318,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40322,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2003,Subject 40324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,43,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40326,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40327,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40328,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40329,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2004,Subject 40330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40331,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,56,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40332,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40333,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40334,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40335,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40337,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40339,Screening,Discontinued,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40343,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40344,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40345,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,4,12,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40347,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40348,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40349,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40352,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40353,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40354,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40355,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2005,Subject 40356,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40357,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,58,0,,,,0,0,0,0,0,0,0,0,0,55,2,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,1,0,0,0,0,0,0,1,0,13,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40359,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40360,Unplanned visit (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,0,22,0,0,0,0,2,0,54,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40361,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40362,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40364,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40365,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40366,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40368,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,1,0,0,0,0,0,0,1,0,12,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40370,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40371,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40372,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,4,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40373,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40374,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,11,9,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,MEX,Site 2006,Subject 40375,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,38,5,0,0,0,5
Study 22,AMERICA,USA,Site 177,Subject 1593,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 1594,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 1595,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 1596,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 177,Subject 1597,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 1598,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 1599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3453,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3454,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3455,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 3456,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 177,Subject 3457,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,USA,Site 177,Subject 40376,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40377,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,USA,Site 177,Subject 40378,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,USA,Site 177,Subject 40379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,0,0,0,0,0,3,22,0,1,0,0,1,0,52,8,0,0,1,7
Study 22,AMERICA,USA,Site 177,Subject 40381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40384,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40386,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40387,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40388,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40389,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40393,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40396,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40397,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,3,0,0,0,3,1,12,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40399,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40400,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 177,Subject 40401,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 63,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,96,0,,,,0,0,0,1,0,0,0,1,1,90,0,0,0,0,0,0,76,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 64,Unplanned visit (2),On Trial,,,,,,,,,,7,67,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 65,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 66,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 67,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 68,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 69,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 70,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 71,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 72,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 73,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 74,End of Study (EOS) (1),Discontinued,,,,,,,,,,7,102,0,,,,0,0,0,4,0,0,0,4,3,32,0,0,0,0,0,0,84,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 75,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 76,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3458,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,48,2,0,0,0,2
Study 22,AMERICA,USA,Site 18,Subject 3459,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,1,32,0,0,0,0,2,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3461,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3462,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3463,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3464,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 18,Subject 3465,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 1600,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 3393,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,4,57,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 3394,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40402,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40403,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40404,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,157,0,,,,0,0,0,2,0,0,0,2,9,73,2,0,0,0,0,0,104,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40405,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40406,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40407,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40408,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40409,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40410,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40411,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40412,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40413,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,79,0,,,,0,0,0,1,0,0,0,1,4,10,0,0,0,0,0,0,72,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40414,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40415,Unplanned visit (2),On Trial,,,,,,,,,,7,121,0,,,,0,0,0,2,0,0,0,2,8,44,0,0,0,0,0,0,90,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40416,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40417,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,4,11,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40418,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40419,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40420,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40421,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40422,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,2,0,0,2,0
Study 22,AMERICA,USA,Site 178,Subject 40423,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40425,Screening,Discontinued,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,1,0,18,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40426,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40427,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 178,Subject 40428,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 77,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,9,52,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 78,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 79,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 80,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 81,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,9,1,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 4756,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 4757,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14942,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14943,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14944,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14946,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14947,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14948,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14949,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14950,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14951,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14952,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14953,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14954,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14955,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14956,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14957,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 14958,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40429,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40430,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40432,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40433,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40434,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40436,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40438,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40441,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40442,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40443,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40444,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40445,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40446,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40447,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,0,20,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40448,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40449,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40450,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40451,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40452,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40454,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40455,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40457,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,69,0,,,,0,0,0,2,0,0,0,2,14,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40458,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 19,Subject 40460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 325,Subject 2648,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 325,Subject 2649,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 325,Subject 2650,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 325,Subject 2651,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 325,Subject 14959,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 82,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 1601,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 1602,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 1603,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 2840,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 2841,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 2842,Unplanned visit (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40461,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40462,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,77,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40463,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40464,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40465,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40466,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40467,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,67,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40468,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40469,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40470,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40471,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40472,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40473,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40474,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40475,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40476,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40477,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40478,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40480,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40482,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40484,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40485,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40486,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40487,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40488,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40489,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40490,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40491,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40493,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40494,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40497,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40498,Unplanned visit (2),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 20,Subject 40502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2652,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 326,Subject 2653,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 326,Subject 2654,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2655,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,2,0,0,0,2,1,7,0,0,0,0,0,1,55,8,0,0,1,7
Study 22,AMERICA,USA,Site 326,Subject 2656,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,56,7,0,0,0,7
Study 22,AMERICA,USA,Site 326,Subject 2657,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2658,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2659,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,4,0,0,0,4,1,6,0,0,0,0,0,1,54,9,0,0,1,8
Study 22,AMERICA,USA,Site 326,Subject 2660,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2661,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 2662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,44,2,0,0,0,2
Study 22,AMERICA,USA,Site 326,Subject 2663,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40503,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,62,0,,,,0,0,0,0,0,0,0,0,0,21,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40505,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,AMERICA,USA,Site 326,Subject 40506,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40507,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,1,44,7,0,0,3,4
Study 22,AMERICA,USA,Site 326,Subject 40508,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40511,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40512,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,2,0,0,0,2
Study 22,AMERICA,USA,Site 326,Subject 40513,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 326,Subject 40514,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 1604,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 1605,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,1,0,0,0,1,2,53,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,USA,Site 179,Subject 1606,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,24,0,0,0,0,0,0,51,1,1,0,2,0
Study 22,AMERICA,USA,Site 179,Subject 1607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,3,10,0,0,0,0,0,0,54,1,1,2,4,0
Study 22,AMERICA,USA,Site 179,Subject 1608,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 1609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,51,1,1,0,2,0
Study 22,AMERICA,USA,Site 179,Subject 40515,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 40516,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,2,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 179,Subject 40517,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 179,Subject 40518,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,45,0,9,0,1,8
Study 22,AMERICA,USA,Site 179,Subject 40519,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,8,0,1,7
Study 22,AMERICA,USA,Site 179,Subject 40520,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,3,0,0,0,3,12,10,0,0,0,0,0,0,45,8,0,5,5,8
Study 22,AMERICA,USA,Site 179,Subject 40521,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 179,Subject 40522,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,1,0,0,8
Study 22,AMERICA,USA,Site 179,Subject 40523,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 40524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 179,Subject 40525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,0,7,0,0,7
Study 22,AMERICA,USA,Site 179,Subject 40526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,39,0,7,0,0,7
Study 22,AMERICA,USA,Site 179,Subject 40527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,7,0,0,7
Study 22,AMERICA,USA,Site 328,Subject 2668,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 2669,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40528,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,3,58,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40529,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40530,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,3,8,0,0,0,0,1,0,60,1,0,0,1,0
Study 22,AMERICA,USA,Site 328,Subject 40531,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40532,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40533,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40534,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40535,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40536,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40537,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40538,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40539,Unplanned visit (3),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,1,0,52,9,0,0,0,9
Study 22,AMERICA,USA,Site 328,Subject 40540,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40541,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40542,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40543,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40544,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40546,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 328,Subject 40547,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 1610,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 1611,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,79,0,,,,0,0,0,0,0,0,0,0,0,75,0,0,0,0,0,0,68,3,1,0,3,1
Study 22,AMERICA,USA,Site 180,Subject 1612,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 1613,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,9,0,0,1,8
Study 22,AMERICA,USA,Site 180,Subject 14996,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,1,0,0,3,0,0,0,4,1,11,0,0,0,0,0,0,50,14,0,0,3,11
Study 22,AMERICA,USA,Site 180,Subject 14997,Unplanned visit (3),On Trial,,,,,,,,,,6,89,0,,,,1,0,0,5,0,0,0,6,0,25,0,0,0,0,0,0,54,9,11,0,3,17
Study 22,AMERICA,USA,Site 180,Subject 14998,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 14999,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15001,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15002,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,2,0,0,1,1
Study 22,AMERICA,USA,Site 180,Subject 15003,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15004,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15006,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15007,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 180,Subject 15008,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,1,2,0,2,1
Study 22,AMERICA,USA,Site 180,Subject 15009,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15010,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15011,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,52,2,0,0,1,1
Study 22,AMERICA,USA,Site 180,Subject 15013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,2,0,0,0,2
Study 22,AMERICA,USA,Site 180,Subject 15014,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,2,0,0,1,1
Study 22,AMERICA,USA,Site 180,Subject 15015,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15016,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15017,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,1,9,0,2,8
Study 22,AMERICA,USA,Site 180,Subject 15018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,7,0,0,7
Study 22,AMERICA,USA,Site 180,Subject 15019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,1,8,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,9,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15021,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,3,0,0,0,3,0,4,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15022,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 180,Subject 15023,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15024,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,82,0,,,,0,0,0,6,0,0,0,6,17,10,0,0,0,0,0,0,41,15,0,0,4,11
Study 22,AMERICA,USA,Site 180,Subject 15025,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15026,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15027,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,80,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,56,11,0,0,4,7
Study 22,AMERICA,USA,Site 180,Subject 15028,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15029,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,9,0,0,2,7
Study 22,AMERICA,USA,Site 180,Subject 15030,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 180,Subject 15031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,20,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15033,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 180,Subject 15034,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15035,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15036,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15037,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,2,0,0,2,0
Study 22,AMERICA,USA,Site 180,Subject 15038,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15039,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 15040,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 40548,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 180,Subject 40549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 1614,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 2670,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 2671,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 2672,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 2673,End of Study (EOS) (1),Discontinued,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 181,Subject 2674,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 329,Subject 2683,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 329,Subject 2684,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 329,Subject 2685,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 329,Subject 2686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 1615,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,AMERICA,USA,Site 182,Subject 40550,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40551,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40552,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40553,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,AMERICA,USA,Site 182,Subject 40554,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,46,6,0,0,0,6
Study 22,AMERICA,USA,Site 182,Subject 40555,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,AMERICA,USA,Site 182,Subject 40556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40557,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,1,0,1,0,0,0,2,1,16,0,0,0,0,0,0,51,6,0,0,0,6
Study 22,AMERICA,USA,Site 182,Subject 40558,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40559,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40560,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40561,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40563,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40564,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40565,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40568,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40569,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40572,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40573,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40574,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,1,0,0,1,0
Study 22,AMERICA,USA,Site 182,Subject 40575,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40576,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40577,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40578,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40579,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40580,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40581,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40582,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40583,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40585,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40586,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 182,Subject 40587,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15041,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,3,50,0,0,0,0,4,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15042,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,81,0,,,,0,0,0,2,0,0,0,2,0,70,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15043,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15044,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,25,0,0,0,0,0,0,54,7,0,0,1,6
Study 22,AMERICA,USA,Site 1022,Subject 15045,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15046,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15047,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15048,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15049,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15050,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15051,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,2,0,0,1,1
Study 22,AMERICA,USA,Site 1022,Subject 15052,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15053,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15054,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15055,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15056,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1022,Subject 15057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 3820,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15121,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15122,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15123,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15124,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15125,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,58,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15126,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,41,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15127,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15128,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 15129,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40588,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40589,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40590,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40591,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40592,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40593,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40594,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40595,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40597,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40598,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40600,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40601,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40602,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40603,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40604,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40605,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40606,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40607,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40608,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40609,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40610,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40611,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40612,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40613,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40614,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40615,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40616,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40617,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40618,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40619,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40620,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40622,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40623,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40624,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40625,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40627,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 535,Subject 40628,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40629,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40630,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40632,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40633,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40634,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40635,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40636,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 535,Subject 40638,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 535,Subject 40640,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40641,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40642,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40644,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40647,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40648,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40649,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40651,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,67,0,,,,1,0,0,2,0,0,0,3,6,12,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 535,Subject 40652,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 1616,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,59,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 1617,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,61,0,0,0,1,0
Study 22,AMERICA,USA,Site 183,Subject 1618,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40653,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40654,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40656,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 183,Subject 40658,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 86,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 1619,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 1620,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 1621,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 1622,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 1623,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,AMERICA,USA,Site 22,Subject 15141,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,0,15,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15147,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15148,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 22,Subject 15149,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15266,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15267,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15268,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15269,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15270,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15271,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,1,1,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15272,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,64,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15273,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15274,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15275,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15276,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15277,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15278,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15279,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15280,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15281,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15283,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15284,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1024,Subject 15286,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 1624,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 1625,Unplanned visit (2),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 1626,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 1627,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15301,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15303,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15304,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 184,Subject 15306,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40659,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40660,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,76,0,,,,0,0,0,0,0,0,0,0,1,19,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40661,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,61,0,0,1,1,0
Study 22,AMERICA,USA,Site 2007,Subject 40662,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,60,0,0,1,1,0
Study 22,AMERICA,USA,Site 2007,Subject 40663,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40664,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,3,11,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40665,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40666,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,61,0,0,1,1,0
Study 22,AMERICA,USA,Site 2007,Subject 40667,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40668,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40669,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,69,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40670,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40671,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40672,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40673,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40674,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40675,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40676,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40677,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40678,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40679,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40680,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40681,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40682,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40683,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40684,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40685,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40686,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40687,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40689,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40690,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40691,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40692,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40693,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40694,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,1,19,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40695,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40696,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40697,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40698,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40700,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40701,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40702,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40703,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,1,0,2,0,0,0,3,10,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40713,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40715,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40716,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2007,Subject 40718,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 185,Subject 1628,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 185,Subject 1629,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,8,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 185,Subject 1630,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 185,Subject 1631,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 185,Subject 1632,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 87,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,60,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 88,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 89,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 15373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 15374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 90,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,10,52,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 2701,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 2702,Unplanned visit (1),On Trial,,,,,,,,,,6,79,0,,,,0,0,0,1,0,0,0,1,1,24,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15385,Unplanned visit (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15387,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,90,0,,,,0,0,0,4,0,0,0,4,17,19,0,1,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15388,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 24,Subject 15393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 2703,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,80,0,,,,0,0,0,0,0,0,0,0,0,77,0,0,0,0,1,0,72,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15398,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15399,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15400,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,84,0,,,,0,0,0,2,0,0,0,2,2,23,0,0,0,0,0,0,70,1,0,0,1,0
Study 22,AMERICA,USA,Site 330,Subject 15401,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15402,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,0,17,0,1,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15403,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15404,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15405,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15406,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15407,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15408,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15409,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15410,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15411,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15412,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15413,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15414,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,69,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15415,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15416,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15417,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15418,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15419,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15420,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15421,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15422,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15423,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15424,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15425,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15426,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15427,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15428,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15429,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15430,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15431,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,58,7,0,0,0,7
Study 22,AMERICA,USA,Site 330,Subject 15432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15433,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15434,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15435,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15437,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15438,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15439,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15440,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15441,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15442,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15444,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15446,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15449,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15450,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15453,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15454,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15456,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15457,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15458,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15459,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,8,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15462,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,3,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15463,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15464,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15465,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,3,9,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15466,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15467,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15469,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15470,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,9,5,0,0,0,0,0,0,55,2,0,0,2,0
Study 22,AMERICA,USA,Site 330,Subject 15471,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15472,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15473,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15474,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15475,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,1,0,0,0,1,1,22,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15476,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15477,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15478,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15479,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15480,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15481,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,1,0,0,3,0,0,0,4,1,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15484,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15486,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15487,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15489,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15490,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15492,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15493,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,3,0,0,2,1
Study 22,AMERICA,USA,Site 330,Subject 15495,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 330,Subject 15497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 3821,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 3822,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 3823,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 3824,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40719,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40720,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,30,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40721,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40722,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40723,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40724,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,60,1,0,0,1,0
Study 22,AMERICA,USA,Site 536,Subject 40725,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40727,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40728,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40729,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 536,Subject 40730,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40731,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,AMERICA,USA,Site 536,Subject 40732,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,AMERICA,USA,Site 536,Subject 40733,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 536,Subject 40734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40738,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40739,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 536,Subject 40740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 537,Subject 3825,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 537,Subject 15498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,26,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 537,Subject 15499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,1,0,0,0,1,0,27,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 537,Subject 15500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 186,Subject 1634,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,58,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 186,Subject 3826,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 186,Subject 15513,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 186,Subject 15514,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 2704,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 2705,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 2706,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,1,0,0,1,1,32,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 2707,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,1,0,0,1,1,8,0,0,0,0,0,0,53,8,0,0,1,7
Study 22,AMERICA,USA,Site 331,Subject 2708,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,1,0,0,1,1,40,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 2709,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,1,0,0,1,1,7,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 40742,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,1,0,0,1,1,6,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 40743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,1,8,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 40744,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,1,0,0,1,1,7,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 331,Subject 40745,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40746,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40747,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40748,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40749,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40751,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40752,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 331,Subject 40756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 1635,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,61,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 1636,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 2710,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 2711,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 2712,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 2713,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15523,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15524,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15525,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15526,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,4,0,0,0,4,3,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15527,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15528,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15529,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15530,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15532,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15533,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15534,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,2,0,0,0,2
Study 22,AMERICA,USA,Site 187,Subject 15536,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15537,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15538,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15539,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15540,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 15541,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40757,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,1,,,,0,0,0,4,0,0,0,4,3,14,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,AMERICA,USA,Site 187,Subject 40758,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,9,0,0,0,9,13,7,0,0,0,0,0,0,52,2,0,0,2,0
Study 22,AMERICA,USA,Site 187,Subject 40760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,USA,Site 187,Subject 40761,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40763,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 187,Subject 40768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 1637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,48,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 1638,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 15542,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 15543,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40769,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40770,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40771,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40772,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40773,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40776,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40778,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 188,Subject 40782,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 188,Subject 40784,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 188,Subject 40786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 188,Subject 40787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40792,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,45,5,0,0,1,4
Study 22,AMERICA,USA,Site 188,Subject 40795,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,30,4,0,0,0,4
Study 22,AMERICA,USA,Site 188,Subject 40796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40797,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40801,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,0,28,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40805,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40806,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 188,Subject 40807,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 538,Subject 3827,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 538,Subject 3828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,0,68,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 538,Subject 3829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 538,Subject 15544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 538,Subject 40808,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 189,Subject 1639,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,1,0,0,0,1,0,61,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 189,Subject 1640,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,65,1,0,0,1,0
Study 22,AMERICA,USA,Site 189,Subject 3830,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,4,0,0,0,4,0,10,0,0,0,0,1,0,56,3,0,0,2,1
Study 22,AMERICA,USA,Site 189,Subject 3831,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 189,Subject 15545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1027,Subject 15547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,24,0,0,0,24,14,54,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 332,Subject 2714,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 2715,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,0,20,0,0,0,0,0,0,64,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 2716,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 2717,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 2718,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 15564,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,0,0,64,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 15565,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 15566,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 15567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,54,2,0,0,0,2
Study 22,AMERICA,USA,Site 332,Subject 15568,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40809,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,82,0,,,,0,0,0,1,0,0,0,1,0,26,0,0,0,0,0,0,68,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40810,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40811,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40812,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40813,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,42,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40814,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40815,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40816,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,66,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40817,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,93,0,,,,0,0,0,0,0,0,0,0,0,34,0,0,0,0,0,0,76,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40818,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40819,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,79,0,,,,0,0,0,0,0,0,0,0,0,20,0,0,0,0,0,0,70,1,0,0,1,0
Study 22,AMERICA,USA,Site 332,Subject 40820,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,81,0,,,,0,0,0,2,0,0,0,2,0,26,0,0,0,0,0,0,65,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40821,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40822,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,56,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40825,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40826,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40827,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40828,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40829,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40830,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40831,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40832,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40833,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40834,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40835,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40836,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40837,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,59,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40838,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40839,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40840,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40841,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,56,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40842,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,6,0,0,0,6
Study 22,AMERICA,USA,Site 332,Subject 40843,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,52,0,,,,1,0,0,0,0,0,0,1,0,9,0,0,0,0,1,0,46,4,0,0,1,3
Study 22,AMERICA,USA,Site 332,Subject 40844,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,65,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40845,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40846,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40847,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40848,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,1,17,0,0,0,0,0,0,58,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40849,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40850,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,58,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,6,0,0,0,6
Study 22,AMERICA,USA,Site 332,Subject 40851,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40852,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40853,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40854,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40855,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,1,0,0,3,0,0,0,4,1,8,0,0,0,0,0,0,51,10,0,0,1,9
Study 22,AMERICA,USA,Site 332,Subject 40856,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40857,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40858,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 332,Subject 40859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40862,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40866,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40868,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40869,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40871,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,56,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40872,Unplanned visit (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,86,0,,,,0,0,0,0,0,0,0,0,0,37,0,0,0,0,1,0,65,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40874,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40880,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40881,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40884,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40885,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40886,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,61,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40887,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40888,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40889,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40890,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40893,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40894,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40895,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40896,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40897,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40898,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40899,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40900,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40901,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40902,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40903,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40904,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40905,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,1,0,0,2,1,15,0,0,0,0,0,0,51,5,0,0,4,1
Study 22,AMERICA,USA,Site 332,Subject 40906,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40908,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,1,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,AMERICA,USA,Site 332,Subject 40912,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40914,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40917,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40919,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40920,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40922,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40923,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40925,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40926,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40928,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40932,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40934,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 332,Subject 40935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2719,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2720,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2721,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2722,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2723,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,62,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2724,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2725,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2726,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2727,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 2728,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 15569,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 15570,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 15571,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 15572,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 15573,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40936,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40937,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40938,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40939,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40940,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40941,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40942,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40943,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40944,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40945,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40946,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40947,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40948,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40949,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40950,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40951,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40952,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40953,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40954,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40955,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40956,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40957,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40958,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40959,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,2,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40960,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40961,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40962,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40963,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40964,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40965,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40966,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40967,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40968,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40969,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40970,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40971,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40972,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40973,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40974,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40975,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40976,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40977,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40978,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40982,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40983,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40986,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40988,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40992,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40993,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40994,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40995,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40996,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 40999,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41000,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41001,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41002,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41004,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41007,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41008,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41009,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41018,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41021,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41022,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41023,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41025,Unplanned visit (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 333,Subject 41027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 2729,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41028,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41029,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,1,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41030,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41031,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41032,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41033,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41034,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41035,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41036,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41037,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41038,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,58,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41039,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,51,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,53,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41041,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 334,Subject 41042,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,61,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,53,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41044,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,53,2,0,0,1,1
Study 22,AMERICA,USA,Site 334,Subject 41045,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41046,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41051,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41052,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 334,Subject 41053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 335,Subject 2730,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,4,57,0,0,0,0,2,0,53,0,5,0,1,4
Study 22,AMERICA,USA,Site 335,Subject 2731,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,53,0,6,0,0,6
Study 22,AMERICA,USA,Site 335,Subject 2732,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,52,0,6,0,0,6
Study 22,AMERICA,USA,Site 335,Subject 2733,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,52,0,6,0,0,6
Study 22,AMERICA,USA,Site 335,Subject 2734,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 335,Subject 2735,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,7,0,7
Study 22,AMERICA,USA,Site 335,Subject 2736,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2008,Subject 41054,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41055,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41056,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41057,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41058,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,1,0,0,0,1,2,60,0,0,0,0,0,1,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41059,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41061,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41062,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,1,0,0,1,1,33,0,0,0,0,0,0,60,1,0,0,1,0
Study 22,AMERICA,USA,Site 2008,Subject 41063,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41064,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41065,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41066,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41067,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41069,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41070,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41071,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41072,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41073,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41074,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41075,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41076,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41078,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41079,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41080,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41081,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41084,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,1,53,7,0,0,0,7
Study 22,AMERICA,USA,Site 2008,Subject 41085,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41086,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41087,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41088,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41089,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41090,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41091,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41092,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41093,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41095,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41096,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41097,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41098,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2008,Subject 41099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 15574,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41100,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41101,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41102,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41104,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41105,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41106,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,2,0,0,2,1,13,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41107,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41108,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41109,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,43,7,0,0,1,6
Study 22,AMERICA,USA,Site 1029,Subject 41110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41111,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1029,Subject 41112,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 4013,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15575,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,1,64,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15576,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15577,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,76,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15578,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15579,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15580,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,3,0,0,0,3
Study 22,AMERICA,USA,Site 593,Subject 15581,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15582,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 15583,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41113,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 593,Subject 41115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41116,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 593,Subject 41120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 594,Subject 4014,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,36,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 594,Subject 4015,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 594,Subject 4016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 594,Subject 15584,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 594,Subject 15585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15591,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15592,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15593,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15595,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15596,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15597,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15598,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15600,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 15601,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,2,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41121,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41122,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41123,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41124,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41125,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41126,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41127,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41128,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,1,1,2,0,0,4,2,16,0,0,0,0,0,0,46,5,0,0,5,0
Study 22,AMERICA,USA,Site 1030,Subject 41129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41131,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41132,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 41133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 2739,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,2,62,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 2740,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 2741,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 2742,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 2743,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41134,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,2,0,0,0,2,6,16,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41138,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41139,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41140,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41141,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 336,Subject 41142,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41143,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41144,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,AMERICA,USA,Site 2009,Subject 41145,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41146,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41147,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,24,8,1,5,10,4
Study 22,AMERICA,USA,Site 2009,Subject 41148,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41149,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2009,Subject 41150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,7,0,0,7
Study 22,AMERICA,USA,Site 2010,Subject 41151,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41152,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41153,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41154,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41155,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41156,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41157,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41158,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41159,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41160,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41161,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41162,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41163,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41164,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,10,0,0,3,7
Study 22,AMERICA,USA,Site 2010,Subject 41165,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41166,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41167,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41168,End of Study (EOS) (1),Discontinued,,,,,,,,,,6,66,0,,,,1,0,0,1,0,0,0,2,0,17,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41170,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41171,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41172,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41173,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41174,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41175,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41176,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41177,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41178,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41179,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41180,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41181,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41182,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41183,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41184,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2010,Subject 41187,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 2760,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 2761,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 2762,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41188,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41189,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41190,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,2,0,0,2,2,59,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 339,Subject 41191,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41192,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41193,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,1,0,0,1,1,8,0,0,0,0,0,0,53,8,0,0,1,7
Study 22,AMERICA,USA,Site 2011,Subject 41194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41195,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41196,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41197,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41198,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,0,1,0,0,1,1,27,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41199,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,1,0,0,0,1,0,0,2,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41200,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,1,0,0,0,1,0,0,2,1,8,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41202,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 339,Subject 41203,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2763,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2764,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2766,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2767,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 2768,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 41204,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,21,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 41205,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 41206,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 41207,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 340,Subject 41208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41209,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,70,0,,,,0,0,0,5,0,0,0,5,5,62,0,0,0,0,0,0,60,4,0,0,4,0
Study 22,AMERICA,USA,Site 2012,Subject 41210,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41211,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41212,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41213,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41214,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41215,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41216,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41217,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,54,6,0,0,0,6
Study 22,AMERICA,USA,Site 2012,Subject 41218,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41219,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41220,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41221,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41225,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,52,5,0,0,0,5
Study 22,AMERICA,USA,Site 2012,Subject 41226,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41227,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41228,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41229,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41230,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41231,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41232,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41233,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,1,1,0
Study 22,AMERICA,USA,Site 2012,Subject 41235,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41238,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41239,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41242,Unplanned visit (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41243,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41244,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41245,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41247,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41248,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 2012,Subject 41249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41251,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41253,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2012,Subject 41254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 2770,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,62,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41255,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41256,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41257,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41258,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41259,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,76,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41260,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41261,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41263,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41264,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41265,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41266,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41267,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41268,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41269,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 342,Subject 41270,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41272,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,48,8,0,0,1,7
Study 22,AMERICA,USA,Site 342,Subject 41273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41275,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41276,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41278,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41279,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41284,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 342,Subject 41287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2013,Subject 41288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2013,Subject 41289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,2,2,0
Study 22,AMERICA,USA,Site 2013,Subject 41290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,46,0,0,7,0,7
Study 22,AMERICA,USA,Site 2013,Subject 41291,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2013,Subject 41292,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2013,Subject 41293,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2013,Subject 41294,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2014,Subject 41295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2014,Subject 41296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2014,Subject 41297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2014,Subject 41298,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41301,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,1,0,0,0,1,1,24,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,AMERICA,USA,Site 2015,Subject 41306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41309,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41310,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41313,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41314,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41315,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41316,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41317,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41318,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41319,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41322,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41323,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41325,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41326,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41327,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41328,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41331,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41332,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41333,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41334,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41335,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41337,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41339,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,2,0,0,0,2,1,23,0,0,0,0,0,0,53,3,0,0,3,0
Study 22,AMERICA,USA,Site 2015,Subject 41341,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41343,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41344,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2015,Subject 41345,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41346,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41347,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41349,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41350,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41353,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41354,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2016,Subject 41355,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 2771,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 2772,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41356,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41357,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41358,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41359,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41360,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41361,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41362,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41363,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41364,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,79,0,,,,0,0,0,2,0,0,0,2,2,23,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41365,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41366,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41368,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41370,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,60,0,,,,1,0,0,0,0,0,0,1,1,15,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41373,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41375,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41377,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41378,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41379,Visit 1 (1),On Trial,,,,,,,,,,2,31,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,29,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41382,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41383,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41384,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41385,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41387,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41389,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41390,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,49,6,0,0,0,6
Study 22,AMERICA,USA,Site 343,Subject 41391,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41393,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41396,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41397,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41399,Visit 1 (1),Discontinued,,,,,,,,,,2,22,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,21,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41401,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 343,Subject 41403,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41404,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,118,0,,,,1,0,0,7,0,0,0,8,2,85,1,0,0,0,0,0,77,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41407,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 2017,Subject 41408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41410,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41412,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41414,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41415,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2017,Subject 41417,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41418,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,7,52,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41419,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41420,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,8,0,0,1,7
Study 22,AMERICA,USA,Site 2018,Subject 41421,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41422,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41424,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,1,1,0,0,2,4,16,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41425,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41426,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41427,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,8,0,0,0,8,2,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41430,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2018,Subject 41431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15677,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,3,44,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15678,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 1035,Subject 15679,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15680,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,7,0,7
Study 22,AMERICA,USA,Site 1035,Subject 15681,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15682,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15683,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15684,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15685,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,0,6,0,0,6
Study 22,AMERICA,USA,Site 1035,Subject 15686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,6,0,0,6
Study 22,AMERICA,USA,Site 1035,Subject 15687,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,42,1,6,0,1,6
Study 22,AMERICA,USA,Site 1035,Subject 15689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 1035,Subject 15690,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15691,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,5,0,0,0,5
Study 22,AMERICA,USA,Site 1035,Subject 15693,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15694,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 1035,Subject 15695,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 15697,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,3,0,0,3
Study 22,AMERICA,USA,Site 1035,Subject 15698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 41432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 41433,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 41434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1035,Subject 41435,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,35,0,11,0,4,7
Study 22,AMERICA,USA,Site 1035,Subject 41436,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,35,0,10,0,3,7
Study 22,AMERICA,USA,Site 1037,Subject 15713,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,58,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 1037,Subject 15714,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,USA,Site 1037,Subject 15715,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1037,Subject 15716,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,58,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,49,7,0,0,1,6
Study 22,AMERICA,USA,Site 1037,Subject 15717,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1037,Subject 15718,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15732,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15733,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15734,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,AMERICA,USA,Site 1038,Subject 15735,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15736,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15737,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15738,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1038,Subject 15739,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15744,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15745,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,95,0,,,,0,0,0,0,0,0,0,0,1,68,0,0,0,0,0,0,67,6,0,0,0,6
Study 22,AMERICA,USA,Site 1041,Subject 15746,Screening,Screen Failure,,,,,,,,,,1,24,0,,,,0,0,0,0,0,0,0,0,0,10,22,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15747,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,53,6,0,0,0,6
Study 22,AMERICA,USA,Site 1041,Subject 15748,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,56,7,0,0,1,6
Study 22,AMERICA,USA,Site 1041,Subject 15749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15751,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15754,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15755,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15756,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15757,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15758,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,1,0,0,0,1,1,24,0,0,0,0,0,0,56,7,0,0,1,6
Study 22,AMERICA,USA,Site 1041,Subject 15759,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 1041,Subject 15761,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1041,Subject 15762,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1042,Subject 15782,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1042,Subject 15783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,22,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,AMERICA,USA,Site 1042,Subject 15784,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1042,Subject 15785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1042,Subject 15786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41437,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,8,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41438,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41439,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41440,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41441,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41442,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41443,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41444,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41445,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41446,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41447,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41448,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41449,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41450,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,1,0,0,0,1,2,16,0,0,0,0,0,0,60,6,0,0,0,6
Study 22,AMERICA,USA,Site 2019,Subject 41451,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41453,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41454,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41456,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41457,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41458,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41459,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41462,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41463,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41464,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41465,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41466,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41467,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41470,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41472,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41473,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,AMERICA,USA,Site 2019,Subject 41475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41477,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,68,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2019,Subject 41480,Unplanned visit (1),Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1044,Subject 15858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,17,34,0,0,0,0,2,0,48,0,0,2,2,0
Study 22,AMERICA,USA,Site 1044,Subject 15859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,28,0,0,15,0,15
Study 22,AMERICA,USA,Site 2020,Subject 41481,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41482,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,3,13,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41484,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,2,0,0,0,0,0,0,2,0,26,0,0,0,0,0,0,60,4,0,0,1,3
Study 22,AMERICA,USA,Site 2020,Subject 41485,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41486,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41487,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41488,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41489,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41490,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41491,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,93,0,,,,0,0,0,0,0,0,0,0,5,44,1,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41496,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41498,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41499,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2020,Subject 41500,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41501,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,86,0,,,,0,0,0,1,0,0,0,1,0,81,0,0,0,0,0,0,71,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41502,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41503,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41504,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41506,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41507,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41508,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41509,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41510,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41511,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41512,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41513,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41514,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41515,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,2,0,0,0,2,0,16,0,0,0,0,0,0,54,1,0,0,0,1
Study 22,AMERICA,USA,Site 2021,Subject 41516,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41517,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41518,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41520,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41521,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41522,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41523,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41525,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2021,Subject 41526,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41527,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,7,55,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41529,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41530,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41532,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41534,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41535,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41536,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41537,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41538,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41539,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41540,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41541,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41542,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41543,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41544,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41545,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41546,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41547,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41551,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2022,Subject 41557,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41558,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41559,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,51,0,0,0,0,1,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 2023,Subject 41560,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 2023,Subject 41562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,AMERICA,USA,Site 2023,Subject 41563,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,57,1,0,0,1,0
Study 22,AMERICA,USA,Site 2023,Subject 41564,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,2,0,0,2,1,5,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,USA,Site 2023,Subject 41565,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41566,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41568,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41569,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,2,4,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,AMERICA,USA,Site 2023,Subject 41570,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41572,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2023,Subject 41575,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41576,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,2,0,0,0,0,0,0,2,2,61,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41577,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41578,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41579,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41580,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41581,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41582,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41583,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41584,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 41585,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15898,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,1,0,0,0,1,8,56,0,0,0,0,1,0,55,1,0,0,0,1
Study 22,AMERICA,USA,Site 1047,Subject 15899,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15900,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15901,Unplanned visit (1),Discontinued,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15902,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15903,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15904,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15905,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15906,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 15908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 1047,Subject 15909,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 41586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 41587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1047,Subject 41588,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 15910,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,0,69,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 15911,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41589,Unplanned visit (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,58,3,0,0,0,3
Study 22,AMERICA,USA,Site 1048,Subject 41590,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41591,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,2,15,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41592,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41593,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,USA,Site 1048,Subject 41594,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41595,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,6,0,0,0,6
Study 22,AMERICA,USA,Site 1048,Subject 41596,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,73,0,,,,1,0,0,1,0,0,0,2,1,18,0,0,0,0,1,0,57,7,0,0,0,7
Study 22,AMERICA,USA,Site 1048,Subject 41597,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41598,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41600,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41601,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41602,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41604,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41605,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41606,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41607,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1048,Subject 41609,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41610,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,58,1,0,0,1,0
Study 22,AMERICA,USA,Site 2025,Subject 41611,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41612,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,52,5,0,0,0,5
Study 22,AMERICA,USA,Site 2025,Subject 41613,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,1,0,0,0,1
Study 22,AMERICA,USA,Site 2025,Subject 41614,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41616,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41617,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41618,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41619,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41621,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2025,Subject 41625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41626,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2025,Subject 41628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41629,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,30,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41630,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41632,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41635,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41636,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41637,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41638,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,AMERICA,USA,Site 2026,Subject 41639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41640,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41641,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41642,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,AMERICA,USA,Site 2026,Subject 41643,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2026,Subject 41644,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41645,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2026,Subject 41646,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41647,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,USA,Site 2026,Subject 41648,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2026,Subject 41649,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41650,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41651,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 2026,Subject 41652,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41653,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 2026,Subject 41654,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,48,8,0,0,1,7
Study 22,AMERICA,USA,Site 2026,Subject 41655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41659,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41660,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41661,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41662,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41664,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41665,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41666,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41667,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41668,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41669,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41671,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41674,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41675,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41676,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41679,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41681,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41684,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2026,Subject 41687,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2026,Subject 41688,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15912,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,16,36,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,8,0,0,0,8,18,5,0,0,0,0,0,0,50,3,0,0,1,2
Study 22,AMERICA,USA,Site 1049,Subject 15915,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 1049,Subject 15917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,43,0,8,0,2,6
Study 22,AMERICA,USA,Site 1049,Subject 15918,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,101,0,,,,0,0,0,1,0,0,0,1,25,24,0,0,0,0,0,0,65,0,8,0,2,6
Study 22,AMERICA,USA,Site 1049,Subject 15919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,42,0,9,0,2,7
Study 22,AMERICA,USA,Site 1049,Subject 15920,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,1,0,44,7,0,0,1,6
Study 22,AMERICA,USA,Site 1049,Subject 15922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,7,0,0,1,6
Study 22,AMERICA,USA,Site 1049,Subject 15923,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15924,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,42,8,0,0,2,6
Study 22,AMERICA,USA,Site 1049,Subject 15925,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 15926,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,42,8,1,0,3,6
Study 22,AMERICA,USA,Site 1049,Subject 15927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 1049,Subject 41689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 41690,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 41691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,AMERICA,USA,Site 1049,Subject 41692,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1049,Subject 41693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 1049,Subject 41694,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,AMERICA,USA,Site 1051,Subject 15944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15966,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15967,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15968,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15969,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15970,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15971,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15972,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15973,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15974,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,33,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15975,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15976,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15978,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 1052,Subject 15980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1052,Subject 15981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1020,Subject 15982,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,56,2,,,,0,0,0,10,0,0,0,10,14,39,0,0,0,0,0,0,42,1,0,2,0,3
Study 22,AMERICA,USA,Site 1020,Subject 15983,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1020,Subject 15984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,4,2,0,0,6,1,7,0,0,0,0,0,0,43,0,0,1,1,0
Study 22,AMERICA,USA,Site 1020,Subject 15985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1020,Subject 15986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,5,0,0,0,5,2,6,0,0,0,0,1,0,36,0,6,0,0,6
Study 22,AMERICA,USA,Site 1020,Subject 15987,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1020,Subject 15988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,3,1,0,0,4,2,6,0,0,0,0,1,0,32,0,5,4,1,8
Study 22,AMERICA,USA,Site 2027,Subject 41695,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,35,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41697,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41698,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2027,Subject 41704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 16060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16065,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16066,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16067,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,2,0,0,0,2,0,64,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16069,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,2,0,0,0,2,0,17,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16070,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16071,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16072,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16073,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16076,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16077,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16078,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16079,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16080,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 16082,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41705,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41708,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41711,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41712,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1040,Subject 41713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2028,Subject 41714,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2028,Subject 41715,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2028,Subject 41716,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2028,Subject 41717,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 2028,Subject 41718,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2028,Subject 41719,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 16092,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 16093,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41720,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41721,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41722,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41723,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41724,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41725,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41727,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,1,0,0,0,1,1,20,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41728,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41729,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41730,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41731,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41732,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,4,0,0,0,4,16,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41733,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41734,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41738,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41739,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1056,Subject 41741,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 16094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 16095,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 16096,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 16097,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41742,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,95,0,,,,0,0,0,6,0,0,0,6,0,47,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41746,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41747,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41749,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1057,Subject 41750,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41752,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41753,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41754,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41756,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,16,1,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41757,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41758,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41759,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41760,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41761,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41762,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,67,0,,,,0,0,0,0,0,0,0,0,9,34,0,0,0,0,1,0,58,1,0,0,0,1
Study 22,AMERICA,USA,Site 2029,Subject 41763,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,31,0,0,0,0,0,0,61,1,0,0,0,1
Study 22,AMERICA,USA,Site 2029,Subject 41764,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,5,9,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41765,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41766,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,86,0,,,,0,0,0,0,0,0,0,0,2,20,0,0,0,0,0,0,67,7,0,0,0,7
Study 22,AMERICA,USA,Site 2029,Subject 41767,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,51,9,0,0,2,7
Study 22,AMERICA,USA,Site 2029,Subject 41768,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,76,0,,,,0,1,0,1,0,0,0,2,11,5,0,0,0,0,0,0,52,13,0,0,4,9
Study 22,AMERICA,USA,Site 2029,Subject 41769,Screening,Screen Failure,,,,,,,,,,1,34,0,,,,0,0,0,0,0,0,0,0,0,16,30,0,0,0,0,0,23,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41770,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41771,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41772,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41773,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41774,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41776,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,8,0,0,2,6
Study 22,AMERICA,USA,Site 2029,Subject 41777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,1,10,0,1,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41779,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41780,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41782,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41783,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41784,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41785,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41787,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41788,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41789,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41790,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41791,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41792,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41793,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41794,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41795,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41796,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41797,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41798,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2029,Subject 41799,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41800,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41801,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41802,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,38,0,0,0,0,0,0,46,0,2,0,0,2
Study 22,AMERICA,USA,Site 2030,Subject 41804,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41805,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41807,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41808,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41809,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41810,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,3,37,0,0,0,0,0,0,34,1,2,1,4,0
Study 22,AMERICA,USA,Site 2030,Subject 41811,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 2030,Subject 41812,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41813,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41814,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,76,0,,,,0,0,0,1,0,0,0,1,19,54,0,0,0,0,0,0,68,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41815,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41816,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41817,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41818,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41819,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41820,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2031,Subject 41821,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16098,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16099,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 1058,Subject 16100,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16101,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16102,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16103,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16104,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 1058,Subject 16105,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16106,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 1058,Subject 16107,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,1,0,0,1,0
Study 22,AMERICA,USA,Site 1058,Subject 16108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,3,0,0,2,1
Study 22,AMERICA,USA,Site 1058,Subject 16109,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16110,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,AMERICA,USA,Site 1058,Subject 16111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16112,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 1058,Subject 16113,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,7,0,0,1,6
Study 22,AMERICA,USA,Site 1058,Subject 16115,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16116,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16119,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16120,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16121,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16122,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,1,0,43,2,0,0,2,0
Study 22,AMERICA,USA,Site 1058,Subject 16124,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16125,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16126,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16127,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16128,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16130,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16131,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1058,Subject 16133,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,42,3,0,0,3,0
Study 22,AMERICA,USA,Site 1059,Subject 16135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 16136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41822,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41823,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41826,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,2,0,0,0,2,8,7,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41828,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1059,Subject 41830,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2032,Subject 41831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,0,59,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2032,Subject 41832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2032,Subject 41833,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41834,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,AMERICA,USA,Site 2033,Subject 41835,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,52,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41837,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41838,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,2,0,0,2,0
Study 22,AMERICA,USA,Site 2033,Subject 41840,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,1,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41842,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41843,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41844,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41845,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,2,0,0,2,0
Study 22,AMERICA,USA,Site 2033,Subject 41846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41847,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41848,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41849,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2033,Subject 41850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2034,Subject 41851,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41852,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41854,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41855,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41856,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41858,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,79,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41861,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41862,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41864,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41865,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41866,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2034,Subject 41868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 16262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,1,,,,0,0,0,0,0,0,0,0,0,41,0,0,0,0,2,0,42,6,0,0,0,6
Study 22,AMERICA,USA,Site 1067,Subject 16263,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 16264,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 16265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,1,0,0,1
Study 22,AMERICA,USA,Site 1067,Subject 16266,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 16267,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 16268,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 16269,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,1,0,0,1,1,11,0,0,0,0,0,1,44,7,0,0,1,6
Study 22,AMERICA,USA,Site 2035,Subject 16270,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,1,0,46,6,0,0,0,6
Study 22,AMERICA,USA,Site 1067,Subject 16271,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 16272,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 16273,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,42,0,,,,0,1,0,0,0,0,0,1,0,8,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 41869,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 41870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 41871,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 41872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1067,Subject 41873,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 41874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 41875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 41876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41879,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41880,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41881,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41882,Unplanned visit (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41883,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,59,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41884,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41885,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41890,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41891,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41892,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41893,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41895,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2036,Subject 41896,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41897,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41898,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 2037,Subject 41899,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 2037,Subject 41900,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41902,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41904,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2037,Subject 41906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,37,0,0,14,0,14
Study 22,AMERICA,USA,Site 2038,Subject 41908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,41,0,8,2,3,7
Study 22,AMERICA,USA,Site 2038,Subject 41909,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,43,0,0,1,0,1
Study 22,AMERICA,USA,Site 2038,Subject 41911,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41912,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,29,0,0,8,0,8
Study 22,AMERICA,USA,Site 2038,Subject 41913,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,3,0,0,0,3,0,4,0,0,0,0,0,0,35,0,7,1,1,7
Study 22,AMERICA,USA,Site 2038,Subject 41914,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,37,0,7,0,0,7
Study 22,AMERICA,USA,Site 2038,Subject 41916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,33,0,0,12,3,9
Study 22,AMERICA,USA,Site 2038,Subject 41917,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,33,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,30,0,1,0,0,1
Study 22,AMERICA,USA,Site 2038,Subject 41918,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41919,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41920,Screening,Discontinued,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41921,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41922,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41923,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,0,1,1,0
Study 22,AMERICA,USA,Site 2038,Subject 41924,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2038,Subject 41925,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16343,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,64,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16345,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16347,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16348,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1072,Subject 16349,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2039,Subject 41926,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 41927,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,7,26,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2039,Subject 41928,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 41929,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,28,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2039,Subject 41930,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 23,Subject 41931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2039,Subject 41932,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,2,0,0,0,2,0,47,0,0,0,0,0,0,43,10,0,0,3,7
Study 22,AMERICA,USA,Site 1073,Subject 16376,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16377,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16378,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16379,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16380,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1073,Subject 16381,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16383,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16384,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16385,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16387,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16389,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,7,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 1074,Subject 16390,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41933,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,37,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41935,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41936,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41937,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41940,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41941,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41943,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2040,Subject 41945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41946,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,8,54,0,0,0,0,0,0,55,1,0,0,0,1
Study 22,AMERICA,USA,Site 2041,Subject 41947,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41948,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41949,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,28,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41950,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41952,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41953,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41954,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2041,Subject 41955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41956,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,4,0,0,0,4,15,48,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41957,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41958,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41959,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41960,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41961,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41962,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41963,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41964,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41965,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,7,0,0,0,7,7,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41966,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41967,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41968,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41969,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41970,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41971,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41972,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41974,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41975,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41976,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41977,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41978,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41979,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41981,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41982,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41983,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41984,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41985,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41986,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,33,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41987,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41988,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41989,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41990,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41991,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41992,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41994,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41995,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41996,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41997,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41998,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 41999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42000,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42001,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42002,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42003,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42004,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42005,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42006,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42007,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42008,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42009,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42014,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42015,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42016,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42017,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42018,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42019,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42020,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42021,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42022,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42023,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42024,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42025,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42026,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42027,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42028,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42029,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42030,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42031,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42032,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42033,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42034,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,3,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42035,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42036,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42037,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42038,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42039,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2042,Subject 42041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42042,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42043,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42044,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42045,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42046,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42047,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42048,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42049,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42050,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42051,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42052,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42053,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42054,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42055,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42056,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42058,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42059,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42061,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42063,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42065,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42067,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2042,Subject 42068,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42069,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42070,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42071,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,41,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42072,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42073,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42076,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42077,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,54,2,1,0,1,2
Study 22,AMERICA,USA,Site 2043,Subject 42079,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42081,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 2043,Subject 42082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,35,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42083,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42084,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42085,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42086,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42087,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,6,0,0,0,6,2,13,0,0,0,0,0,0,44,10,0,0,1,9
Study 22,AMERICA,USA,Site 2043,Subject 42088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42089,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42090,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2043,Subject 42091,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 2043,Subject 42092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42093,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42094,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42095,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42096,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42097,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42098,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42100,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,1,5,0,2,4
Study 22,AMERICA,USA,Site 2043,Subject 42102,Visit 1 (1),Discontinued,,,,,,,,,,2,48,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42103,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2043,Subject 42104,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2044,Subject 16459,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1080,Subject 16460,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 1080,Subject 16461,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 1080,Subject 42105,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,0,5,46,0,47,0,0,0,0,0,0,33,0,33
Study 22,AMERICA,USA,Site 1080,Subject 42106,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 1080,Subject 42107,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,6,48,0,49,0,0,0,0,0,0,36,0,36
Study 22,AMERICA,USA,Site 1080,Subject 42108,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 1080,Subject 42109,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 1080,Subject 42110,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,31,0,32,0,0,0,0,0,0,16,0,16
Study 22,AMERICA,USA,Site 1080,Subject 42111,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,0,0,0,10,0,10
Study 22,AMERICA,USA,Site 1080,Subject 42112,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,16,0,0,0,0,0,0,8,0,8
Study 22,AMERICA,USA,Site 1080,Subject 42113,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,18,0,0,0,0,0,0,11,0,11
Study 22,AMERICA,USA,Site 2045,Subject 42114,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,34,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2045,Subject 42115,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2045,Subject 42116,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2045,Subject 42117,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2045,Subject 42118,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2045,Subject 42119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,AMERICA,USA,Site 2045,Subject 42120,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16481,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,59,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16482,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16483,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16484,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16485,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16486,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16487,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16488,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16489,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16490,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,8,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1083,Subject 16493,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42121,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,1,0,0,0,1,0,29,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42122,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2046,Subject 42124,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,2,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2046,Subject 42126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 2046,Subject 42127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2046,Subject 42128,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42129,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42130,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42131,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42132,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42133,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,0,67,0,0,0,0,1,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42134,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,34,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42135,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42136,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,42,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42137,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42138,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42139,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,1,1,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42140,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42141,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42142,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42143,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42144,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42145,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42146,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42147,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42148,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,1,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42149,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42150,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42151,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42153,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42154,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42155,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42156,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42157,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42158,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42159,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42160,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,1,0,0,0,1,2,16,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42161,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42162,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42163,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42165,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42166,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42167,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42169,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2047,Subject 42175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16504,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16505,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16506,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16507,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,1,59,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 1084,Subject 16508,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,2,7,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 1084,Subject 16509,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16510,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16511,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16512,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16513,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16514,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16515,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 1084,Subject 16518,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42176,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42177,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42178,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,56,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42179,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42180,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42181,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42182,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42183,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42184,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,1,0,46,2,0,0,2,0
Study 22,AMERICA,USA,Site 2048,Subject 42187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,70,0,,,,0,0,0,2,0,0,0,2,9,11,0,0,0,0,0,0,53,5,0,0,5,0
Study 22,AMERICA,USA,Site 2048,Subject 42188,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42190,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42192,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,75,0,,,,0,0,0,0,0,0,0,0,0,30,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42195,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42196,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42197,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16572,Unplanned visit (2),On Trial,,,,,,,,,,3,42,0,,,,0,0,0,0,0,0,0,0,5,36,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16573,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16575,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16576,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16577,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16579,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 1088,Subject 16581,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16612,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,1,8,0,0,0,0,0,0,53,6,0,0,0,6
Study 22,AMERICA,USA,Site 1090,Subject 16613,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16614,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,3,0,0,0,3,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16615,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16616,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16617,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16618,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16619,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16620,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 1090,Subject 16621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1092,Subject 16656,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,9,0,0,2,1,1
Study 22,AMERICA,USA,Site 1092,Subject 16657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,1,,,,0,0,0,3,0,0,0,3,2,42,0,0,0,0,0,0,18,0,0,26,5,21
Study 22,AMERICA,USA,Site 2049,Subject 42198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42201,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42203,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42206,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,10,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2049,Subject 42210,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1093,Subject 16684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,1,43,0,0,0,0,0,0,29,0,7,8,1,14
Study 22,AMERICA,USA,Site 1093,Subject 16685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,27,0,7,11,4,14
Study 22,AMERICA,USA,Site 1093,Subject 16686,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1093,Subject 16687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,26,0,8,10,4,14
Study 22,AMERICA,USA,Site 2050,Subject 42211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2050,Subject 42212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1095,Subject 16700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,25,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1095,Subject 16701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,3,0,0,0,3,0,13,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1095,Subject 16702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,2,0,44,0,1,0,1,0
Study 22,AMERICA,USA,Site 1095,Subject 16703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,2,0,0,0,0,0,0,2,2,52,0,0,0,0,1,0,44,0,8,0,1,7
Study 22,AMERICA,USA,Site 1099,Subject 16750,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,USA,Site 1099,Subject 16753,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16755,Screening,Discontinued,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16756,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 16757,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 42213,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 42214,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,36,0,0,8,1,7
Study 22,AMERICA,USA,Site 1099,Subject 42215,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 42216,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1099,Subject 42217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,36,0,8,0,1,7
Study 22,AMERICA,USA,Site 1100,Subject 16758,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16760,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16761,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16762,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16763,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16764,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16765,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16766,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16767,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16768,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16769,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16770,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16771,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16772,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,8,0,0,1,7
Study 22,AMERICA,USA,Site 1100,Subject 16773,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16774,Unplanned visit (2),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,3,0,0,0,3
Study 22,AMERICA,USA,Site 1100,Subject 16775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16776,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16777,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1100,Subject 16778,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1102,Subject 16784,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1102,Subject 16785,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1102,Subject 16786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 1102,Subject 16787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1102,Subject 16788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,USA,Site 1102,Subject 16789,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16797,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,8,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,10,52,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16799,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,25,0,0,0,0,1,0,44,8,0,0,1,7
Study 22,AMERICA,USA,Site 1103,Subject 16801,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16802,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,49,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 16803,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 42218,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42219,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42220,Unplanned visit (1),On Trial,,,,,,,,,,2,49,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42221,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42222,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 2051,Subject 42223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 2051,Subject 42224,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42225,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42227,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42228,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42229,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42231,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42232,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42233,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42234,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42235,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42236,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42237,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42239,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42240,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42241,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42242,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2051,Subject 42243,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 16827,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,77,0,,,,0,0,0,4,0,0,0,4,3,70,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 16828,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 16829,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 16830,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42244,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,4,0,0,0,4,0,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42245,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,11,0,0,0,11,0,22,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2048,Subject 42247,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42248,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42249,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,56,0,,,,0,0,0,7,0,0,0,7,0,14,1,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42250,Unplanned visit (2),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 1106,Subject 42251,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1108,Subject 16844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,8,48,0,0,0,0,1,0,47,1,0,1,1,1
Study 22,AMERICA,USA,Site 1108,Subject 16845,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1108,Subject 16846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1108,Subject 16847,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,AMERICA,USA,Site 1108,Subject 42252,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42253,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42254,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42255,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42256,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42257,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42258,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42259,Unplanned visit (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,60,4,0,0,0,4
Study 22,AMERICA,USA,Site 2052,Subject 42260,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42261,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42262,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,USA,Site 2052,Subject 42263,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,8,0,0,1,7
Study 22,AMERICA,USA,Site 2052,Subject 42264,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42265,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,USA,Site 2052,Subject 42266,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,60,9,0,0,2,7
Study 22,AMERICA,USA,Site 2052,Subject 42267,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42268,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42269,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42270,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42271,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42272,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,AMERICA,USA,Site 2052,Subject 42274,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42275,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42276,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42277,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42278,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42281,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42282,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42284,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42285,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42288,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42289,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42291,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,8,0,0,1,7
Study 22,AMERICA,USA,Site 2052,Subject 42292,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42293,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42294,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,8,0,0,1,7
Study 22,AMERICA,USA,Site 2052,Subject 42295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42296,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,47,10,0,0,3,7
Study 22,AMERICA,USA,Site 2052,Subject 42297,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42299,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,1,0,5,0,0,0,6,6,8,0,0,0,0,0,0,48,5,0,0,4,1
Study 22,AMERICA,USA,Site 2052,Subject 42300,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42301,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42302,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42304,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42305,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2052,Subject 42308,Visit 1 (1),Discontinued,,,,,,,,,,2,26,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,24,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16860,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,85,0,,,,0,0,0,0,0,0,0,0,0,32,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16862,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16864,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16865,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16866,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16868,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16869,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16870,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 16871,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42309,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,77,0,,,,0,0,0,6,0,0,0,6,9,14,0,0,0,0,0,0,61,2,0,0,2,0
Study 22,AMERICA,USA,Site 1109,Subject 42310,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42311,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42312,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42313,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,6,0,0,0,6
Study 22,AMERICA,USA,Site 1109,Subject 42314,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42316,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1109,Subject 42318,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16873,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16874,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16877,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16881,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16882,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,1,0,0,2,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1110,Subject 16884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42319,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,2,1,0,0,3,21,50,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42320,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42322,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,55,5,0,0,2,3
Study 22,AMERICA,USA,Site 2053,Subject 42323,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42324,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42325,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 2053,Subject 42326,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,AMERICA,USA,Site 2053,Subject 42327,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42328,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,9,8,0,0,0,0,0,0,46,10,0,0,3,7
Study 22,AMERICA,USA,Site 2053,Subject 42329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42330,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42331,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42334,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42336,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,1,0,0,1,4,4,0,0,0,0,1,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2053,Subject 42337,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2053,Subject 42338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17039,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17040,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17042,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17044,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17045,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17046,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17047,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17048,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 17049,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 42339,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 42340,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1112,Subject 42341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2054,Subject 42342,Screening,Discontinued,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2054,Subject 42343,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 17050,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,0,0,0,0,0,4,46,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 17051,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 17052,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42344,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42345,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42346,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,41,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42347,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42348,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,41,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,1,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42349,Visit 1 (1),Discontinued,,,,,,,,,,2,26,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,24,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42350,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42351,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42352,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42354,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42355,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42357,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42358,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42359,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42360,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42362,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42363,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42364,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42365,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42367,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42368,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42369,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42370,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42372,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42374,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42375,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42377,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42378,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42382,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42383,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42385,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42386,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42387,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42388,Unplanned visit (2),Screen Failure,,,,,,,,,,1,22,0,,,,0,0,0,0,0,0,0,0,0,2,20,0,0,0,0,0,21,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42389,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1113,Subject 42392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42393,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42394,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42395,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,8,47,0,0,0,0,0,0,47,2,0,0,1,1
Study 22,AMERICA,USA,Site 1054,Subject 42397,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,11,4,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,AMERICA,USA,Site 2055,Subject 42398,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,44,8,0,0,3,5
Study 22,AMERICA,USA,Site 1054,Subject 42400,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,41,9,0,0,3,6
Study 22,AMERICA,USA,Site 1054,Subject 42401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,2,3,0,0,0,0,0,0,54,5,0,0,0,5
Study 22,AMERICA,USA,Site 1054,Subject 42402,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,2,20,0,0,0,0,0,0,55,5,0,0,0,5
Study 22,AMERICA,USA,Site 2055,Subject 42403,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42407,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42408,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,58,1,0,0,1,0
Study 22,AMERICA,USA,Site 1054,Subject 42410,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,3,0,0,3,0
Study 22,AMERICA,USA,Site 1054,Subject 42411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1054,Subject 42412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,1,0,0,0,1,12,12,0,0,0,0,0,0,48,3,0,0,3,0
Study 22,AMERICA,USA,Site 2055,Subject 42413,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42414,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2055,Subject 42415,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42416,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42417,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42418,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42419,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,1,0,0,0,1
Study 22,AMERICA,USA,Site 2056,Subject 42420,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,2,0,0,0,2,1,21,0,0,0,0,0,0,53,8,0,0,8,0
Study 22,AMERICA,USA,Site 2056,Subject 42421,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42422,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,7,0,0,0,7
Study 22,AMERICA,USA,Site 2056,Subject 42424,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42425,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,7,0,0,0,7
Study 22,AMERICA,USA,Site 2056,Subject 42427,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42428,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,80,0,,,,0,0,0,3,0,0,0,3,3,22,0,0,0,0,0,0,57,8,0,0,1,7
Study 22,AMERICA,USA,Site 2056,Subject 42429,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42430,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42434,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42435,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42436,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42437,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2056,Subject 42438,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17053,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,1,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17054,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17055,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17056,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17057,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17058,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17059,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,2,0,0,0,2
Study 22,AMERICA,USA,Site 1114,Subject 17061,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17062,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17063,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17064,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,1,0,0,0,1,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17065,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17066,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17067,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17068,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,AMERICA,USA,Site 1114,Subject 17069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17071,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17072,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17073,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17074,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1114,Subject 17075,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1115,Subject 17087,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,10,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1115,Subject 17088,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,36,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2057,Subject 42439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2057,Subject 42440,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,AMERICA,USA,Site 2057,Subject 42441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,USA,Site 2057,Subject 42442,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2057,Subject 42443,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2057,Subject 42444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,USA,Site 1117,Subject 17094,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2058,Subject 42445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,11,33,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2058,Subject 42446,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,1,0,0,0,1,2,5,0,0,0,0,2,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42447,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,1,0,0,0,1,0,58,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 2059,Subject 42448,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,8,0,0,1,7
Study 22,AMERICA,USA,Site 2059,Subject 42449,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42450,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42451,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,75,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,60,7,0,0,0,7
Study 22,AMERICA,USA,Site 2059,Subject 42452,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42453,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42454,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42456,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42457,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42458,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42459,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,41,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42461,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42462,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42463,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42464,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2059,Subject 42465,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42466,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42467,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2059,Subject 42469,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42470,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42471,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,56,0,,,,0,0,0,2,0,0,0,2,6,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42475,Visit 1 (1),On Trial,,,,,,,,,,2,32,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,30,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2059,Subject 42477,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42478,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42479,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,12,5,0,0,0,0,1,0,51,2,0,0,1,1
Study 22,AMERICA,USA,Site 2060,Subject 42480,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42481,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42482,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,30,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42484,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,AMERICA,USA,Site 2060,Subject 42485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42486,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42487,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42488,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2060,Subject 42489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42490,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42492,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42493,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2060,Subject 42494,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17118,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17119,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17120,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17121,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17122,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 17124,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 42495,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1120,Subject 42496,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17125,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,7,54,0,0,0,0,0,0,54,1,0,0,0,1
Study 22,AMERICA,USA,Site 1025,Subject 17126,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17127,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,58,6,0,0,0,6
Study 22,AMERICA,USA,Site 1025,Subject 17128,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,72,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,58,6,0,0,0,6
Study 22,AMERICA,USA,Site 1025,Subject 17129,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,6,0,0,0,6
Study 22,AMERICA,USA,Site 1025,Subject 17130,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17131,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17132,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17133,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17134,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17135,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17136,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17138,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17139,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17140,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17143,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17144,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17147,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17148,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17149,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1025,Subject 17153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 17174,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42497,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,33,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42499,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42500,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42503,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42504,Visit 1 (1),On Trial,,,,,,,,,,2,36,0,,,,0,0,0,3,0,0,0,3,0,8,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42505,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42506,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42507,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42509,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42511,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,32,2,0,0,0,2
Study 22,AMERICA,USA,Site 1121,Subject 42512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42513,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1121,Subject 42515,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42516,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,9,51,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42517,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42518,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42519,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42520,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42521,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42522,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42523,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42524,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42525,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42526,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42527,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42528,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42529,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42530,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42531,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,1,0,0,0,1,4,19,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42532,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42533,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,54,7,0,0,0,7
Study 22,AMERICA,USA,Site 2061,Subject 42534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42535,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,1,0,0,1,0,0,0,2,7,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,2,0,0,1,0,0,0,3,4,8,0,0,0,0,0,0,47,1,0,0,1,0
Study 22,AMERICA,USA,Site 2061,Subject 42538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42539,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42542,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42544,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42545,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42546,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42548,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42549,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42551,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2061,Subject 42552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42553,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,1,0,0,1,1,34,0,0,0,0,0,0,53,1,0,0,1,0
Study 22,AMERICA,USA,Site 2062,Subject 42554,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42555,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42557,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42558,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42559,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42560,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42561,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42562,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,1,0,0,1,0,5,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,AMERICA,USA,Site 2062,Subject 42563,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42564,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42565,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42566,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2062,Subject 42570,End of Study (EOS) (1),On Trial,,,,,,,,,,3,36,0,,,,1,0,0,0,0,0,0,1,0,5,0,0,0,0,0,0,31,3,0,0,2,1
Study 22,AMERICA,USA,Site 2062,Subject 42571,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17186,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,20,0,0,0,0,0,0,38,1,0,0,1,0
Study 22,AMERICA,USA,Site 1123,Subject 17187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17188,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17189,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17190,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17191,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17192,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,2,0,0,2,0
Study 22,AMERICA,USA,Site 1123,Subject 17193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,USA,Site 1123,Subject 17194,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,AMERICA,USA,Site 1123,Subject 17195,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17196,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 17197,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42572,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42573,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42574,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42575,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42576,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42577,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42578,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42579,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42580,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42581,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1123,Subject 42582,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,41,1,0,0,1,0
Study 22,AMERICA,USA,Site 1123,Subject 42583,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,42,0,,,,0,0,0,2,0,0,0,2,0,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42584,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42585,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 2063,Subject 42586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42587,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42588,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42589,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42590,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,1,6,0,1,6
Study 22,AMERICA,USA,Site 2063,Subject 42592,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42593,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,1,1,0,2,0,0,0,4,1,8,0,0,0,0,0,0,39,0,2,2,4,0
Study 22,AMERICA,USA,Site 2063,Subject 42594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,8,0,0,1,7
Study 22,AMERICA,USA,Site 2063,Subject 42595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,48,2,0,0,2,0
Study 22,AMERICA,USA,Site 2063,Subject 42597,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42598,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42600,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2063,Subject 42602,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42603,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42604,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42605,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,10,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42606,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42607,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,26,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42609,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2064,Subject 42610,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17215,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,2,0,0,0,2,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17216,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17217,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17218,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,2,0,0,0,2,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17219,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17220,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17221,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17222,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17224,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17225,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17226,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17227,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17228,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1125,Subject 17230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42611,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,62,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42612,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,70,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42613,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42614,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42615,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42616,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,64,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42617,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42618,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42619,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42620,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42621,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,68,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42622,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42623,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42624,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42625,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42626,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42627,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42628,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42629,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42630,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42631,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42632,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42633,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42634,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42635,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42636,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42637,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42638,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42639,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42640,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42643,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42645,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42646,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2024,Subject 42648,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42649,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42651,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42652,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42653,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42655,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42659,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42660,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42662,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2065,Subject 42664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42665,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42666,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42667,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42668,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,71,0,,,,0,0,0,0,0,0,0,0,0,39,0,0,0,0,0,0,55,0,8,1,2,7
Study 22,AMERICA,USA,Site 2066,Subject 42669,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,0,9,0,2,7
Study 22,AMERICA,USA,Site 2066,Subject 42670,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42671,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42672,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,7,2,0,2,7
Study 22,AMERICA,USA,Site 2066,Subject 42673,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42674,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 2066,Subject 42675,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42676,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,83,0,,,,0,0,0,0,0,0,0,0,2,26,0,0,0,0,0,0,60,8,0,1,2,7
Study 22,AMERICA,USA,Site 2066,Subject 42677,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,USA,Site 2066,Subject 42678,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42679,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,53,0,0,1,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42680,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42681,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42682,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42683,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42684,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42685,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42686,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,57,0,0,1,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42687,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,2,0,0,2,0
Study 22,AMERICA,USA,Site 2066,Subject 42688,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,2,0,7,2,7
Study 22,AMERICA,USA,Site 2066,Subject 42690,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,3,14,0,0,0,0,1,0,41,1,0,12,2,11
Study 22,AMERICA,USA,Site 2066,Subject 42691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,1,0,7,1,7
Study 22,AMERICA,USA,Site 2066,Subject 42692,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,35,1,0,0,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42693,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,42,4,0,0,0,4
Study 22,AMERICA,USA,Site 2066,Subject 42694,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42695,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,42,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42696,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42697,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42698,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,42,7,0,0,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42700,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42701,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42702,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,42,8,0,0,2,6
Study 22,AMERICA,USA,Site 2066,Subject 42703,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,43,1,6,0,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42704,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42705,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,35,0,0,1,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42706,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42707,Visit 1 (1),On Trial,,,,,,,,,,2,29,0,,,,1,0,0,0,0,0,0,1,2,3,0,0,0,0,0,0,23,4,0,0,2,2
Study 22,AMERICA,USA,Site 2066,Subject 42708,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,42,7,0,0,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42709,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,35,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,34,2,0,6,2,6
Study 22,AMERICA,USA,Site 2066,Subject 42712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,4,3,0,0,0,0,0,0,31,0,6,4,10,0
Study 22,AMERICA,USA,Site 2066,Subject 42713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,11,22,0,0,0,0,0,0,40,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42715,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,1,0,35,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42716,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,35,1,0,0,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,1,0,35,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42718,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,4,3,0,0,0,0,0,0,35,1,0,6,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42720,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,3,0,0,0,0,0,0,34,2,0,6,2,6
Study 22,AMERICA,USA,Site 2066,Subject 42722,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42723,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42724,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,2,0,0,0,0,0,0,34,2,0,6,2,6
Study 22,AMERICA,USA,Site 2066,Subject 42726,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42727,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,8,0,0,0,0,0,1,0,35,1,6,0,1,6
Study 22,AMERICA,USA,Site 2066,Subject 42728,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2066,Subject 42729,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,35,1,0,0,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42730,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,35,1,0,7,1,7
Study 22,AMERICA,USA,Site 2066,Subject 42731,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,1,1,0
Study 22,AMERICA,USA,Site 2066,Subject 42732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,35,1,7,0,1,7
Study 22,AMERICA,USA,Site 1128,Subject 17262,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17263,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17264,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,2,0,0,0,2,1,36,0,0,0,0,0,0,43,0,8,0,1,7
Study 22,AMERICA,USA,Site 1128,Subject 17266,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17267,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17268,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17269,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1128,Subject 17270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,2,0,0,0,2,0,4,0,0,0,0,0,0,37,0,6,2,0,8
Study 22,AMERICA,USA,Site 1128,Subject 17271,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 2067,Subject 42733,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2067,Subject 42734,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2067,Subject 42735,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2067,Subject 42736,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2068,Subject 42737,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,19,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,31,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2011,Subject 42739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2046,Subject 42740,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 42741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2068,Subject 42742,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,16,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 42743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 42744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2068,Subject 42745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,16,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2068,Subject 42746,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2069,Subject 42747,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,56,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1129,Subject 17287,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1129,Subject 17288,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1129,Subject 17289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,24,0,0,0,0,0,0,35,8,0,0,2,6
Study 22,AMERICA,USA,Site 1129,Subject 17290,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1129,Subject 17291,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,AMERICA,USA,Site 1129,Subject 17292,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,51,2,0,0,1,1
Study 22,AMERICA,USA,Site 1129,Subject 17293,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,AMERICA,USA,Site 1129,Subject 17294,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,8,38,0,0,0,0,0,0,38,2,0,0,1,1
Study 22,AMERICA,USA,Site 1129,Subject 17295,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1129,Subject 17296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,AMERICA,USA,Site 1129,Subject 17297,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,AMERICA,USA,Site 1129,Subject 17298,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2070,Subject 42748,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2070,Subject 42749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,3,0,0,0,3,8,37,0,0,0,0,0,0,37,1,0,0,0,1
Study 22,AMERICA,USA,Site 2071,Subject 42750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,7,60,1,0,0,0,0,0,56,1,0,0,0,1
Study 22,AMERICA,USA,Site 2071,Subject 42751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2071,Subject 42752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 17381,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 17382,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 17383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 17384,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 17385,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 17386,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 17387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42755,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1136,Subject 42756,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,5,0,0,0,5,6,3,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,AMERICA,USA,Site 2072,Subject 42758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1137,Subject 17388,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,2,25,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,AMERICA,USA,Site 1137,Subject 17389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1137,Subject 17390,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1137,Subject 17391,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2073,Subject 42763,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,53,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2073,Subject 42764,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2073,Subject 42765,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2073,Subject 42766,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2073,Subject 42767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42768,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42769,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42770,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42771,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42772,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,1,0,0,2,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42773,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42775,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42776,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42777,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42778,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,0,0,46,7,0,0,1,6
Study 22,AMERICA,USA,Site 2074,Subject 42781,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42782,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42783,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42784,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42789,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2074,Subject 42790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42791,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42792,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42795,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,1,0,0,1,2,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42798,Visit 1 (1),Discontinued,,,,,,,,,,2,33,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42801,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,38,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,6,2,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42803,Visit 1 (1),Discontinued,,,,,,,,,,2,34,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,1,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,1,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42809,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42812,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,5,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42815,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42816,Visit 1 (1),Discontinued,,,,,,,,,,2,34,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,33,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42817,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42818,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,0,0,0,0,0,21,5,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42819,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42820,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42822,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42823,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42826,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42827,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42830,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42832,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42834,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42836,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,1,0,0,0,1,3,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42840,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42842,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42843,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42844,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42845,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,5,0,0,0,5,13,1,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42847,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,1,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42848,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42849,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42852,Unplanned visit (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,13,2,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42855,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42858,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42860,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42861,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42862,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,6,1,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42865,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,13,2,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42869,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2075,Subject 42870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,5,2,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42871,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,49,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42872,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42873,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42874,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42878,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42879,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,2,0,0,0,2,10,6,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2076,Subject 42881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1139,Subject 17404,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,2,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1139,Subject 42882,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1139,Subject 42883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1139,Subject 42884,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1139,Subject 42885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,USA,Site 2077,Subject 42886,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2077,Subject 42887,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2077,Subject 42888,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2077,Subject 42889,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2077,Subject 42890,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42891,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,8,54,0,0,0,0,0,0,53,3,0,0,2,1
Study 22,AMERICA,USA,Site 2078,Subject 42892,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,1,10,0,0,0,0,1,0,54,7,0,0,1,6
Study 22,AMERICA,USA,Site 2078,Subject 42893,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42894,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,54,8,0,0,0,8
Study 22,AMERICA,USA,Site 2078,Subject 42895,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,54,8,0,0,0,8
Study 22,AMERICA,USA,Site 2078,Subject 42896,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,1,0,0,0,1,1,20,0,0,0,0,0,0,52,13,0,0,3,10
Study 22,AMERICA,USA,Site 2078,Subject 42897,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,52,8,0,0,1,7
Study 22,AMERICA,USA,Site 2078,Subject 42898,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,0,0,54,7,0,0,1,6
Study 22,AMERICA,USA,Site 2078,Subject 42899,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,55,7,0,0,0,7
Study 22,AMERICA,USA,Site 2078,Subject 42900,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,56,7,2,0,2,7
Study 22,AMERICA,USA,Site 2078,Subject 42901,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,12,0,0,0,0,0,0,53,7,0,0,1,6
Study 22,AMERICA,USA,Site 2078,Subject 42902,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,59,1,0,0,1,0
Study 22,AMERICA,USA,Site 2078,Subject 42903,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,2,0,0,1,1
Study 22,AMERICA,USA,Site 2078,Subject 42904,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42905,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42906,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42907,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42908,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42909,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42910,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,1,0,1,0
Study 22,AMERICA,USA,Site 2078,Subject 42911,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,AMERICA,USA,Site 2078,Subject 42912,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,58,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,1,0,47,0,1,0,1,0
Study 22,AMERICA,USA,Site 2078,Subject 42913,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,8,0,1,7
Study 22,AMERICA,USA,Site 2078,Subject 42914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,45,0,7,0,0,7
Study 22,AMERICA,USA,Site 2078,Subject 42915,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,1,7,0,1,7
Study 22,AMERICA,USA,Site 2078,Subject 42916,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42917,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2078,Subject 42918,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,1,0,1,0
Study 22,AMERICA,USA,Site 2079,Subject 42919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2079,Subject 42920,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2079,Subject 42921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,7,0,0,7
Study 22,AMERICA,USA,Site 2079,Subject 42922,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,45,0,0,8,1,7
Study 22,AMERICA,USA,Site 2072,Subject 42924,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,10,3,7
Study 22,AMERICA,USA,Site 2072,Subject 42925,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,0,7,0,7
Study 22,AMERICA,USA,Site 2072,Subject 42926,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42927,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,7,0,0,7
Study 22,AMERICA,USA,Site 2072,Subject 42928,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,10,0,3,7
Study 22,AMERICA,USA,Site 2072,Subject 42929,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42930,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,46,0,7,0,0,7
Study 22,AMERICA,USA,Site 2072,Subject 42931,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42932,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,8,1,2,7
Study 22,AMERICA,USA,Site 2072,Subject 42933,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,8,0,0,1,7
Study 22,AMERICA,USA,Site 2072,Subject 42934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42936,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42937,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42938,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,38,0,9,0,1,8
Study 22,AMERICA,USA,Site 2072,Subject 42940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,0,8,1,7
Study 22,AMERICA,USA,Site 2072,Subject 42941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,2,0,0,0,0,0,0,37,1,0,7,1,7
Study 22,AMERICA,USA,Site 2072,Subject 42942,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2072,Subject 42943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,0,8,0,1,7
Study 22,AMERICA,USA,Site 2072,Subject 42944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,7,0,0,7
Study 22,AMERICA,USA,Site 2072,Subject 42945,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42946,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,10,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42947,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42948,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,65,0,,,,0,0,0,0,0,0,0,0,3,61,0,0,0,0,1,0,63,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42949,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42950,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42951,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42952,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42953,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42954,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42955,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42956,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,78,0,,,,0,0,0,1,0,0,0,1,0,47,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42957,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42958,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42959,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,7,0,0,0,7
Study 22,AMERICA,USA,Site 2080,Subject 42960,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42961,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 2080,Subject 42962,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42963,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,0,0,52,6,0,0,0,6
Study 22,AMERICA,USA,Site 2080,Subject 42964,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42965,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,1,7,0,0,0,0,1,0,46,6,0,0,0,6
Study 22,AMERICA,USA,Site 2080,Subject 42966,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,4,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42968,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42969,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42970,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42971,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42972,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42973,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2080,Subject 42975,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42976,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42977,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42978,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42979,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42980,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,68,0,,,,0,0,0,2,0,0,1,3,0,26,1,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42981,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42982,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42983,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42984,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,90,0,,,,0,0,0,8,0,0,0,8,19,24,0,0,0,0,0,0,64,1,0,0,1,0
Study 22,AMERICA,USA,Site 2081,Subject 42985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42986,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42987,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42988,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42989,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42991,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42992,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42993,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42994,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42995,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42996,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2081,Subject 42997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 42998,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,26,33,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 42999,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43000,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43001,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,4,5,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43002,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43003,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43004,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43005,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43006,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43007,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,AMERICA,USA,Site 2082,Subject 43008,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43009,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,7,0,0,0,7
Study 22,AMERICA,USA,Site 2082,Subject 43010,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43011,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43012,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43014,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43015,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43016,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43017,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43018,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43019,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,3,6,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43020,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43021,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43022,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43023,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43024,Unplanned visit (1),Screen Failure,,,,,,,,,,1,21,0,,,,0,0,0,0,0,0,0,0,0,3,20,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43025,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43026,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43027,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43028,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43029,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43030,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,5,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43031,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43032,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43033,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43034,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,4,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43035,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43036,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43037,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43040,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2082,Subject 43042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 43043,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1030,Subject 43044,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2083,Subject 43045,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17405,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,49,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,49,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,2,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,39,0,0,0,0,0,1,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1140,Subject 17410,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,14,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2069,Subject 43046,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 43047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,30,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 43048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2069,Subject 43049,Unplanned visit (1),Discontinued,,,,,,,,,,1,21,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 2011,Subject 43050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2069,Subject 43051,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2084,Subject 43052,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2084,Subject 43053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2084,Subject 43054,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2084,Subject 43055,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2084,Subject 43056,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43057,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43058,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43059,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43060,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43061,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43062,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43063,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43064,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43066,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2085,Subject 43069,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43070,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,7,45,0,0,0,0,2,0,44,1,0,0,0,1
Study 22,AMERICA,USA,Site 2086,Subject 43071,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43073,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43074,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43075,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43076,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,0,0,2,2,0
Study 22,AMERICA,USA,Site 2086,Subject 43077,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,1,1,0
Study 22,AMERICA,USA,Site 2086,Subject 43078,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43079,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2086,Subject 43081,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,0,0,0,0,0,7,53,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43083,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43084,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43085,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43086,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43087,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43089,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,AMERICA,USA,Site 2087,Subject 43090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43091,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43092,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43093,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43094,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43096,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,5,7,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,AMERICA,USA,Site 2087,Subject 43099,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43100,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2087,Subject 43101,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,52,0,,,,0,0,0,11,0,0,0,11,0,13,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 17493,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 17494,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,44,2,0,0,1,1
Study 22,AMERICA,USA,Site 1145,Subject 17495,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 17496,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 17497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 43102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,2,2,0
Study 22,AMERICA,USA,Site 1145,Subject 43103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 43104,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1145,Subject 43105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,6,0,0,6
Study 22,AMERICA,USA,Site 2088,Subject 43106,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43107,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43108,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,1,41,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43109,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,2,0,0,0,2,7,58,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43110,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,78,0,,,,0,0,0,7,0,0,0,7,7,8,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43112,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,1,0,0,0,1,1,9,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43113,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43114,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43117,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43118,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43119,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43120,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,66,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43121,Visit 1 (1),Discontinued,,,,,,,,,,2,36,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43122,Screening,Discontinued,,,,,,,,,,1,22,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43126,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43128,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43129,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43130,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43132,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43133,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43134,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43135,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43136,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43137,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,1,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43138,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43139,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43140,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43141,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43142,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43144,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,1,4,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43145,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43146,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43147,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43148,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43149,Unplanned visit (1),Screen Failure,,,,,,,,,,1,20,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,19,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43150,Visit 1 (1),Discontinued,,,,,,,,,,2,31,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,30,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43152,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43153,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43154,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43155,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43156,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43158,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43159,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43160,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43162,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43163,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43164,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43167,Visit 1 (1),Discontinued,,,,,,,,,,2,34,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43169,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43170,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43171,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43172,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43176,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43177,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43178,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2088,Subject 43179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43181,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,9,0,0,0,9,1,5,0,0,0,0,0,0,43,0,3,0,3,0
Study 22,AMERICA,USA,Site 2089,Subject 43184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43186,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43187,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43188,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2089,Subject 43189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,1,0,1,0
Study 22,AMERICA,USA,Site 1148,Subject 17522,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 17523,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 17524,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43190,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43192,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43193,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43194,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,51,0,,,,0,0,0,1,0,0,0,1,0,13,0,1,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43195,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43196,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43197,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43199,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1148,Subject 43201,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 17548,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,1,,,,0,0,0,1,0,0,0,1,0,50,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43202,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43204,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43205,Unplanned visit (1),On Trial,,,,,,,,,,5,49,1,,,,0,0,0,2,0,0,0,2,0,6,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43206,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,3,0,0,0,3
Study 22,AMERICA,USA,Site 1152,Subject 43208,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1152,Subject 43209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,AMERICA,USA,Site 1152,Subject 43210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,1,0,0,0,1
Study 22,AMERICA,USA,Site 1152,Subject 43211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17549,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17550,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17551,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17552,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17553,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,21,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17554,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17555,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1153,Subject 17556,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43212,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,9,42,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43213,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43214,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43215,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43216,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 1103,Subject 43217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43218,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43219,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43221,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43222,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43223,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43225,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43227,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2090,Subject 43228,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,56,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1103,Subject 43229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43230,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,8,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43231,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43232,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43233,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,55,7,0,0,0,7
Study 22,AMERICA,USA,Site 2091,Subject 43234,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43235,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43236,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43237,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43238,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43239,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43240,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43241,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43242,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2091,Subject 43243,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,2,0,0,0,2
Study 22,AMERICA,USA,Site 2091,Subject 43244,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17585,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,8,52,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17586,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17587,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17588,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17590,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17591,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17592,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 17593,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,7,0,0,0,7,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43245,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43247,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,45,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43250,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1155,Subject 43253,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2092,Subject 43254,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,60,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,AMERICA,USA,Site 2092,Subject 43255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2092,Subject 43256,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2092,Subject 43257,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1026,Subject 17594,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,10,43,0,0,0,0,1,0,44,1,0,0,0,1
Study 22,AMERICA,USA,Site 1026,Subject 43258,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1026,Subject 43259,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 17595,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 17596,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,11,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 17597,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 17598,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 17599,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1156,Subject 43260,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,9,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17600,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17601,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17602,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,2,0,0,0,2,0,21,0,0,0,0,0,0,55,0,0,7,0,7
Study 22,AMERICA,USA,Site 1157,Subject 17603,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,10,0,0,0,0,0,0,45,0,0,7,0,7
Study 22,AMERICA,USA,Site 1157,Subject 17604,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17605,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17606,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 17607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,1,0,0,0,1,0,6,1,0,0,0,0,0,47,0,0,7,0,7
Study 22,AMERICA,USA,Site 1157,Subject 17608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,44,0,0,7,0,7
Study 22,AMERICA,USA,Site 1157,Subject 17609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,3,0,0,0,3,0,5,0,0,0,0,0,0,46,0,0,7,0,7
Study 22,AMERICA,USA,Site 1157,Subject 43261,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 43262,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,9,1,8
Study 22,AMERICA,USA,Site 1157,Subject 43263,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1157,Subject 43264,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,2,0,0,0,2,0,3,0,0,0,0,0,0,40,0,0,7,0,7
Study 22,AMERICA,USA,Site 1116,Subject 17610,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,7,52,0,0,0,0,0,0,52,0,1,0,0,1
Study 22,AMERICA,USA,Site 1116,Subject 17611,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1116,Subject 43265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,1,0,1
Study 22,AMERICA,USA,Site 1116,Subject 43266,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,61,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,7,0,0,0,7
Study 22,AMERICA,USA,Site 1116,Subject 43267,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1116,Subject 43268,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1116,Subject 43269,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1116,Subject 43270,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,34,0,0,0,0,0
Study 22,AMERICA,USA,Site 1116,Subject 43271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,1,2,0
Study 22,AMERICA,USA,Site 2093,Subject 43272,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2093,Subject 43273,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,61,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2093,Subject 43274,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2093,Subject 43275,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2093,Subject 43276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2093,Subject 43277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43278,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43279,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43280,Unplanned visit (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,57,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43281,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43282,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43284,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43285,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43286,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43287,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43288,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43289,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43290,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43291,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43292,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43293,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43294,Visit 1 (1),On Trial,,,,,,,,,,2,33,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,32,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43295,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43296,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43297,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43298,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43299,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43300,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43301,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43302,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43303,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43304,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43305,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43306,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43307,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43308,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43309,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43310,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43311,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,93,0,,,,0,0,0,4,0,0,0,4,0,38,0,0,0,0,0,0,70,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43312,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43314,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43315,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43316,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,6,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43317,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43318,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43319,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43320,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43321,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43322,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43323,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43324,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43325,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43326,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43327,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43328,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43329,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43330,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43331,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43332,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43333,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43334,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43335,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43336,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43337,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43340,Visit 1 (1),On Trial,,,,,,,,,,2,30,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,28,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43342,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,107,0,,,,0,0,0,6,0,0,0,6,13,47,0,1,0,0,0,0,62,5,3,0,7,1
Study 22,AMERICA,USA,Site 2094,Subject 43343,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43344,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2094,Subject 43345,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43346,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43347,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,4,48,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43348,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43350,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43352,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43353,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43355,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43357,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43358,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43359,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43360,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,1,1,0
Study 22,AMERICA,USA,Site 2095,Subject 43362,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43365,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43368,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,1,22,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43370,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,94,0,,,,0,0,0,1,0,0,0,1,7,39,0,0,0,0,1,0,67,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43371,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43372,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43373,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43374,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43375,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2095,Subject 43376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,47,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17663,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,1,0,0,0,1,0,20,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17665,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17667,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17668,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17671,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17672,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17673,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1161,Subject 17674,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2096,Subject 43377,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,3,0,0,3,1,36,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,AMERICA,USA,Site 2096,Subject 43378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,5,1,0,0,6,0,4,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2096,Subject 43379,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,3,0,0,3
Study 22,AMERICA,USA,Site 2096,Subject 43380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2096,Subject 43381,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2096,Subject 43382,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1102,Subject 43383,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,60,0,,,,0,0,0,0,0,0,0,0,0,13,1,0,0,0,0,0,48,2,0,0,0,2
Study 22,AMERICA,USA,Site 2096,Subject 43384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,1,0,0,0,1
Study 22,AMERICA,USA,Site 2096,Subject 43385,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1162,Subject 17725,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,3,46,0,0,0,0,1,0,29,1,0,16,2,15
Study 22,AMERICA,USA,Site 1162,Subject 17726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,21,2,6,17,3,22
Study 22,AMERICA,USA,Site 1163,Subject 17739,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17740,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,45,0,,,,0,0,0,0,0,0,0,0,0,34,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17741,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17742,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17743,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17744,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17745,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17746,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17747,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17750,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,1,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1163,Subject 17751,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,1,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17755,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,3,62,0,1,0,0,0,0,61,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17756,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17757,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17758,Visit 1 (1),Discontinued,,,,,,,,,,2,27,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,26,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17760,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17761,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17762,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,63,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17763,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17764,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17765,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 17766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43386,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43387,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43388,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43389,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43390,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43391,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43392,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43393,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43394,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43395,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43397,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43398,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43399,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43400,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43401,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43402,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43403,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43406,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43407,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43408,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43409,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43410,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43411,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43412,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43413,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43414,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43415,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43416,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43417,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43418,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43420,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43421,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43422,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43423,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43424,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43425,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43426,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43427,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43428,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43429,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43430,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43431,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43432,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43434,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43435,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43436,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43437,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43438,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43439,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43440,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43444,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43446,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43447,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43448,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43449,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43450,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43451,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43456,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43458,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43459,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43460,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43461,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43464,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43466,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1164,Subject 43467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43468,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43469,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43470,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43471,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43472,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43473,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43474,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43475,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,10,1,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43477,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43478,End of Study (EOS) (1),Discontinued,,,,,,,,,,3,34,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,31,2,0,0,2,0
Study 22,AMERICA,USA,Site 2097,Subject 43479,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43480,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43481,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43482,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43483,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,59,0,7,0,0,7
Study 22,AMERICA,USA,Site 2097,Subject 43484,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43485,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43487,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43489,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43490,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43491,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43492,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43493,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43494,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2097,Subject 43495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,AMERICA,USA,Site 2097,Subject 43496,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,2,0,0,0,2,6,7,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2098,Subject 43497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2098,Subject 43498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43499,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43500,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43501,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43502,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43503,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2099,Subject 43505,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17771,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17772,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17773,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,38,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 17777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43510,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43511,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43518,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43520,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43521,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43524,Unplanned visit (1),Screen Failure,,,,,,,,,,1,19,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43525,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1166,Subject 43527,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43528,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,7,1,0,0,8,13,51,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43530,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43531,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43532,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43533,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43536,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,1,0,0,0,0,0,0,1,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2100,Subject 43538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,52,0,,,,1,0,0,0,0,0,0,1,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43539,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,45,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43541,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43544,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43545,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43548,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2101,Subject 43549,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2102,Subject 43550,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43551,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,41,0,,,,0,0,0,0,0,0,0,0,3,30,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43555,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43556,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43557,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43558,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2103,Subject 43559,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2104,Subject 43560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2104,Subject 43561,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,7,0,0,1,6
Study 22,AMERICA,USA,Site 2104,Subject 43562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,35,7,0,0,1,6
Study 22,AMERICA,USA,Site 2105,Subject 43563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,USA,Site 2105,Subject 43564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43565,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43566,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43567,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43568,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43575,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43581,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43583,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43585,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 43587,Screening,Screen Failure,,,,,,,,,,1,25,0,,,,0,0,0,0,0,0,0,0,0,10,23,0,0,0,0,0,18,0,0,0,0,0
Study 22,AMERICA,USA,Site 2107,Subject 43588,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2107,Subject 43589,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2107,Subject 43590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,3,43,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2108,Subject 43591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,4,0,0,0,4,12,41,0,0,0,0,4,0,40,0,0,3,2,1
Study 22,AMERICA,USA,Site 2108,Subject 43592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,3,0,0,0,3,1,6,0,0,0,0,1,0,30,0,7,8,1,14
Study 22,AMERICA,USA,Site 2108,Subject 43593,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,35,0,,,,0,0,0,5,0,0,0,5,0,7,0,0,0,0,3,0,30,0,0,2,0,2
Study 22,AMERICA,USA,Site 2108,Subject 43594,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2108,Subject 43595,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2108,Subject 43596,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2108,Subject 43597,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,32,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,28,0,0,2,0,2
Study 22,AMERICA,USA,Site 2108,Subject 43598,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,29,0,6,7,0,13
Study 22,AMERICA,USA,Site 2035,Subject 43599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43600,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43601,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43602,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43603,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43604,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43605,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43606,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43607,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43608,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43609,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,USA,Site 2035,Subject 43611,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,AMERICA,USA,Site 2035,Subject 43612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2109,Subject 43613,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2109,Subject 43614,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2109,Subject 43615,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1169,Subject 17792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 1169,Subject 17793,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1169,Subject 17794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1169,Subject 17795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,1,0,1,0,0,0,2,8,4,0,0,0,0,1,0,44,4,0,0,3,1
Study 22,AMERICA,USA,Site 2110,Subject 43616,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,51,0,,,,0,0,0,0,0,0,0,0,0,48,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2110,Subject 43617,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2110,Subject 43618,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2110,Subject 43619,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2110,Subject 43620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1170,Subject 17796,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,47,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43622,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43624,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43625,Unplanned visit (1),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2111,Subject 43627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43628,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43630,Unplanned visit (1),Discontinued,,,,,,,,,,4,58,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43631,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,1,1,0
Study 22,AMERICA,USA,Site 2112,Subject 43633,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43634,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,8,0,0,0,8,2,12,0,0,0,0,2,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43637,Unplanned visit (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,4,0,0,0,4,2,13,0,0,0,0,1,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 2112,Subject 43638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43639,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43640,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2112,Subject 43641,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2113,Subject 43642,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2113,Subject 43643,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2113,Subject 43644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2113,Subject 43645,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2113,Subject 43646,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,1,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2114,Subject 43647,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,7,31,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 2114,Subject 43648,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1171,Subject 17804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2115,Subject 43649,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2115,Subject 43650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,48,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2115,Subject 43651,Unplanned visit (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2115,Subject 43652,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2115,Subject 43653,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43654,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,52,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43659,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43661,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43663,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43664,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43665,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43667,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43668,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43669,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43671,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,59,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43673,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43674,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43675,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43676,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43677,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43678,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,7,0,0,1,6
Study 22,AMERICA,USA,Site 2116,Subject 43680,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,5,0,0,0,5,8,6,0,0,0,0,0,0,36,7,0,0,2,5
Study 22,AMERICA,USA,Site 2116,Subject 43682,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43683,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43684,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43685,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43686,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 2116,Subject 43687,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 17807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 17808,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 17809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 17810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43688,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43690,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43694,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43695,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43700,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43701,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43706,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43709,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43712,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43714,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43715,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1172,Subject 43719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43720,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43721,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43723,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43724,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43725,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43726,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43727,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43728,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43730,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43731,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43732,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43733,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43734,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43735,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43737,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43738,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43739,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,AMERICA,USA,Site 2117,Subject 43740,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43741,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43742,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,9,0,0,0,9
Study 22,AMERICA,USA,Site 2117,Subject 43744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,1,0,0,1,0,16,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,1,1,0,17,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2117,Subject 43747,Visit 1 (1),Discontinued,,,,,,,,,,2,32,0,,,,0,0,0,1,0,0,0,1,1,4,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 17811,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 17812,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,USA,Site 1173,Subject 17813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43748,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,USA,Site 1173,Subject 43752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43753,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1173,Subject 43754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43755,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43756,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43757,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,7,38,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2118,Subject 43760,Unplanned visit (2),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,41,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43762,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43763,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43764,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43766,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43768,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,2,0,0,0,0,0,0,2,0,4,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43771,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43772,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43776,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43779,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43780,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43781,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43782,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,1,0,0,0,0,0,0,1,1,6,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2119,Subject 43784,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43788,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,66,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43794,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43795,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43796,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43797,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43798,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2119,Subject 43799,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2120,Subject 43800,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,7,0,0,6,6,0
Study 22,AMERICA,USA,Site 2120,Subject 43801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,2,0,0,0,2,1,44,0,0,0,0,0,0,28,0,0,17,2,15
Study 22,AMERICA,USA,Site 2120,Subject 43802,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,2,0,0,0,2,0,5,0,0,0,0,0,0,29,0,0,8,1,7
Study 22,AMERICA,USA,Site 2120,Subject 43803,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,1,0,28,0,7,9,2,14
Study 22,AMERICA,USA,Site 2120,Subject 43804,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,2,0,0,0,2,0,3,0,0,0,0,0,0,8,0,0,5,4,1
Study 22,AMERICA,USA,Site 2120,Subject 43805,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,24,0,7,32,8,31
Study 22,AMERICA,USA,Site 2120,Subject 43806,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,12,0,12
Study 22,AMERICA,USA,Site 2120,Subject 43807,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,0,0,0,38,0,38
Study 22,AMERICA,USA,Site 2120,Subject 43808,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,2,0,0,0,2,0,4,0,0,0,0,0,0,0,0,0,37,0,37
Study 22,AMERICA,USA,Site 2120,Subject 43809,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,1,0,0,0,1,0,2,0,0,0,0,0,0,0,0,0,7,0,7
Study 22,AMERICA,USA,Site 2121,Subject 43810,Unplanned visit (2),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43811,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43812,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43813,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,1,0,0,1,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43818,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2121,Subject 43819,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1174,Subject 17814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1174,Subject 17815,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1174,Subject 17816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1174,Subject 17817,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1174,Subject 17818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 17824,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 17825,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,34,0,,,,0,0,0,6,0,0,0,6,0,4,0,0,0,0,0,0,31,2,0,0,2,0
Study 22,AMERICA,USA,Site 1175,Subject 17826,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,1,0,0,0,1,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 17827,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,36,6,0,0,0,6
Study 22,AMERICA,USA,Site 1175,Subject 17828,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43821,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43822,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43823,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43824,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43825,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,32,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,31,0,0,0,0,0
Study 22,AMERICA,USA,Site 1175,Subject 43826,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,6,0,0,0,6
Study 22,AMERICA,USA,Site 1175,Subject 43827,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,USA,Site 2122,Subject 43828,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,29,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43830,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43831,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43832,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43833,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43834,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43835,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,19,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43836,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43837,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43838,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43839,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43840,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,AMERICA,USA,Site 2122,Subject 43842,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43843,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43844,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43845,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43846,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43847,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43848,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43849,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43850,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2122,Subject 43851,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1177,Subject 17831,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1177,Subject 17832,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1177,Subject 43852,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,11,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2123,Subject 43853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,29,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 2123,Subject 43854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2123,Subject 43855,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 17841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,USA,Site 1179,Subject 43856,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43858,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43859,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43860,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43861,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43862,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43863,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43864,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43865,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43866,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,7,0,0,1,6
Study 22,AMERICA,USA,Site 1179,Subject 43868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,AMERICA,USA,Site 1179,Subject 43869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,AMERICA,USA,Site 1179,Subject 43870,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43871,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43872,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43873,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43874,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43875,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43876,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43877,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43878,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43879,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43880,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,3,33,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,31,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43881,Unplanned visit (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,1,0,0,1,0
Study 22,AMERICA,USA,Site 1179,Subject 43882,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 1179,Subject 43883,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,AMERICA,USA,Site 2124,Subject 43884,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,15,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2124,Subject 43885,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2124,Subject 43886,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,11,0,0,1,0,1
Study 22,AMERICA,USA,Site 2124,Subject 43887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,3,0,0,0,3,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,AMERICA,USA,Site 2124,Subject 43888,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2124,Subject 43889,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17843,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17844,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17845,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17846,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17847,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17848,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17849,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17850,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,42,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,39,0,1,0,0,1
Study 22,AMERICA,USA,Site 1180,Subject 17851,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17853,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,3,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17854,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17855,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,34,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,33,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,35,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1180,Subject 17857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17866,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,1,0,0,0,0,0,0,1,7,45,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,AMERICA,USA,Site 1181,Subject 17868,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17869,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,AMERICA,USA,Site 1181,Subject 17870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,9,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17871,Screening,Screen Failure,,,,,,,,,,1,17,1,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17874,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17876,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17877,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,1,0,0,0,0,0,0,1,1,10,0,0,0,0,0,0,43,4,0,0,1,3
Study 22,AMERICA,USA,Site 1181,Subject 17878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17879,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1181,Subject 17880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,11,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1182,Subject 17883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1182,Subject 17884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,AMERICA,USA,Site 1182,Subject 17885,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1182,Subject 17886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,AMERICA,USA,Site 1182,Subject 17887,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1182,Subject 17888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,AMERICA,USA,Site 1182,Subject 17889,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1182,Subject 17890,Unplanned visit (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,2,0,0,0,2,19,6,0,0,0,0,0,0,57,1,0,0,1,0
Study 22,AMERICA,USA,Site 1184,Subject 17928,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1184,Subject 17929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,6,39,0,0,0,0,0,0,39,1,0,0,0,1
Study 22,AMERICA,USA,Site 2125,Subject 43890,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,44,0,0,0,0,0,0,51,1,0,0,1,0
Study 22,AMERICA,USA,Site 2125,Subject 43891,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,1,0,0,0,1,2,8,0,0,0,0,0,0,44,6,0,0,1,5
Study 22,AMERICA,USA,Site 2125,Subject 43892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,45,5,0,0,0,5
Study 22,AMERICA,USA,Site 2125,Subject 43893,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,2,0,0,0,2,2,16,0,0,0,0,0,0,52,5,0,0,0,5
Study 22,AMERICA,USA,Site 2125,Subject 43894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43895,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,44,5,0,0,0,5
Study 22,AMERICA,USA,Site 2125,Subject 43896,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43897,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43898,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,86,0,,,,0,0,0,10,0,0,0,10,2,34,0,0,0,0,2,0,65,3,0,0,3,0
Study 22,AMERICA,USA,Site 2125,Subject 43899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43900,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43902,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43903,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43904,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43906,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,78,0,,,,0,0,0,1,0,0,0,1,0,32,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2125,Subject 43908,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2126,Subject 43909,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,2,0,0,2,2,42,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,AMERICA,USA,Site 2126,Subject 43910,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2126,Subject 43911,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,AMERICA,USA,Site 2126,Subject 43912,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,58,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2126,Subject 43913,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,AMERICA,USA,Site 2126,Subject 43914,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17938,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17942,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,1,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17943,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,36,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1028,Subject 17945,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2127,Subject 43915,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,16,18,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2127,Subject 43916,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2127,Subject 43917,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,1,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2127,Subject 43918,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43919,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,2,0,0,0,2,0,56,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43920,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43921,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,7,0,0,0,7
Study 22,AMERICA,USA,Site 2128,Subject 43922,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2128,Subject 43925,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43926,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43927,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43928,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43930,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2129,Subject 43931,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43932,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,11,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43933,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43934,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43935,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,2,26,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43937,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43938,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43940,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,1,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43943,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43944,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2130,Subject 43952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,AMERICA,USA,Site 2044,Subject 43953,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 2044,Subject 43954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,2,0,0,0,2,17,35,0,0,0,0,0,0,52,2,0,0,2,0
Study 22,AMERICA,USA,Site 2044,Subject 43955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2044,Subject 43956,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2044,Subject 43957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1187,Subject 17972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,3,43,0,0,0,0,0,0,43,2,0,0,2,0
Study 22,AMERICA,USA,Site 1187,Subject 17973,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17976,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,9,45,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17977,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17978,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,9,0,0,2,7
Study 22,AMERICA,USA,Site 1188,Subject 17979,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17981,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,AMERICA,USA,Site 1188,Subject 17982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 17994,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,46,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,AMERICA,USA,Site 1189,Subject 17995,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 17996,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43958,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43959,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,0,0,0,0,0,1,18,0,0,0,0,0,0,56,6,0,0,0,6
Study 22,AMERICA,USA,Site 1189,Subject 43960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43964,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43965,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43966,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1189,Subject 43967,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43968,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,11,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43969,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43970,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43971,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43973,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43974,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43975,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2131,Subject 43976,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18026,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18028,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18029,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18030,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18031,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18033,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1191,Subject 18034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2132,Subject 43977,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,1,42,0,0,0,0,0,0,0,0,7,35,0,42
Study 22,AMERICA,USA,Site 2132,Subject 43978,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,0,0,7,36,0,43
Study 22,AMERICA,USA,Site 2132,Subject 43979,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,0,0,0,0,7,36,0,43
Study 22,AMERICA,USA,Site 2132,Subject 43980,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,8,36,0,44
Study 22,AMERICA,USA,Site 2132,Subject 43981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,0,7,35,0,42
Study 22,AMERICA,USA,Site 2132,Subject 43982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,0,7,0,35,0,42
Study 22,AMERICA,USA,Site 2132,Subject 43983,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,0,0,0,12,0,12
Study 22,AMERICA,USA,Site 2133,Subject 43984,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43985,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,8,38,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43987,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43988,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43990,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,2,0,0,0,2,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43991,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2133,Subject 43993,Screening,Discontinued,,,,,,,,,,1,22,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,20,0,0,0,0,0
Study 22,AMERICA,USA,Site 2134,Subject 43994,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,1,60,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2134,Subject 43995,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 43996,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,4,45,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 43997,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 43998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 43999,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44000,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44001,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44002,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44003,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44004,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44008,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44009,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44010,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44013,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2135,Subject 44015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,0,0,0,0,0,0,18,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44018,Unplanned visit (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44019,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44020,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44021,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 2136,Subject 44022,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,AMERICA,USA,Site 1039,Subject 18040,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1039,Subject 18041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,35,1,0,10,2,9
Study 22,AMERICA,USA,Site 1039,Subject 18042,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,1,0,0,0,1,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1039,Subject 18043,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 1039,Subject 18044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,0,7,0,1,6
Study 22,AMERICA,USA,Site 1192,Subject 18055,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,AMERICA,USA,Site 1192,Subject 18056,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,AMERICA,USA,Site 2137,Subject 19533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,3,57,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,AMERICA,USA,Site 2137,Subject 44023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 2137,Subject 44024,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,AMERICA,USA,Site 2137,Subject 44025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 19534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 19535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 19536,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,36,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 19537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1291,Subject 19538,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,18,0,19,0,0,0,16,0,0,0,0,0
Study 22,AMERICA,USA,Site 1291,Subject 19539,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,17,0,0,0,14,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 44026,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,AMERICA,USA,Site 2106,Subject 44027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19549,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,9,42,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19551,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,AMERICA,USA,Site 1294,Subject 19554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1668,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,63,0,,,,0,0,0,1,0,0,0,1,0,62,0,0,0,0,1,0,54,7,0,0,0,7
Study 22,ASIA,CHN,Site 191,Subject 1669,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,7,0,0,0,7
Study 22,ASIA,CHN,Site 191,Subject 1670,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,5,0,0,0,5,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1671,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1672,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1673,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1674,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 191,Subject 1676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 1689,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 1690,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 1691,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 1692,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,7,0,0,0,7
Study 22,ASIA,CHN,Site 192,Subject 1693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 2773,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 2774,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 2775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 2776,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,47,1,0,0,1,0
Study 22,ASIA,CHN,Site 192,Subject 2777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 2778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 19557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,1,38,6,0,0,0,6
Study 22,ASIA,CHN,Site 192,Subject 44028,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 44029,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,54,0,,,,0,0,0,1,0,0,0,1,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 44030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 44031,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 192,Subject 44032,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 352,Subject 2843,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 352,Subject 19560,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,4,41,0,0,0,0,1,0,43,0,1,0,1,0
Study 22,ASIA,CHN,Site 352,Subject 19561,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,4,8,0,0,0,0,0,0,41,9,0,0,1,8
Study 22,ASIA,CHN,Site 193,Subject 1698,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2781,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2783,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2784,Unplanned visit (2),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,5,7,0,0,0,0,0,1,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2785,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2787,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2788,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 193,Subject 2789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2794,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2795,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2798,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2799,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,3,0,56,7,0,0,0,7
Study 22,ASIA,CHN,Site 344,Subject 2800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2801,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 2802,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19567,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19570,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19571,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19573,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19575,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19576,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 19577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44033,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44034,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44036,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44037,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44038,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44039,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44040,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44041,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44042,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44043,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44045,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44046,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44047,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44048,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44051,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44052,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44053,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,CHN,Site 344,Subject 44054,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1699,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,0,60,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1700,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,3,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1701,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1702,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1703,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,4,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1706,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 194,Subject 1707,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,2,54,0,0,0,0,1,1,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,2,0,0,2,0
Study 22,ASIA,CHN,Site 345,Subject 2807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2808,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 2809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,2,0,0,0,2,6,9,0,0,0,0,0,2,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 19596,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 19597,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 19598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,7,0,0,0,7
Study 22,ASIA,CHN,Site 345,Subject 19599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,6,0,0,0,6
Study 22,ASIA,CHN,Site 345,Subject 19600,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,7,0,0,0,7
Study 22,ASIA,CHN,Site 345,Subject 19601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 19602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44055,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44056,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,21,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44058,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,42,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44060,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44061,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44063,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44064,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44065,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 345,Subject 44066,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 1712,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 1713,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 1714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 1715,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,0,0,0,0,0,0,23,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 1716,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19603,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19604,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19605,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19606,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19607,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19608,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,1,0,0,1,0,0,0,2,9,5,0,0,0,0,0,0,50,5,0,0,3,2
Study 22,ASIA,CHN,Site 196,Subject 19609,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,ASIA,CHN,Site 196,Subject 19610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19611,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 19612,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44068,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44070,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44071,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,ASIA,CHN,Site 196,Subject 44072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,42,4,0,0,1,3
Study 22,ASIA,CHN,Site 198,Subject 1723,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,5,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1724,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1725,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1726,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,70,0,,,,0,0,0,0,0,0,0,0,6,38,0,0,0,0,1,0,56,1,0,0,0,1
Study 22,ASIA,CHN,Site 198,Subject 1727,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1728,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,6,0,0,0,6
Study 22,ASIA,CHN,Site 198,Subject 1729,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,59,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,6,0,0,0,6
Study 22,ASIA,CHN,Site 198,Subject 1730,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1731,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1732,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,5,10,0,0,0,0,1,1,51,4,2,0,5,1
Study 22,ASIA,CHN,Site 198,Subject 1733,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1734,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1735,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,80,0,,,,0,0,0,2,0,0,0,2,8,21,0,0,0,0,0,2,65,1,1,0,1,1
Study 22,ASIA,CHN,Site 198,Subject 1736,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1737,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,2,16,0,0,0,0,2,0,48,7,0,0,1,6
Study 22,ASIA,CHN,Site 198,Subject 1740,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,19,0,0,0,0,0
Study 22,ASIA,CHN,Site 198,Subject 1741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,6,0,0,0,6
Study 22,ASIA,CHN,Site 198,Subject 1742,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,6,0,0,0,6
Study 22,ASIA,CHN,Site 200,Subject 1744,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1745,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1746,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1747,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,88,0,,,,0,0,0,0,0,0,0,0,4,79,0,0,0,0,0,0,69,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1748,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1749,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1750,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,0,0,0,0,0,4,17,0,0,0,0,2,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 1751,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 2811,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 2812,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 2813,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,1,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44073,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44074,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,8,8,0,0,0,0,1,0,56,1,0,0,0,1
Study 22,ASIA,CHN,Site 200,Subject 44075,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44076,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44077,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44078,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,2,0,0,0,2,5,19,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44079,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44080,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44081,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44082,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,2,15,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44083,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44084,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44085,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44086,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44087,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44088,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44089,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44090,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,81,0,,,,0,0,0,0,0,0,0,0,11,18,0,0,0,0,0,0,62,2,0,0,2,0
Study 22,ASIA,CHN,Site 200,Subject 44091,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,1,0,0,0,0,0,0,1,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44093,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,5,9,0,0,0,0,0,0,52,7,0,0,1,6
Study 22,ASIA,CHN,Site 200,Subject 44094,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44095,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,ASIA,CHN,Site 200,Subject 44096,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44097,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,1,0,43,7,0,0,1,6
Study 22,ASIA,CHN,Site 200,Subject 44098,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44099,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,5,9,0,0,0,0,0,0,50,8,0,0,2,6
Study 22,ASIA,CHN,Site 200,Subject 44100,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,2,12,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44104,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44106,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,4,11,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44107,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44108,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44109,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44110,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,10,4,0,0,0,0,0,0,45,4,0,0,3,1
Study 22,ASIA,CHN,Site 200,Subject 44111,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44112,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 200,Subject 44113,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1752,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1753,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,16,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1754,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1755,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1756,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,17,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 201,Subject 1757,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,16,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 19752,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 19753,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 19754,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 19755,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44114,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44115,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,3,0,0,0,3,16,4,0,0,0,0,0,0,50,7,0,0,6,1
Study 22,ASIA,CHN,Site 1295,Subject 44117,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44118,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44119,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44120,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44121,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44122,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44123,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,42,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 1295,Subject 44124,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1760,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,2,57,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1761,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1762,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1763,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1764,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,86,0,,,,0,0,0,1,0,0,0,1,6,27,0,0,0,0,0,0,65,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1765,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1766,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1767,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1768,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1769,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1770,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1771,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1772,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,ASIA,CHN,Site 202,Subject 1773,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1774,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,8,6,0,0,0,0,0,0,49,7,0,0,0,7
Study 22,ASIA,CHN,Site 202,Subject 1775,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1776,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 1778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44125,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44126,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44127,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44128,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44129,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44130,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 202,Subject 44131,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19756,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19757,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,9,42,0,0,0,0,0,0,42,3,0,0,2,1
Study 22,ASIA,CHN,Site 1296,Subject 19758,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19759,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,7,0,0,0,7
Study 22,ASIA,CHN,Site 1296,Subject 19760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19762,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19763,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1296,Subject 19764,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 1779,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 19773,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,3,11,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 19774,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 19775,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,5,58,0,0,0,0,1,0,58,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44132,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44133,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44134,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44135,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44136,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,2,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,3,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44139,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,13,1,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44140,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44141,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,3,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44142,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,1,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,2,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44144,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44145,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,ASIA,CHN,Site 203,Subject 44147,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44148,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44149,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44150,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44151,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44152,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44153,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,47,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44154,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44158,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,1,11,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44160,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44161,Unplanned visit (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,1,0,0,0,1,9,3,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,ASIA,CHN,Site 203,Subject 44162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44163,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 203,Subject 44166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19776,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,3,58,0,0,0,0,2,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19777,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,10,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19778,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19779,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19780,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19781,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19782,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19784,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19785,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1297,Subject 19788,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,ASIA,CHN,Site 204,Subject 1780,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,11,42,0,0,0,0,1,0,45,0,1,0,0,1
Study 22,ASIA,CHN,Site 204,Subject 1781,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 204,Subject 1782,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,42,8,0,0,1,7
Study 22,ASIA,CHN,Site 204,Subject 1783,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 204,Subject 1784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,41,3,0,0,2,1
Study 22,ASIA,CHN,Site 205,Subject 1786,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,53,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 205,Subject 1787,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 205,Subject 1788,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 205,Subject 1789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 205,Subject 44167,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1790,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1791,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1792,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1793,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1795,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1797,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1798,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1799,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1800,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1804,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1805,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1806,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,2,0,58,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1807,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1808,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 1809,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44168,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44169,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44170,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44171,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44172,Unplanned visit (3),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,0,0,0,0,1,2,19,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44176,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44177,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 206,Subject 44178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 1298,Subject 19795,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1298,Subject 19796,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,66,0,,,,0,0,0,0,0,0,0,0,0,63,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 1298,Subject 19797,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,7,0,0,7
Study 22,ASIA,CHN,Site 1298,Subject 19798,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1298,Subject 19799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,1,0,0,1,0,6,0,0,0,0,2,1,43,1,0,0,1,0
Study 22,ASIA,CHN,Site 1299,Subject 19800,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 1299,Subject 19801,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1299,Subject 19802,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,1,0,0,1,0
Study 22,ASIA,CHN,Site 1299,Subject 19803,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1299,Subject 19804,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1299,Subject 19805,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1299,Subject 19806,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 207,Subject 1810,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 207,Subject 1811,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 207,Subject 1812,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 207,Subject 1813,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44179,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,8,53,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44180,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44181,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,78,0,,,,0,0,0,1,0,0,0,1,3,20,0,0,0,0,1,1,65,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44182,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44183,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44184,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44185,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44186,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44187,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44188,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44189,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44190,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44192,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44193,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44194,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44195,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,1,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44196,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44197,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44198,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44199,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,1,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44200,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,1,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44202,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 2138,Subject 44204,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 208,Subject 1820,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 208,Subject 1821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,7,47,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 208,Subject 1822,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 1824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 1825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 1826,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 1827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,5,12,0,0,0,0,1,0,59,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19860,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19862,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,1,0,0,1,0,0,0,2,7,6,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19866,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19867,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,8,12,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19870,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19871,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 19874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44206,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44207,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,2,17,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,1,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44210,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44211,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44212,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44213,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44214,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44215,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,4,52,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44217,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44218,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44219,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44220,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 209,Subject 44222,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,4,47,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1829,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,4,8,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1831,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 1833,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,95,0,,,,0,0,0,2,0,0,0,2,16,23,0,0,0,0,0,0,68,3,0,0,3,0
Study 22,ASIA,CHN,Site 210,Subject 44223,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44224,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,3,11,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44225,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44226,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,2,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44227,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44228,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 210,Subject 44229,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 195,Subject 1834,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,5,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 195,Subject 1835,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,2,0,0,0,2,8,61,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,CHN,Site 195,Subject 19875,Unplanned visit (1),On Trial,,,,,,,,,,5,58,0,,,,0,1,0,1,0,0,0,2,4,8,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 195,Subject 19876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19931,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,50,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19932,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19933,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,4,0,0,0,4,1,6,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,7,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,2,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19940,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1302,Subject 19941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1836,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1837,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,36,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1838,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,10,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1839,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1840,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1841,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 211,Subject 1843,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 212,Subject 1850,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 212,Subject 1851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 212,Subject 1852,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,CHN,Site 212,Subject 1853,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 213,Subject 1863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,6,0,0,0,6,10,36,0,0,0,0,1,0,42,3,0,0,3,0
Study 22,ASIA,CHN,Site 214,Subject 1870,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,1,0,0,0,1,0,65,0,0,0,0,0,0,60,1,0,0,1,0
Study 22,ASIA,CHN,Site 214,Subject 19981,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19982,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,1,0,0,0,1,0,19,0,1,0,0,0,0,52,2,0,0,2,0
Study 22,ASIA,CHN,Site 214,Subject 19983,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19984,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19985,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19986,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19988,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19989,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,1,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 214,Subject 19990,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19993,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,50,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19994,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19995,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19996,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19997,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19998,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 19999,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,1,0,0,0,1,4,10,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 20000,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 20001,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 20002,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 44230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1301,Subject 44231,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1871,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,53,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1872,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1873,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1874,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1875,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1877,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1881,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1882,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1888,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1889,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1890,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1891,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1892,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1893,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1894,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 215,Subject 1895,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20010,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,8,45,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20011,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20012,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,ASIA,CHN,Site 1303,Subject 20013,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,8,0,0,1,7
Study 22,ASIA,CHN,Site 1303,Subject 20014,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20015,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,9,0,0,2,7
Study 22,ASIA,CHN,Site 1303,Subject 20016,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20017,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1303,Subject 20018,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1304,Subject 20051,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,10,41,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1304,Subject 20052,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1304,Subject 20053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44232,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,6,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44233,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44234,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,12,1,0,0,1,0
Study 22,ASIA,CHN,Site 2139,Subject 44235,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44236,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44237,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,4,40,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44239,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,7,0,0,1,6
Study 22,ASIA,CHN,Site 2139,Subject 44240,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44241,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44242,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44243,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44244,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44245,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 2139,Subject 44246,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 219,Subject 1923,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,8,57,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,CHN,Site 219,Subject 1924,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 219,Subject 20100,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 219,Subject 20101,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20133,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20134,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20135,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20136,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20138,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 20139,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44247,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44248,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44249,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44250,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44251,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44252,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,13,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44254,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,11,0,0,0,0,1,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44255,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44256,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1306,Subject 44257,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 1307,Subject 20140,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1307,Subject 20141,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1307,Subject 20142,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,1,15,1,0,0,0,4,0,58,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,60,0,0,0,0,2,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,0,16,0,1,0,0,2,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20150,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,2,13,0,0,0,0,4,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20151,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20153,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20154,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20156,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20157,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20158,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20159,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,3,11,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20160,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1308,Subject 20162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20163,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,1,58,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20164,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,1,0,0,0,1,0,6,0,0,0,0,0,1,52,1,0,0,1,0
Study 22,ASIA,CHN,Site 1309,Subject 20165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20167,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20168,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1309,Subject 20169,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 2140,Subject 44258,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 2140,Subject 44259,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,CHN,Site 2140,Subject 44260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 2140,Subject 44261,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20173,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,49,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20174,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20175,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,76,0,,,,0,0,0,0,0,0,0,0,2,23,0,0,0,0,2,0,63,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20176,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20177,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,73,0,,,,0,0,0,2,0,0,0,2,5,17,0,0,0,0,1,0,62,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20178,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,1,0,0,0,1,8,8,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20179,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20180,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20181,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20182,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20183,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20184,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20185,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20186,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20187,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20188,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,1,19,0,0,0,0,1,0,61,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20189,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,61,0,,,,0,0,0,1,0,0,0,1,4,12,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20190,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,60,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 20191,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44262,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44263,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,3,0,0,0,3,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44264,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44265,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44266,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44267,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,71,0,,,,0,0,0,2,0,0,0,2,11,12,0,0,0,0,1,0,58,1,0,0,1,0
Study 22,ASIA,CHN,Site 1310,Subject 44268,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44269,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44270,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44271,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,0,0,0,0,0,0,22,0,0,0,0,2,0,51,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44272,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44273,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44274,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44275,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44276,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44277,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44278,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44279,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44280,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44281,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44282,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,42,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44283,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44284,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44285,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44286,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44287,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,CHN,Site 1310,Subject 44288,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44289,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,1,58,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44290,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44291,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,74,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,2,0,65,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44292,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,63,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44293,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44294,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44295,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44296,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44297,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44298,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,66,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,63,1,0,0,0,1
Study 22,ASIA,HKG,Site 2141,Subject 44299,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44300,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44301,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44302,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44303,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44304,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44305,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,64,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,55,8,0,0,1,7
Study 22,ASIA,HKG,Site 2141,Subject 44306,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44307,Unplanned visit (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44308,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44309,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44310,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,0,0,0,0,0,0,24,0,0,0,0,0,0,57,1,0,0,1,0
Study 22,ASIA,HKG,Site 2141,Subject 44312,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44315,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44317,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44318,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44320,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44321,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44322,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44323,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44324,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,ASIA,HKG,Site 2141,Subject 44325,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44326,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,43,1,0,0,0,1
Study 22,ASIA,HKG,Site 2141,Subject 44327,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,ASIA,HKG,Site 2141,Subject 44328,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,1,0,0,0,1,0,3,0,0,0,0,0,0,36,8,0,0,1,7
Study 22,ASIA,HKG,Site 2141,Subject 44329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,37,8,0,0,1,7
Study 22,ASIA,HKG,Site 2141,Subject 44330,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44331,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44332,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44333,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44334,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,ASIA,HKG,Site 2141,Subject 44335,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,7,43,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44337,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44338,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44339,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44342,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,ASIA,HKG,Site 2142,Subject 44343,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44344,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44345,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44346,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,62,0,,,,0,0,0,0,0,0,0,0,0,61,0,0,0,0,2,0,60,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44347,Visit 6 (Month 27) (1),On Trial,,,,,,,,,,7,60,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,51,8,0,0,0,8
Study 22,ASIA,HKG,Site 2143,Subject 44348,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44349,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,1,0,0,0,1
Study 22,ASIA,HKG,Site 2143,Subject 44350,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44351,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44354,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44355,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,60,0,,,,0,0,0,0,0,0,0,0,0,20,1,1,0,0,0,0,51,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44357,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44358,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44359,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44362,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44364,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44365,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44366,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44367,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44368,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44369,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,0,0,0,0,9,0,0,0,0,0
Study 22,ASIA,HKG,Site 2143,Subject 44370,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44371,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,68,0,,,,0,0,0,0,0,0,0,0,0,64,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44372,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,50,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44373,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44374,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,0,12,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,2,0,0,0,2,8,13,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44376,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44377,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44379,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44380,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,47,0,,,,0,0,0,1,0,0,0,1,0,13,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44381,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,ASIA,HKG,Site 2144,Subject 44382,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,HRV,Site 2145,Subject 44383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,7,36,0,0,0,0,0,0,41,2,0,0,2,0
Study 22,EMEA,HRV,Site 2145,Subject 44384,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 2145,Subject 44385,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 2145,Subject 44386,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2145,Subject 44387,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,2,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2814,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,0,55,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2820,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 2821,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 346,Subject 20285,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1331,Subject 20287,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,3,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20288,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20289,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,2,0,0,0,2
Study 22,EMEA,HRV,Site 1337,Subject 20290,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,HRV,Site 1332,Subject 20305,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1332,Subject 20306,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1332,Subject 20307,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1332,Subject 20308,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20336,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20337,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20338,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20339,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20340,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20341,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20342,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 20343,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44390,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44392,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44393,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44394,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44395,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44396,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44397,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44398,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44399,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1333,Subject 44400,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1330,Subject 20349,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,4,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1330,Subject 20350,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,42,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1330,Subject 20351,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1330,Subject 20352,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1335,Subject 20360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1335,Subject 20361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1335,Subject 20362,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1335,Subject 20363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 1335,Subject 20364,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,HRV,Site 1336,Subject 20377,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20378,Unplanned visit (2),Screen Failure,,,,,,,,,,1,21,0,,,,0,0,0,0,0,0,0,0,0,2,19,0,0,0,0,0,20,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20379,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20380,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,HRV,Site 1336,Subject 44401,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,8,0,0,2,6
Study 22,EMEA,HRV,Site 1336,Subject 44402,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,1,0,0,0,0,0,0,1,1,15,0,0,0,0,0,0,50,5,0,0,0,5
Study 22,EMEA,HRV,Site 1336,Subject 44403,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44404,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,62,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,49,6,0,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44405,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,HRV,Site 1336,Subject 44406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44407,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44408,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44409,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,42,7,0,0,1,6
Study 22,EMEA,HRV,Site 1336,Subject 44410,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44411,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,7,0,0,1,6
Study 22,EMEA,HRV,Site 1336,Subject 44412,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44413,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44414,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44415,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44416,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44417,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44420,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44421,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44422,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44423,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44424,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,4,0,0,3,1
Study 22,EMEA,HRV,Site 1336,Subject 44425,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44426,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44427,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,12,0,0,0,1,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44428,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44429,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44430,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44431,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44432,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,1,0,0,0,1
Study 22,EMEA,HRV,Site 1336,Subject 44433,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44434,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44435,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44436,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44437,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44438,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44439,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44440,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44441,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44442,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44443,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44444,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44445,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,2,0,0,0,2
Study 22,EMEA,HRV,Site 1336,Subject 44446,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44447,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44448,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44449,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44450,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44451,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44452,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44453,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44454,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44455,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44456,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44457,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44458,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44459,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,1,0,0,0,1
Study 22,EMEA,HRV,Site 1336,Subject 44460,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44461,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44462,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44463,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,EMEA,HRV,Site 1336,Subject 44464,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44465,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44466,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44468,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44469,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44471,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44472,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44473,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,2,6,0,0,8
Study 22,EMEA,HRV,Site 1336,Subject 44476,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44477,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44478,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,43,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44480,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44481,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44482,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,40,9,0,0,2,7
Study 22,EMEA,HRV,Site 1336,Subject 44484,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44487,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,5,0,0,0,5
Study 22,EMEA,HRV,Site 1336,Subject 44490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,44,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,HRV,Site 1336,Subject 44494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1336,Subject 44495,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44496,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44497,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44498,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44499,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44500,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44501,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44502,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44503,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44504,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44505,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44506,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44507,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44508,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44509,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44510,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,42,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,1,0,0,0,1
Study 22,EMEA,HRV,Site 1336,Subject 44511,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44512,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44513,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44514,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44515,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44516,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44517,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44518,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44519,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44520,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44521,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44522,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44523,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44524,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44525,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44526,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44527,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44528,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44529,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44530,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44531,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44532,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 44533,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20381,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,58,0,,,,0,0,0,0,0,0,0,0,8,49,0,0,0,0,0,0,49,2,0,0,1,1
Study 22,EMEA,HRV,Site 1337,Subject 20382,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20383,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,0,0,1,1,0
Study 22,EMEA,HRV,Site 1337,Subject 20384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20387,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,EMEA,HRV,Site 1337,Subject 20389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20390,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20391,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20392,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 20394,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44534,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44537,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1337,Subject 44538,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44539,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44540,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44541,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44542,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44543,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44544,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44545,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44546,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44547,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44548,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1337,Subject 44549,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20395,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,7,39,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20396,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,HRV,Site 1338,Subject 20397,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1336,Subject 20398,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,36,2,0,0,0,2
Study 22,EMEA,HRV,Site 1339,Subject 20415,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1339,Subject 20416,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1339,Subject 20417,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1339,Subject 20418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,1,59,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,37,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20492,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20494,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20495,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20496,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1340,Subject 20497,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1341,Subject 20500,Visit 1 (1),Discontinued,,,,,,,,,,2,20,0,,,,0,0,0,0,0,0,0,0,0,12,0,0,0,0,1,0,17,0,0,1,0,1
Study 22,EMEA,HRV,Site 1341,Subject 20501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,42,0,0,2,2,0
Study 22,EMEA,HRV,Site 1341,Subject 20502,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 20504,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 20505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 20506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 20507,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44550,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44551,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44552,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,0,6,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44553,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,0,6,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44554,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,34,0,0,11,3,8
Study 22,EMEA,HRV,Site 1342,Subject 44555,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,0,6,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44556,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,0,7,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44557,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44558,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,0,7,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44560,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44561,Unplanned visit (1),Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,HRV,Site 1342,Subject 44563,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44564,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,HRV,Site 1342,Subject 44566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,HRV,Site 1342,Subject 44567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,7,0,0,7
Study 22,EMEA,HRV,Site 1342,Subject 44568,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,36,7,0,0,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44570,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,41,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44572,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,36,7,0,0,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44575,Visit 1 (1),Discontinued,,,,,,,,,,2,26,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,24,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44576,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,38,8,0,0,2,6
Study 22,EMEA,HRV,Site 1342,Subject 44578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44579,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44581,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,7,6,0,0,0,0,0,0,37,7,0,0,1,6
Study 22,EMEA,HRV,Site 1342,Subject 44582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44583,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,5,0,0,0,5
Study 22,EMEA,HRV,Site 1342,Subject 44584,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44587,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44588,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44589,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44590,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44591,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44592,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,19,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44593,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44594,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44595,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44596,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44597,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44598,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44599,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44600,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44601,Visit 1 (1),On Trial,,,,,,,,,,2,29,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,26,0,1,0,1,0
Study 22,EMEA,HRV,Site 1342,Subject 44602,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44603,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44604,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44605,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44606,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44607,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44608,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44609,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44610,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44611,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44612,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44613,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44614,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44615,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44616,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44617,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44618,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44619,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44620,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44621,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44622,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44623,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,29,1,0,7,1,7
Study 22,EMEA,HRV,Site 1342,Subject 44624,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44625,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44626,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44627,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44628,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44629,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,30,0,0,7,0,7
Study 22,EMEA,HRV,Site 1342,Subject 44630,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44631,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44632,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1342,Subject 44633,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,31,0,0,6,0,6
Study 22,EMEA,HRV,Site 1342,Subject 44634,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 1343,Subject 20508,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,3,43,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44635,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44636,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,9,36,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44637,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44638,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,13,2,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44639,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44640,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,9,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44641,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,1,0,0,0,1,2,11,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44642,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,16,1,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 2146,Subject 44643,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44644,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,8,35,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44645,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44646,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44647,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,3,11,0,0,0,0,1,0,41,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44648,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 2147,Subject 44649,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44650,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44651,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44652,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44653,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44654,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44655,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44656,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44657,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44658,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44659,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44660,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44661,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44664,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44665,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44666,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44667,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44668,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44669,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44670,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,HRV,Site 2148,Subject 44671,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 3838,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 3839,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44672,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44673,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,DNK,Site 542,Subject 44674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44675,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44677,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44678,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44680,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44682,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44683,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44686,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44687,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44689,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44690,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44691,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44692,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44693,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,DNK,Site 542,Subject 44694,Unplanned visit (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,3,0,0,0,3
Study 22,EMEA,DNK,Site 542,Subject 44695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20557,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20558,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20559,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20560,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20561,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20562,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20563,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20565,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20566,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 20568,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 44696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1346,Subject 44697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20569,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20570,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20571,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20572,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20573,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,75,0,,,,0,0,0,2,0,0,0,2,1,25,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20575,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,69,0,,,,0,0,0,2,0,0,0,2,0,25,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20576,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20577,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20579,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20580,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20581,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20582,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20583,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20584,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 20585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44700,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44702,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1347,Subject 44704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 2149,Subject 20586,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,45,0,6,0,0,6
Study 22,EMEA,DNK,Site 1348,Subject 20587,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20588,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20589,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,0,0,49,7,0,0,0,7
Study 22,EMEA,DNK,Site 1348,Subject 20590,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20591,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,1,0,1,1
Study 22,EMEA,DNK,Site 1348,Subject 20593,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20594,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,0,23,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,38,1,6,0,0,7
Study 22,EMEA,DNK,Site 1348,Subject 20596,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 20597,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1348,Subject 44705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,DNK,Site 1348,Subject 44706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,1,0,0,0,1,0,25,0,0,0,0,0,0,46,8,0,0,1,7
Study 22,EMEA,DNK,Site 1349,Subject 20598,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 20599,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,9,7,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 20600,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 20601,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,48,7,0,0,1,6
Study 22,EMEA,DNK,Site 1349,Subject 20602,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44709,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44711,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44712,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44713,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,64,0,,,,0,0,0,1,0,0,0,1,0,18,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,EMEA,DNK,Site 1349,Subject 44714,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44715,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44716,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44717,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44718,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44719,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44721,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44723,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44724,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44726,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44727,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44728,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1349,Subject 44729,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 20603,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,13,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 20604,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 20605,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44730,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44731,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,8,44,0,0,0,0,0,0,44,2,0,0,1,1
Study 22,EMEA,DNK,Site 1350,Subject 44732,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44733,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44734,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44735,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44736,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,7,0,0,1,6
Study 22,EMEA,DNK,Site 1350,Subject 44737,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44738,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,DNK,Site 1350,Subject 44739,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,DNK,Site 1350,Subject 44740,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44741,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,DNK,Site 1350,Subject 44742,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44743,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44744,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44746,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44748,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44749,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44750,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,42,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,1,0,40,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44752,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44753,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44754,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44755,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44756,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,1,0,0,0,1,5,10,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44759,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44760,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44761,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44762,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44763,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44764,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44765,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44766,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44768,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44769,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44771,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44772,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44773,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44774,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44775,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44776,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44777,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,12,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44778,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44779,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44780,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44781,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44782,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44783,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44784,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44785,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44787,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44788,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44789,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44790,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44791,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44792,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,42,1,0,0,1,0
Study 22,EMEA,DNK,Site 1350,Subject 44793,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44795,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44796,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44797,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44798,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44799,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44801,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44802,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44803,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44804,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44805,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44806,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44807,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,43,4,0,0,4,0
Study 22,EMEA,DNK,Site 1350,Subject 44808,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44809,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44810,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44811,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44812,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44813,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44814,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44815,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44816,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44817,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,DNK,Site 1350,Subject 44820,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1350,Subject 44821,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20606,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20607,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20608,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20609,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20610,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20611,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20612,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 20613,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44822,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44823,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44824,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44825,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44826,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,11,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44827,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44828,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44829,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44830,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44831,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44832,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,5,0,0,0,5
Study 22,EMEA,DNK,Site 1351,Subject 44833,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44834,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44835,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44836,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44837,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44839,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44840,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44841,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44842,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44843,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44844,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44845,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44846,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44847,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44848,Unplanned visit (2),On Trial,,,,,,,,,,5,52,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44849,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,12,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44851,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44852,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44853,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44854,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44855,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,8,0,0,0,7,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44856,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44857,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44858,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44859,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44860,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44861,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44862,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44863,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44864,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44865,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44866,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44868,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44869,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44870,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44871,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44872,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44874,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44877,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44883,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44884,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44885,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44887,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44888,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44890,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,9,0,9,0,0,0,8,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44891,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44892,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44893,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44894,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44896,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44898,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44900,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44901,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44902,Screening,Screen Failure,,,,,,,,,,1,10,0,,,,0,0,0,0,0,0,0,0,0,2,10,0,10,0,0,0,9,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44903,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44904,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44905,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44906,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44907,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44908,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44910,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44911,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44912,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44913,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44914,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,14,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44915,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44916,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44917,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,8,0,0,0,7,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44918,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44919,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44920,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44921,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44922,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44924,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44925,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44926,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44927,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44928,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,15,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44929,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44931,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44932,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44934,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44935,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44936,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44937,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,7,0,7,0,0,0,6,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44938,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44939,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44941,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44942,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44943,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44944,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,13,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44945,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1351,Subject 44946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44947,Screening,Screen Failure,,,,,,,,,,1,8,0,,,,0,0,0,0,0,0,0,0,0,2,8,0,0,0,0,0,7,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44948,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44949,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,44,0,0,0,0,0,0,44,3,0,0,2,1
Study 22,EMEA,DNK,Site 2150,Subject 44950,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44951,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44952,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44953,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44954,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44955,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44956,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44957,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,1,17,0,1,0,0,0,0,54,5,0,0,0,5
Study 22,EMEA,DNK,Site 2150,Subject 44958,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44959,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44962,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44963,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44964,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44965,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44966,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44967,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44968,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44969,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44970,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44971,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44972,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44973,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44974,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44975,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44976,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44977,Visit 1 (1),Discontinued,,,,,,,,,,2,23,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,22,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44978,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44979,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44980,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44981,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44982,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44983,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44984,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44985,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44986,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44987,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44988,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44989,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44990,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44991,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44992,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44993,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,3,12,0,0,0,0,0,0,38,0,11,0,4,7
Study 22,EMEA,DNK,Site 2150,Subject 44994,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44995,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44996,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44997,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44998,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 44999,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45000,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45001,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45002,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45003,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45004,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45005,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45006,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45007,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45008,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45009,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45010,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45011,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45012,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45013,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45014,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45015,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45016,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45017,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45018,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45019,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45020,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45021,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45022,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45023,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45024,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,1,0,1,0
Study 22,EMEA,DNK,Site 2150,Subject 45025,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,8,0,2,6
Study 22,EMEA,DNK,Site 2150,Subject 45026,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45028,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45029,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45030,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,7,0,1,6
Study 22,EMEA,DNK,Site 2150,Subject 45031,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45032,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45033,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,48,0,2,0,2,0
Study 22,EMEA,DNK,Site 2150,Subject 45034,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45035,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45036,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45037,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45038,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45039,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45040,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45041,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45042,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,8,0,1,7
Study 22,EMEA,DNK,Site 2150,Subject 45043,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45044,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45045,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45046,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45047,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45048,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,35,0,8,0,2,6
Study 22,EMEA,DNK,Site 2150,Subject 45050,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45051,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45052,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45054,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45055,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45056,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45057,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45058,Visit 2 (Month 3) (1),On Trial,,,,,,,,,,3,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,1,33,2,0,0,0,2
Study 22,EMEA,DNK,Site 2150,Subject 45059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,71,0,,,,0,0,0,1,0,0,0,1,11,14,0,0,0,0,0,0,43,10,0,0,3,7
Study 22,EMEA,DNK,Site 2150,Subject 45060,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45061,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45062,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,38,0,7,0,1,6
Study 22,EMEA,DNK,Site 2150,Subject 45063,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,40,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45065,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45066,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45069,Screening,Screen Failure,,,,,,,,,,1,9,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,8,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45070,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45071,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,DNK,Site 2150,Subject 45073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,7,0,1,6
Study 22,EMEA,DNK,Site 2150,Subject 45074,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45075,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45076,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 2150,Subject 45077,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,DNK,Site 1354,Subject 20666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,3,0,0,0,3,9,44,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,DNK,Site 1354,Subject 20667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1354,Subject 20668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20675,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,11,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20676,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20680,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20681,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20682,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20683,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20684,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,DNK,Site 1355,Subject 20686,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,DNK,Site 2149,Subject 45078,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2149,Subject 45079,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,43,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,DNK,Site 2149,Subject 45080,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,47,0,0,1,1,0
Study 22,EMEA,DNK,Site 2149,Subject 45081,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,DNK,Site 2149,Subject 45082,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,35,0,9,0,2,7
Study 22,EMEA,DNK,Site 2149,Subject 45083,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45084,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,56,0,,,,0,0,0,0,0,0,0,0,0,53,1,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45085,End of Study (EOS) (1),Discontinued,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45086,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45087,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45088,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45089,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45090,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45091,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45092,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45093,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45094,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45095,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45096,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45097,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45098,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45099,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45100,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45101,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45102,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45103,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45104,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45105,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45106,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45107,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45108,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45109,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45110,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45111,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45112,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45113,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45114,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45115,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45116,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45117,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45118,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45119,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45120,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,57,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,55,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45121,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45122,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45123,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45124,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45125,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,69,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,1,0,60,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45126,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,1,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45127,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45128,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45129,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45130,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45131,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45132,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45133,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45134,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45135,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45136,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45137,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45138,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45139,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45140,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,89,0,,,,0,0,0,1,0,0,0,1,1,37,2,0,0,0,2,0,68,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45141,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45142,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45143,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45144,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45145,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45146,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45147,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45148,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,1,0,0,1,0,0,0,2,10,7,0,0,0,0,0,0,48,8,0,0,2,6
Study 22,EMEA,EST,Site 2151,Subject 45149,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,EST,Site 2151,Subject 45150,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45151,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45152,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45153,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45154,Unplanned visit (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45155,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45156,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45157,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,43,7,0,0,1,6
Study 22,EMEA,EST,Site 2151,Subject 45158,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45159,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45160,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45161,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45162,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45163,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45164,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45165,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45166,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45167,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45168,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45169,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45170,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45171,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45172,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45173,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45174,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45175,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45176,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45177,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45178,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45179,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45181,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45182,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45184,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45185,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45186,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45189,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45190,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45191,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45192,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45193,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45194,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45195,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45196,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45197,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45198,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45199,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45200,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45201,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45202,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,1,16,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45203,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45204,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45205,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45206,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45207,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,65,0,,,,0,0,0,0,0,0,0,0,0,18,0,1,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45208,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45209,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45210,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45211,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45212,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45213,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45214,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45215,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45216,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45217,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45218,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45219,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45220,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45221,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45222,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45223,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45224,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45225,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45226,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45227,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45228,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45229,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45230,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45231,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45232,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,10,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45233,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45234,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45235,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45236,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45237,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45238,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45239,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45240,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45241,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45242,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45243,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45244,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45245,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45246,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45247,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45248,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45249,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2151,Subject 45250,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45251,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,7,45,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45252,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45253,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45254,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45255,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45256,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45257,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45258,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,74,0,,,,0,0,0,0,0,0,0,0,1,26,1,0,0,0,1,0,61,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45259,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45260,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45261,Unplanned visit (1),Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45262,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45263,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45264,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45265,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,53,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,48,2,0,0,1,1
Study 22,EMEA,EST,Site 2152,Subject 45266,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45267,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45268,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45269,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45270,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45271,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,36,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,35,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45272,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2152,Subject 45273,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45274,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45275,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45276,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45277,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45278,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45279,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45280,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45281,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45282,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45283,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45284,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45285,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45286,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45287,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45288,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45289,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45290,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45291,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45292,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45293,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45294,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45295,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45296,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45297,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45298,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45299,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45300,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45301,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45302,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45303,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45304,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,69,0,,,,0,0,0,2,0,0,0,2,0,26,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45305,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45306,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45307,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45308,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45309,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45310,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45311,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45312,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,1,17,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45313,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45314,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,61,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45315,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45316,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,16,0,1,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45317,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45318,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45320,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45321,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45322,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45323,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45324,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45325,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45326,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45327,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45328,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45329,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,0,17,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45330,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45331,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45332,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45333,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,39,6,0,0,0,6
Study 22,EMEA,EST,Site 2153,Subject 45334,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45335,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45336,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45337,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45338,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45339,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45340,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45341,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45342,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45343,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45344,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45345,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2153,Subject 45346,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2154,Subject 45347,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,35,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,EST,Site 2154,Subject 45348,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2154,Subject 45349,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,5,0,0,0,5,0,6,0,0,0,0,0,0,37,2,0,0,1,1
Study 22,EMEA,EST,Site 2154,Subject 45350,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,1,14,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45351,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,5,73,0,,,,0,0,0,0,0,0,0,0,0,69,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45352,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45353,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45354,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45355,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45356,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45357,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45358,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45359,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45360,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,58,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45361,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45362,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45363,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45364,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45365,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45366,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45367,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,51,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45368,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45369,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45370,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45371,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45372,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45373,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,EST,Site 2155,Subject 45374,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,51,0,,,,0,0,0,1,0,0,0,1,4,10,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45375,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,9,44,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45376,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45377,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45378,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45379,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45380,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45381,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45382,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45383,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45384,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45385,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45386,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45387,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45388,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45389,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45390,Screening,Screen Failure,,,,,,,,,,1,7,0,,,,0,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,6,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45391,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45392,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45393,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45394,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,EST,Site 2156,Subject 45395,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45396,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,50,1,0,0,1,0
Study 22,EMEA,EST,Site 2157,Subject 45397,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,EST,Site 2157,Subject 45398,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,42,2,0,0,2,0
Study 22,EMEA,EST,Site 2157,Subject 45399,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45400,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45401,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45402,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,EST,Site 2157,Subject 45403,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45404,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,EST,Site 2157,Subject 45405,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45406,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45407,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45408,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45409,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45410,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45411,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,LVA,Site 2158,Subject 45412,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45413,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,16,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45414,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45415,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45416,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 2158,Subject 45417,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20748,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20749,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,44,1,0,0,0,1
Study 22,EMEA,LVA,Site 1359,Subject 20750,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20751,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20752,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20753,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20754,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20755,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20756,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20757,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,7,0,0,0,7
Study 22,EMEA,LVA,Site 1359,Subject 20759,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20760,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1359,Subject 20761,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1360,Subject 20813,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,7,37,0,0,0,0,0,0,37,1,0,0,0,1
Study 22,EMEA,LVA,Site 1360,Subject 20814,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,9,0,1,8
Study 22,EMEA,LVA,Site 1360,Subject 20815,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,35,0,10,0,3,7
Study 22,EMEA,LVA,Site 1360,Subject 20816,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,8,0,0,0,8
Study 22,EMEA,LVA,Site 1360,Subject 20817,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,1,6,0,1,6
Study 22,EMEA,LVA,Site 1360,Subject 20818,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,36,7,0,2,1,8
Study 22,EMEA,LVA,Site 1360,Subject 20819,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,28,6,0,10,3,13
Study 22,EMEA,LVA,Site 1360,Subject 20820,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,29,0,0,9,2,7
Study 22,EMEA,LVA,Site 1360,Subject 20821,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,29,0,0,9,2,7
Study 22,EMEA,LVA,Site 1360,Subject 20822,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,29,0,0,9,1,8
Study 22,EMEA,LVA,Site 1362,Subject 20854,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,0,54,0,0,0,0,1,0,53,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20855,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20856,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,46,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20858,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20859,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20860,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,61,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,3,0,0,2,1
Study 22,EMEA,LVA,Site 1362,Subject 20862,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20863,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20865,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20866,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20867,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,46,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20868,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20872,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20873,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20874,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20875,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,9,0,0,0,9
Study 22,EMEA,LVA,Site 1362,Subject 20876,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20877,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20878,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20879,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,55,0,,,,0,0,0,0,0,0,0,0,0,17,1,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20882,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20883,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,3,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20884,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20885,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20886,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20889,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20890,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20891,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20892,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20893,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20894,Screening,Screen Failure,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20895,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20896,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20897,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20898,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20899,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20900,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20901,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,7,0
Study 22,EMEA,LVA,Site 1362,Subject 20902,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LVA,Site 1362,Subject 20903,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20904,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20905,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20906,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20907,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,1,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,1,0,1,0
Study 22,EMEA,LVA,Site 1362,Subject 20908,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20909,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20910,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20911,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,43,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20912,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20913,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1362,Subject 20914,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,2,0,0,0,2
Study 22,EMEA,LVA,Site 1362,Subject 20915,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20940,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,51,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20941,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20942,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20943,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20944,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20945,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20946,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,LVA,Site 1363,Subject 20947,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20948,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20949,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20950,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20951,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20952,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20953,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20954,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20955,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20956,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20957,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20958,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20959,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20960,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 20961,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 45418,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 45419,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 45420,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 45421,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LVA,Site 1363,Subject 45422,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20962,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20963,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20964,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20965,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20966,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20967,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20968,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20969,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20970,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LVA,Site 1364,Subject 20971,Visit 1 (1),Discontinued,,,,,,,,,,2,21,0,,,,0,0,0,0,0,0,0,0,0,5,0,0,0,0,1,0,19,0,0,0,0,0
Study 22,EMEA,LVA,Site 1365,Subject 21027,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,47,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LVA,Site 1365,Subject 21028,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 3840,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 3841,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 3842,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 3843,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45423,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45424,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45425,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45426,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45427,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45428,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45429,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,4,0,0,0,4,1,24,0,0,0,0,0,0,61,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45430,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45431,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45432,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45433,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45434,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45435,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45436,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45437,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45438,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45439,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45440,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45441,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45442,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45443,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45444,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45445,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45446,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45447,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45448,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45449,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45450,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45451,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,56,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,54,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45452,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45453,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45454,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45455,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45456,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45457,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45458,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,2,14,0,0,0,0,0,0,56,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45459,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45460,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45461,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45462,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45463,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45464,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45465,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45466,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45467,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45468,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45469,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45470,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45471,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45472,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,72,0,,,,0,0,0,1,0,0,0,1,4,20,0,0,0,0,0,0,60,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45473,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45474,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45475,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45476,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45477,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45478,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45479,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45480,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45481,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45482,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45483,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,62,0,,,,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45484,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45485,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45486,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45487,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,66,0,,,,0,0,0,1,0,0,0,1,2,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45488,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45489,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45490,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45491,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45492,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45493,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45494,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45495,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45496,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,3,13,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45497,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45498,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45499,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45500,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45501,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45502,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45503,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45504,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45505,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,2,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45506,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45507,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45508,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45509,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,63,0,,,,0,0,0,1,0,0,0,1,0,19,0,0,0,0,0,0,53,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45510,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45511,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45512,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45513,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45514,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,2,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45515,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45516,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,0,0,0,0,0,1,13,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45517,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45518,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,42,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45519,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45520,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45521,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45522,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45523,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,0,0,0,0,0,0,15,0,0,0,0,1,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45524,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45525,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45526,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45527,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45528,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45529,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45530,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45531,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45532,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45533,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45534,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,1,0,0,0,1,0,15,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45535,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,3,0,0,0,3,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45536,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45537,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45538,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45539,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45540,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,2,0,0,0,2,0,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45541,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45542,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45543,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45544,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45545,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45546,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45547,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45548,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45549,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45550,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45551,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45552,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45553,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45554,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45555,Unplanned visit (1),On Trial,,,,,,,,,,4,55,0,,,,0,0,0,1,0,0,0,1,6,8,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45556,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45557,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45558,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45559,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45560,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45561,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 543,Subject 45562,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 3844,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 3845,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 3846,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 3847,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 3848,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21694,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21695,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21698,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21699,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21701,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21702,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,48,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21704,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21705,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21708,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,1,0,0,1,0,0,0,2,1,6,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21709,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21710,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,41,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21711,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21712,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21713,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21714,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 544,Subject 21715,Screening,Discontinued,,,,,,,,,,1,18,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,17,0,0,0,0,0
Study 22,EMEA,LTU,Site 545,Subject 3849,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,7,44,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 545,Subject 3850,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,3,0,0,0,3,8,7,0,0,0,0,0,2,48,0,0,0,0,0
Study 22,EMEA,LTU,Site 545,Subject 3851,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 545,Subject 21770,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 545,Subject 21771,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21818,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21819,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21820,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,51,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21821,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21822,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21823,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21824,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21825,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21826,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21827,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21828,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21829,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,40,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,1,0,1,0
Study 22,EMEA,LTU,Site 1388,Subject 21830,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,43,6,0,0,0,6
Study 22,EMEA,LTU,Site 1388,Subject 21831,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,6,0,0,6
Study 22,EMEA,LTU,Site 1388,Subject 21832,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21833,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21834,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21835,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,42,0,1,0,1,0
Study 22,EMEA,LTU,Site 1388,Subject 21836,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21837,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21838,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21839,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21840,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21841,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21842,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21843,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21844,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21845,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,17,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LTU,Site 1388,Subject 21846,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 3852,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,14,37,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21851,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21852,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21854,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21855,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,2,0,46,6,0,0,0,6
Study 22,EMEA,LTU,Site 546,Subject 21856,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21858,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21859,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21860,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21861,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21862,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21863,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21864,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21865,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21866,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21867,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21868,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21869,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21870,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21871,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21872,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21873,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21874,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21875,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,50,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21876,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21877,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21878,Visit 2 (Month 3) (1),Discontinued,,,,,,,,,,3,52,0,,,,0,0,0,0,0,0,0,0,0,16,1,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21879,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21880,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21881,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21882,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21883,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21884,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,43,1,0,0,1,0
Study 22,EMEA,LTU,Site 546,Subject 21885,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21886,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21887,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,37,0,6,0,0,6
Study 22,EMEA,LTU,Site 546,Subject 21888,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,LTU,Site 546,Subject 21889,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21890,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 21891,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45563,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45564,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45565,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45566,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 546,Subject 45567,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,LTU,Site 546,Subject 45568,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45569,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45570,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45571,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45572,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 546,Subject 45573,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 3853,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,50,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 3854,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,1,17,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 3855,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21892,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,55,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,54,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21893,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21894,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21895,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21896,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21897,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21898,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21899,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,51,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21900,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,65,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,58,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21901,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,1,0,56,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21902,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21903,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21904,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21905,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21906,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21907,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,64,0,,,,0,0,0,0,0,0,0,0,1,15,0,0,0,0,0,0,57,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21908,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,2,13,0,0,0,0,0,0,55,1,0,0,1,0
Study 22,EMEA,LTU,Site 547,Subject 21909,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21910,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21911,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21912,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21913,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21914,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21915,Visit 3 (Month 9) (1),Discontinued,,,,,,,,,,4,72,0,,,,0,0,0,0,0,0,0,0,0,27,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 21916,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,44,6,0,0,0,6
Study 22,EMEA,LTU,Site 547,Subject 45574,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,74,0,,,,0,0,0,2,0,0,0,2,1,24,0,0,0,0,0,1,60,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45575,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45576,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45577,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45578,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45579,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,7,0,0,1,6
Study 22,EMEA,LTU,Site 547,Subject 45580,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45581,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45583,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45584,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45586,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,44,0,0,1,1,0
Study 22,EMEA,LTU,Site 547,Subject 45587,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45588,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45589,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45590,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45591,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45592,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,67,0,,,,0,0,0,1,0,0,0,1,0,24,0,0,0,0,0,0,55,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45593,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45594,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45596,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45597,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,55,0,,,,0,0,0,1,0,0,0,1,0,14,0,0,0,0,0,0,49,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45598,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45599,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45600,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,48,1,0,0,1,0
Study 22,EMEA,LTU,Site 547,Subject 45601,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,0,9,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45602,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45603,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45604,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45605,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45606,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45607,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,1,0,0,0,1,1,15,0,0,0,0,0,0,49,1,0,0,1,0
Study 22,EMEA,LTU,Site 547,Subject 45608,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45609,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45610,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,60,0,,,,0,0,0,0,0,0,0,0,0,17,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45611,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45612,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45613,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45614,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45615,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45616,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45617,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45618,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45619,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45620,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45621,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45622,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45623,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45624,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45625,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45626,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45627,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45628,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45629,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45630,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45631,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45632,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,44,3,0,0,3,0
Study 22,EMEA,LTU,Site 547,Subject 45633,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,LTU,Site 547,Subject 45634,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45635,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 547,Subject 45636,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45637,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 547,Subject 45638,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,36,7,0,0,1,6
Study 22,EMEA,LTU,Site 547,Subject 45639,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,4,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,LTU,Site 547,Subject 45640,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,50,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,41,2,0,0,2,0
Study 22,EMEA,LTU,Site 547,Subject 45641,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45642,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,39,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45643,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45644,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45645,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45646,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45647,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45648,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45649,Unplanned visit (1),Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45650,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45651,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45652,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45653,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 547,Subject 45654,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,37,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,36,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21917,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21918,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21919,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21920,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21921,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,0,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21922,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,LTU,Site 1389,Subject 21923,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21924,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21925,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21926,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21927,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21928,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21929,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21930,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21931,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21932,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21933,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21934,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,1,0,0,0,1,1,6,0,0,0,0,0,0,39,5,0,0,0,5
Study 22,EMEA,LTU,Site 1389,Subject 21935,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,3,5,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 1389,Subject 21936,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,56,0,,,,0,0,0,2,0,0,0,2,9,6,0,0,0,0,0,0,47,2,0,0,2,0
Study 22,EMEA,LTU,Site 1389,Subject 21937,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,45,1,0,0,1,0
Study 22,EMEA,LTU,Site 1389,Subject 21938,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21939,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21940,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,LTU,Site 1389,Subject 21941,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21942,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21943,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21944,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21945,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21946,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1389,Subject 21947,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 3856,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,8,43,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 3857,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22030,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22031,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22032,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22033,Screening,Screen Failure,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,3,17,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22034,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22035,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,70,0,,,,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,0,62,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22036,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,2,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22037,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22038,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22039,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22040,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,0,0,44,6,0,0,0,6
Study 22,EMEA,LTU,Site 548,Subject 22041,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22042,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,63,0,,,,0,0,0,1,0,0,0,1,9,6,0,0,0,0,0,0,49,7,0,0,1,6
Study 22,EMEA,LTU,Site 548,Subject 22043,Visit 4 (Month 15) (1),Discontinued,,,,,,,,,,5,54,1,,,,0,0,0,1,0,0,0,1,10,4,0,0,0,0,0,0,46,1,0,0,1,0
Study 22,EMEA,LTU,Site 548,Subject 22044,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22045,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22046,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22047,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22048,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22049,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22050,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22051,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22052,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22053,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22054,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22055,Screening,Discontinued,,,,,,,,,,1,17,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,16,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22056,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22057,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22058,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22059,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,49,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,47,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22060,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,15,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22061,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22062,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22063,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22064,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22065,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 45655,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22066,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22067,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22068,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 548,Subject 22069,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22070,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22071,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22072,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,1,0,0,0,1
Study 22,EMEA,LTU,Site 548,Subject 22073,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 548,Subject 22074,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22075,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22076,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 548,Subject 22077,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22089,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,43,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22090,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22091,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22092,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22093,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22094,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22095,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22096,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22097,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22098,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22099,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22100,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22101,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22102,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22103,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22104,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22105,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22106,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22107,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,3,38,0,,,,0,0,0,0,0,0,0,0,2,4,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22108,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 1390,Subject 22109,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 3858,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,10,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45656,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45657,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,1,8,0,0,0,0,3,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45658,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45659,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45660,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,44,6,0,0,0,6
Study 22,EMEA,LTU,Site 549,Subject 45661,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,54,0,,,,0,0,0,0,0,0,0,0,2,7,0,0,0,0,1,0,45,5,0,0,0,5
Study 22,EMEA,LTU,Site 549,Subject 45662,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45663,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45664,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45665,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45666,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45667,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45668,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,1,0,0,0,1,3,14,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45669,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45670,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45671,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,11,1,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45672,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45673,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45674,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45675,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,58,0,,,,0,0,0,0,0,0,0,0,1,14,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45676,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45677,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,43,1,0,0,1,0
Study 22,EMEA,LTU,Site 549,Subject 45678,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45679,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45680,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45681,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,5,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,LTU,Site 549,Subject 45682,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45683,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 549,Subject 45684,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,1,5,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 3859,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 3860,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 3861,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 3862,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22179,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22180,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,15,31,0,0,0,0,0,0,44,1,0,0,1,0
Study 22,EMEA,LTU,Site 550,Subject 22181,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22182,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22183,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,1,44,1,0,0,1,0
Study 22,EMEA,LTU,Site 550,Subject 22184,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22185,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,4,4,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22186,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22187,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22188,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 22189,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45685,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45686,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45687,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45688,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,2,6,0,0,0,0,1,0,37,6,0,0,0,6
Study 22,EMEA,LTU,Site 550,Subject 45689,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,40,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45690,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45691,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,LTU,Site 550,Subject 45692,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,49,0,,,,0,0,0,1,0,0,0,1,1,13,0,0,0,0,0,0,41,1,0,0,1,0
Study 22,EMEA,LTU,Site 550,Subject 45693,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2159,Subject 45694,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,9,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,SWE,Site 2159,Subject 45695,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2159,Subject 45696,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,45,0,0,0,0,0,0,36,0,0,9,0,9
Study 22,EMEA,SWE,Site 1396,Subject 22317,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,14,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SWE,Site 1396,Subject 22318,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1396,Subject 22319,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,2,52,0,0,0,0,1,0,40,0,9,0,2,7
Study 22,EMEA,SWE,Site 1396,Subject 22320,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,35,0,7,0,0,7
Study 22,EMEA,SWE,Site 1396,Subject 22321,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 22369,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,12,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 22370,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 22371,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 22372,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 22373,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45697,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45698,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45699,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45700,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45701,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45702,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45703,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,59,0,,,,0,0,0,0,0,0,0,0,1,16,0,0,0,0,1,0,50,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45704,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45705,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,SWE,Site 1398,Subject 45706,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,38,7,0,0,1,6
Study 22,EMEA,SWE,Site 1398,Subject 45707,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,37,7,0,0,0,7
Study 22,EMEA,SWE,Site 1398,Subject 45708,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45709,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45710,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,67,0,,,,0,0,0,0,0,0,0,0,0,64,0,0,0,0,0,0,59,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45711,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,0,52,0,0,0,0,0,0,52,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45712,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,52,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,51,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45713,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45714,Visit 5 (Month 21) (1),On Trial,,,,,,,,,,6,53,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,0,0,45,6,0,0,0,6
Study 22,EMEA,SWE,Site 2160,Subject 45715,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45716,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45717,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45718,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45719,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45720,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45721,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45722,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45723,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45724,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45725,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45726,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45727,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45728,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45729,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45730,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45731,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45732,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45733,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45734,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45735,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45736,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45737,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45738,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45739,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45740,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45741,Screening,Screen Failure,,,,,,,,,,1,16,0,,,,0,0,0,0,0,0,0,0,0,2,16,0,0,0,0,0,15,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45742,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45743,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45744,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45745,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45746,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45747,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45748,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45749,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45750,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45751,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45752,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,57,0,,,,0,0,0,0,0,0,0,0,0,15,0,1,0,0,0,0,50,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45753,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45754,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45755,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45756,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45757,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,46,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45758,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,1,7,0,0,0,0,2,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45759,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45760,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45761,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,48,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,1,0,46,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45762,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45763,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45764,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45765,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45766,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45767,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45768,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45769,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45770,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45771,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45772,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45773,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45774,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45775,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45776,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45777,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45778,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,38,6,0,0,0,6
Study 22,EMEA,SWE,Site 2160,Subject 45779,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45780,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45781,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45782,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,41,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,40,0,0,0,0,0
Study 22,EMEA,SWE,Site 2160,Subject 45783,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,38,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22568,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22569,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22570,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22571,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22572,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22573,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,44,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,43,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22574,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22575,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,3,14,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22576,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22577,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22578,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22579,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22580,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22581,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22582,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22583,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22584,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22585,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22586,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22587,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22588,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22589,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 22590,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,2,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 45784,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,38,0,,,,0,0,0,0,0,0,0,0,0,6,0,0,0,0,0,0,37,0,0,0,0,0
Study 22,EMEA,SWE,Site 1402,Subject 45785,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 22591,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,10,13,0,0,0,0,0,12,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 22592,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 22593,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 22594,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45786,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45787,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,44,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45788,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45789,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45790,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45791,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45792,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45793,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45794,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45795,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45796,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45797,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45798,Screening,Screen Failure,,,,,,,,,,1,14,0,,,,0,0,0,0,0,0,0,0,0,2,14,0,0,0,0,0,13,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45799,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45800,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,45,0,,,,0,0,0,0,0,0,0,0,1,6,0,0,0,0,0,0,44,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45801,Screening,Screen Failure,,,,,,,,,,1,12,0,,,,0,0,0,0,0,0,0,0,0,2,12,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45802,Screening,Screen Failure,,,,,,,,,,1,15,0,,,,0,0,0,0,0,0,0,0,0,2,15,0,0,0,0,0,14,0,0,0,0,0
Study 22,EMEA,SWE,Site 1403,Subject 45803,Visit 3 (Month 9) (1),On Trial,,,,,,,,,,4,39,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,1,0,37,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22595,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,46,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22596,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,46,0,,,,0,0,0,0,0,0,0,0,0,7,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22597,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22598,Visit 4 (Month 15) (1),On Trial,,,,,,,,,,5,47,0,,,,0,0,0,0,0,0,0,0,0,8,0,0,0,0,0,0,45,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22599,Screening,Screen Failure,,,,,,,,,,1,13,0,,,,0,0,0,0,0,0,0,0,0,3,13,0,0,0,0,0,11,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22600,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
Study 22,EMEA,SWE,Site 1404,Subject 22601,Screening,Screen Failure,,,,,,,,,,1,11,0,,,,0,0,0,0,0,0,0,0,0,2,11,0,0,0,0,0,10,0,0,0,0,0
,,,1059,21558,Total:,,,,,,,,,,,82104,814058,40,,,,117,38,3,1928,110,0,14,Site 805,9807,161275,87116,Site 454,,,,,761591,Site 1557,1682,Site 381,1875,10557
,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
